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2OHOA 2-hydroxyoleic acid 
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ACL ATP citrate lyase 
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Akt Protein kinase B 
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CDK Cyclin-dependent kinases 
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EGFR Epidermal growth factor receptor 
ER Endoplasmic reticulum 
FAS Fatty-acid synthase 
FasR Fas ligand receptor 
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Resumen 
La mayoría de los fármacos utilizados actualmente en terapias humanas 
interactúan con proteínas, modificando su actividad y la de proteínas reguladas por 
ellas, produciendo cambios en la fisiología celular que revierten el proceso patológico. 
Sin embargo, los eventos de señalización celular, pueden verse afectados también por 
modificaciones de la composición lipídica de la membrana plasmática y su estructura. 
Tal participación en las funciones celulares, indica que los lípidos de membrana podrían 
constituir dianas de fármacos cuyo efecto estaría asociado a l a modulación de la 
composición y las propiedades fisicoquímicas de membrana. El ácido 2-hidroxioleico 
(2OHOA) es un fármaco antitumoral diseñado para regular la estructura y composición 
de los lípidos de membrana y la función de importantes proteínas de membrana. Como 
se ha demostrado en diferentes líneas de células tumorales, su mecanismo de acción 
involucra la inhibición de la proliferación celular, induciendo apoptosis o parada del 
ciclo celular seguida de diferenciación y autofagia. El objetivo principal de este trabajo 
fue estudiar cómo el 2OHOA modula la composición lipídica y la estructura de 
membrana en las células tumorales.  
Con el fin de estudiar el efecto del 2OHOA sobre la composición lipídica de la 
membrana, se analizaron los lípidos en células U118 de glioma humano tratadas con 
2OHOA (200µM, 72 h), mediante cromatografía en capa fina (TLC). Se observó que el 
2OHOA indujo profundas alteraciones en el contenido de fosfolípidos, aumentando 4,6 
veces el contenido de esfingomielina (SM), principalmente en la membrana plasmática, 
y disminuyendo el contenido de fosfatidiletanolamina (PE) y de fosfatidilcolina (PC), 
57 y 30%, respectivamente. Este efecto fue específico contra las células cancerosas, ya 
que el tratamiento no afectó la composición lipídica de las células no tumorales MRC-5 
de fibroblastos humanos. En este contexto, se observó que los niveles basales de SM de 
las células cancerosas eran aproximadamente la mitad que las células no tumorales; y 
que el aumento de SM inducido por el 2OHOA en las células cancerosas alcanzó 
niveles similares a los encontrados en las células no tumorales MRC-5. El aumento de 
SM se debió a u na activación rápida y específica de las SM sintasas (SMS). Cabe 
destacar que la inhibición farmacológica de la SMS con el inhibidor D609 disminuyó la 
capacidad del 2OHOA de inducir parada de ciclo celular. Como consecuencia de la 
activación sostenida de la SMS, todo el metabolismo de los esfingolípidos se vio 
afectado. Así, el análisis del contenido de esfingolípidos por espectrometría de masas de 
las células tumorales tratadas con 2OHOA, reveló la acumulación de esfingosina, 
dihidroesfingosina y de esfingolípidos que contenían ácido palmítico (C16-ceramida, 
C16-dihidroSM y C16-glucosilceramida). Cabe destacar que la esfingosina se genera 
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principalmente por la vía de reciclaje, mientras que la dihidroesfingosina se origina por 
la síntesis de novo de los esfingolípidos. Estos resultados confirmaron por tanto la 
desregulación del metabolismo esfingolipídico tras el tratamiento con 2OHOA, tanto 
por la activación de la síntesis de novo como de la vía de reciclaje. En concordancia con 
estos resultados, se observó un aumento del número de lisosomas, que son vesículas 
ácidas donde tiene lugar la vía de reciclaje; y la activación de la serin-palmitoil 
transferasa (SPT) que es la primera enzima de la síntesis de novo. 
Por otra parte, se analizó el efecto del 2OHOA sobre la composición de ácidos 
grasos de las células tumorales mediante cromatografía de gases. Los cambios más 
notorios fueron la disminución de ácido oleico (40-60%) y el aumento de ácido 
esteárico (60-90%). Estos cambios se relacionaron con la inhibición de la estearoil-CoA 
desaturasa (SCD1), que se considera como una nueva diana en la terapia contra el 
cáncer. Por otra parte, el análisis por espectrometría de masas mostró la incorporación 
de 2OHOA en distintas clases de lípidos (aprox. un 15% del total de ácidos grasos). Por 
último, el análisis de los lípidos neutros mediante TLC, mostró un aumento de 
diacilglicerol (DAG), ácidos grasos libres (FFA) y triacilglicerol (TAG). La 
acumulación de éstos últimos se relacionó con un aumento de vesículas lipídicas (LDs). 
Finalmente, se evaluó el impacto de todos estos cambios sobre las propiedades 
biofísicas de membrana mediante espectroscopia de fluorescencia. Para ello, se 
prepararon liposomas reconstituidos a partir de extractos lipídicos de células U118 
control y tratadas. Se observó que el tratamiento con 2OHOA indujo un aumento de la 
rigidez y compactación de los dominios ordenados, debido básicamente al aumento en 
el contenido de SM, mientras que disminuyó el orden global de la membrana, 
probablemente a casusa de los cambios que el tratamiento induce en la composición de 
ácidos grasos. 
Todas estas modificaciones inducidas por el 2OHOA, tanto en la composición 
como en la estructura de las membranas, explicarían las alteraciones observadas en la 
localización de proteínas implicadas en apoptosis celular (receptor Fas) y diferenciación 
(Ras). Teniendo en cuenta los resultados de este estudio, proponemos que niveles bajos 
de SM podrían ser críticos para el proceso de transformación tumorigénica; y que la 
regulación de la actividad de SMS en las células tumorales es un evento crítico en el 
mecanismo antitumoral del 2OHOA. Esta regulación explicaría además la capacidad de 
este compuesto para inducir parada del ciclo celular, diferenciación celular y autofagia o 
apoptosis en las células cancerosas. Debido a que el 2OHOA es un fármaco potente y 
específico para combatir los tumores, sin efectos secundarios a dosis terapéuticas, los 
datos mostrados aquí, no sólo presentan el primer activador de la SMS conocido, sino 
que también definen una diana molecular novedosa para el diseño de nuevos fármacos 
contra el cáncer. 
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Abstract 
Most drugs currently used for human therapy interact with proteins, altering their 
activity and that of downstream proteins, producing changes in the cell physiology that 
reverse the pathological process. However, it is known that changes in membrane lipid 
composition alter membrane structure, protein-membrane interactions and cell 
signaling. The participation of membrane lipids in cellular activities indicates that they 
might constitute targets for drugs whose pharmacological effects would be associated 
with the modulation of the composition and physicochemical properties of membranes. 
2-Hydroxyoleic acid (2OHOA) is a potent antitumor drug that was designed to regulate 
membrane lipid composition and structure and the function of important membrane 
proteins. As it was shown in different tumor cell lines, its mechanism of action involves 
impairment of cell proliferation. Thus, the main goal of this work was to study how 
2OHOA modulates the membrane lipid composition and structure of tumor cells.  
To address this question, we analyzed membrane lipids from human glioma 
U118 cells exposed to 2OHOA (200 µM, 72 h), by thin layer chromatography (TLC). In 
this context, 2OHOA induced dramatic alterations in phospholipid content, increasing 
sphingomyelin (SM) mass 4.6-fold, mainly at the plasma membrane, and decreasing 
phosphatidyl-ethanolamine (PE) and phosphatidylcholine (PC) mass, 57 a nd 30%, 
respectively. This effect was specific against cancer cells as it did not affect non-tumor 
MRC-5 cells. In this context, human cancer cells have markedly lower basal levels of 
SM than non-tumor cells and 2OHOA strongly augmented SM content, restoring the 
levels found in MRC-5 cells. The increased SM mass was due to a rapid and highly 
specific activation of SM synthases (SMS). Importantly, pharmacological inhibition of 
SMS by D609 diminished 2OHOA capability to induce the cell cycle arrest. As a 
consequence of the sustained activation of SMS, the whole sphingolipid metabolism 
was affected. Thus, the analysis by mass spectrometry showed the accumulation of 
sphingosine, dihydrosphingosine and palmitic acid-containing sphingolipids (C16-
ceramide, C16-dihydroSM and C16- glucosylceramide) after treatment with 2OHOA. It 
is worth to point out that sphingosine is mainly generated by the salvage pathway, while 
dihydrosphingosine is originated by the de novo synthesis of sphingolipids. Therefore, 
these results confirmed the deregulation of the sphingolipid metabolism induced by 
2OHOA, both by the activation of the de novo synthesis and the salvage pathway. 
Accordingly, 2OHOA induced the accumulation of lysosomes, acidic vesicles where the 
salvage pathway occurs; and the activation of the serin-palmitoyl transferase (SPT), the 
first enzyme of the de novo synthesis. 
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We also analyzed the effect of 2OHOA on fatty acid composition of tumor cells 
by gas chromatography. The most notorious changes were the decrease in oleic acid 
(40-60%) and the increase in stearic acid (60-90%). These changes were linked to the 
inhibition of stearoyl-CoA desaturase (SCD1), an emerging target in cancer therapy. In 
addition, mass spectrometry analysis showed the incorporation of 2OHOA into different 
lipid classes (ca. 15% of total fatty acids). Finally, the analysis of the neutral lipid 
fraction by TLC showed an increase in diacylglycerol (DAG), free fatty acids (FFA) 
and triacylglycerol (TAG), with the ensuing formation of lipid droplets (LDs). 
Then, the impact of all these changes on membrane biophysical properties was 
evaluated by fluorescence spectroscopy. Thus, the study of the biophysical properties of 
reconstituted liposomes from control and treated cells lipid extracts, showed that 
2OHOA induced an increased packing of the ordered domains, due to the substantial 
increase in SM content, while the global order of the membrane decreased, probably 
due to the global changes in fatty acid composition. 
These modifications would account for the observed alteration in the localization 
of proteins involved in cell apoptosis (Fas receptor) or differentiation (Ras) induced by 
2OHOA. Therefore, we propose that the regulation of SMS activity in tumor cells is a 
critical upstream event in 2OHOA antitumor mechanism and it also explains the ability 
of this compound to trigger cell cycle arrest, cell differentiation and autophagy or 
apoptosis in cancer cells. In addition, low SM levels would be associated with the 
tumorigenic transformation that produces cancer cells. Because 2OHOA is a potent and 
specific drug to combat tumors, with no side effects at therapeutic doses, the data 
presented not only introduce the first known activator of SMS but also, define a novel 
molecular target for the design of new drugs against cancer. 
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1 Introduction 
1.1 Cell membranes 
Biological membranes are composed of lipids, proteins and carbohydrates which 
together form hydrophobic barriers that limit the distribution of aqueous 
macromolecules and metabolites (Figure 1-1; Alberts, 1994; Tamm, 2005). Cells are 
bounded and defined by membranes, which have additional functions, such as 
segregation and protection from the environment, compartmentalization of functions, 
energy production, storage, protein synthesis and secretion, phagocytosis, movement 
and cell-cell interactions. In addition, eukaryotic cells contain ordered structures, called 
organelles, to organize and carry out complex processes and to enable distinct reactions 
that require a hydrophobic environment or specific molecular features not found in the 
cytosol. The level and complexity of compartmentalization varies among organisms and 
among mammalian cells (Fagone, 2009; van Meer et al., 2008). 
The versatility of biological membranes depends on their different lipid and 
protein composition, which dictate the membranes structure and biophysical properties. 
The functions of membranes require a certain fluid plasticity which is accomplished 
through alteration in lipid composition determined through regulation of de novo 
synthesis at designated cellular sites, selective distribution or trafficking to new sites, 
and by localized remodeling reactions. All these processes are highly regulated and 
therefore they allow cells the maintenance of a very diverse lipid composition, not only 
among different organisms, but also among different compartments within the same 
cells and between the two leaflets of the same membrane (Fagone, 2009).  
 
1.2 Membrane proteins 
Membrane proteins can be classified into integral and peripheral on the basis of 
the nature of the membrane–protein interactions (Figure 1-1; Lodish, 2008). Integral 
membrane proteins, also called transmembrane proteins, contain one or more 
hydrophobic regions that transverse the membrane bilayer and therefore these proteins 
become intimately exposed to membrane lipids. Such exposure results in a variety of 
lipid–protein interactions that are relevant to the membrane protein activity. Most 
transmembrane proteins are thought to extend across the bilayer as a single α helix or as 
multiple α helices (Escribá et al., 2008). For example, the epidermal growth factor 
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receptor (EGFR) is a tyrosine kinase receptor that consists of an extracellular portion 
that binds polypeptide ligands, a transmembrane helix, and a cytoplasmic portion that 
possesses tyrosine kinase catalytic activity (Hubbard & Till, 2000). Recently, it w as 
demonstrated that the ganglioside GM3 but no other related lipids strongly inhibited the 
autophosphorylation of the EGFR kinase domain, in liposomes with compositions that 
allow the separation of coexisting liquid domains (Coskun et al., 2011). 
Peripheral membrane proteins reversibly bind to membranes through their lipid 
co/post-translational modifications (a fatty acid chain or isoprenyl group), or specific 
amino acid regions that provide the appropriate context for electrostatic and/or 
hydrophobic interactions. These non-permanent membrane proteins are generally 
soluble and do not fold and assemble into membranes in a constitutive way, but they 
develop the ability to insert and/or translocate onto membranes under specific 
conditions, thereby remaining membrane bound, or returning promptly to the aqueous 
medium where they belong (Escribá et al., 2008). Non-permanent membrane proteins 
may be classified either according to the reversibility of the membrane contact, or to the 
nature (strength) of their interaction with the host membrane (Goñi, 2002). This class of 
proteins is relevant in the context of signal transduction and cellular physiology because 
they can propagate messages from the plasma membrane to intracellular membranous or 
aqueous compartments (Escribá et al., 1995; Vance & Vance, 1996). In this regard, 
small GTPases exhibit continuous dynamic interactions with the internal leaflet of the 
plasma membrane by specific lipid modifications and/or polybasic clusters. For 
example, all Ras proteins contain a C -terminal motif that undergoes posttranslational 
prenylation by the stable linkage of a farnesyl moiety. Some members of the Ras family 
also contain one (N-Ras) or two (H-Ras) palmitoyl moieties or a six-lysine polybasic 
cluster (K-Ras) that interacts electrostatically with negatively-charged phospholipids 
(Eisenberg & Henis, 2008). Prenylation alone excludes proteins from raft-like domains, 
while dual acylation (S-palmitoyl and/or N-myristoyl residues) leads to association with 
raft domains. However, when activated, Ras proteins are predominantly non-raft 
residents (Niv et al., 2002; Prior et al., 2003).  
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Figure 1-1. Schematic illustration of a biomembrane. 
The diagram depicts the membrane lipid asymmetry as well as microdomains enriched in particular lipids and 
those induced by membrane proteins. It also shows how various classes of proteins associate with the lipid 
bilayer. Further from the membrane are membrane associated proteins including the cytoskeleton and the 
extracellular matrix (Pearson Education, 2008). 
 
1.3 Membrane lipids 
1.3.1 Lipid repertoire in nature 
Eukaryotic cells invest substantial resources in generating thousands of different 
lipids (van Meer et al., 2008). The lipidome of a particular cell is constituted by the 
myriad of lipid species present in it. An extraordinary structural variety exists within 
each class so that hundreds of individual lipid species and tens of thousands of 
subspecies exist within each cell (Futerman & Hannun, 2004). Thus, the first goal of 
lipidomics analyses is to define and quantify all of these lipid molecular species in a cell 
(Dennis, 2009; Han, 2007). Secondly, lipidomics seeks a comprehensive understanding 
of the influence of all lipids on a biological system with respect to cell signaling, 
membrane architecture, transcriptional and translational modulation, cell-cell and cell-
protein interactions, and response to environmental changes over time. Recent advances 
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in soft-ionization mass spectrometry, combined with established separation techniques, 
have allowed the rapid and sensitive detection of a variety of lipid species with minimal 
sample preparation (Watson, 2006). 
LIPID Metabolites And Pathways Strategy (LIPID MAPS, www.lipidmaps.org) 
is a multi-institutional effort created in 2003 to identify and quantify, using a systems 
biology approach and sophisticated mass spectrometers, all major — and many minor 
— lipid species in mammalian cells, as well as to quantify the changes in these species 
in response to perturbation. The ultimate goal of their research is a better understanding 
of lipid metabolism and the active role that lipids play in diabetes, stroke, cancer, 
arthritis, Alzheimer's disease and other diseases in which lipids may have a relevant 
role, to facilitate the development of more effective treatments.  
The LIPID MAPS Initiative in conjunction with the International Committee for 
the Classification and Nomenclature of Lipids have developed a “Comprehensive 
Classification System for Lipids”, published in 2005, that have defined eight categories 
of lipids and numerous classes and subclasses to allow the description of lipid molecular 
species. The major categories of lipids present in mammals are: fatty acyls, 
glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, and prenol lipids 
(Figure 1-2; Fahy et al., 2005; Fahy et al., 2009). 
The fatty acyl structure represents the major lipid building block of complex 
lipids and therefore is one of the most fundamental categories of biological lipids. 
However, only traces of free fatty acids are present in free form in tissues and cells. The 
fatty acyl group is characterized by a r epeating series of methylene groups that are 
esterified to the backbone structure of the complex lipids through ester or amide bonds 
and provides hydrophobic character to this category of lipids. The fatty acids differ 
from each other with respect to their hydrocarbon chain length (C4-C36), the degree of 
unsaturation (number of double bonds), which also governs their physical properties 
and of the lipid that contains them, and the substitution at one or more methyl groups 
(Table 1-1; Prasad, 1996). The hydrocarbon chain of the fatty acid may contain one 
(monounsaturated) or more (polyunsaturated) double bonds. The configuration of the 
double bond is mostly cis- which provides a rigid kink of 30° in the hydrocarbon chain, 
whereas the trans- configuration results in an extended chain structure. 
Glycerolipids essentially encompass all glycerol-containing lipids. It is 
purposely a separate category because of their abundance and importance as membrane 
constituents, metabolic fuels, and signaling molecules. The glycerolipid category 
includes mono-, di- and tri-substituted glycerols (MAG, DAG and TAG, respectively), 
the most well-known being the fatty acid esters of glycerol (acylglycerols), but also 
include alkyl and 1Z -alkenyl variants (Coleman & Lee, 2004). TAG formation occurs 
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as an energy storage and lipid-neutralizing mechanism in response to fatty acid 
accumulation within the cell. When this is the case, three fatty acids and one glycerol 
molecule are bound together to form TAG, which, along with cholesterol, are stored in 
lipid droplets (LDs). 
 
Figure 1-2. Summary of the structural diversity of the most common lipid species (Sud et al., 2006). 
 
Glycerophospholipids (also called phospholipids) are ubiquitous in nature and 
are key components of the lipid bilayer of cells. Phospholipids may be subdivided into 
distinct classes based on the nature of the polar “head group” at the sn-3 position of the 
glycerol backbone in eukaryotes and eubacteria or the sn-1 position in the case of 
archaebacteria (Pereto et al., 2004). Phospholipids include: glycerophosphocholine 
(PC), glycerophosphoethanolamine (PE), glycerophosphoserine (PS), glycerophospho-
inositol (PI), glycerophosphoglycerol (PG), phosphatidic acid (PA; Fahy et al., 2009). 
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Cardiolipin (CL) is a glycerolphospho-glycerophosphoglycerol, where a third glycerol 
unit is typically acylated at the sn-1’ and sn-2’ positions to create a pseudosymmetrical 
molecule. In addition, plasmalogens are vinyl-ether linked at the sn-1-position of 
glycerophospholipids and contribute almost 18% to the total lipid mass in humans 
(Fagone, 2009). Lysophospholipids, such as lysophosphatidylcholine (LPC), are 
produced when phospholipase A2 (PLA2) catalyzes the hydrolysis of the fatty acyl ester 
bond at the sn-2 position of glycerophospholipids. LPC has been implicated in several 
types of cell death, as an effector in the lipoapoptosis of hepatocytes (Han et al., 2008). 
Sphingolipids are a complex family of compounds that share a common 
structural feature, a sphingoid base backbone that is synthesized de novo from serine 
and a long chain fatty acyl-CoA, and then converted into ceramides (Cer), 
phosphosphingolipids, glycosphingolipids (GSLs), and other species (Chapter 2). The 
major sphingolipids in mammalian cells are sphingomyelin (SM) and GSLs, which 
contain mono-, di- or oligosaccharides based on glucosylceramide (GlcCer) and 
sometimes galactosylceramide (GalCer). Gangliosides are GSLs with terminal sialic 
acids (Vance & Vance, 1996). Besides playing structural roles in cellular membranes, 
some metabolites including Cer, ceramide-1-phosphate (C1P), sphingosine (Sph) and 
sphingosine-1-phosphate (S1P), have drawn attention as bioactive signaling molecules 
involved in regulation of cell growth, differentiation, senescence, and apoptosis (Bartke 
& Hannun, 2009). 
Sterol lipids are the main non-polar lipids of cell membranes: cholesterol 
predominates in mammals whereas ergosterol predominates in yeast and phytosterol in 
plants. Cholesterol itself and isoprenoid intermediates in cholesterol synthesis are 
biosynthetic precursors of steroid hormones, bile acids, lipid-soluble vitamins, and 
numerous other bioactive molecules (Lodish, 2008). As it will be explained later, 
cholesterol is critical for membrane fluidity regulation. These lipids share a common 
biosynthetic pathway with prenol lipids via the polymerization of dimethylallyl 
pyrophosphate/isopentenyl pyrophosphate but have obvious differences in terms of their 
eventual structure and function (Watson, 2006). 
 
  
Table 1-1. Some common fatty acids. 
Systematic name Common name Carbon Skeleton Structure 
Saturated  
n-Dodecanoic acid  Lauric acid 12:0 CH3(CH2)10COOH 
n-Tetradecanoic acid Myristic acid 14:0 CH3(CH2)12COOH 
n-Hexadecanoic acid Palmitic acid (PA) 16:0 CH3(CH2)14COOH 
n-Octadecanoic acid Stearic acid (SA) 18:0 CH3(CH2)16COOH 
n-Eicosanoic acid  Arachidic acid 20:0 CH3(CH2)18COOH 
n-Docosanoic acid Behenic acid 22:0 CH3(CH2)20COOH 
n-Tetracosanoic acid  Lignoceric acid 24:0 CH3(CH2)22COOH 
Unsaturated  
cis-9-Hexadecenoic acid  Palmitoleic acid  16:1(Δ9) CH3(CH2)5CH=CH(CH2)7COOH 
cis-9-Octadecenoic acid Oleic acid (OA) 18:1(Δ9) CH3(CH2)7CH=CH(CH2)7COOH 
cis-,cis-9,12-Octadecadienoic 
acid 
Linoleic acid (LA) 18:2(Δ9,12) CH3(CH2)4CH=CHCH2CH=CH(CH2)7COOH 
cis-,cis-,cis-9,12,15- 
Octadecatrienoic acid 
α-Linolenic acid 
(ALA) 
18:3(Δ9,12,15) CH3CH2CH=CHCH2CH=CHCH2CH=CH(CH2)7COOH 
cis-,cis-,cis-6,9,12- 
Octadecatrienoic acid 
γ-Linolenic acid 
(GLA) 
18:3(Δ6,9,12) CH3(CH2)4CH=CHCH2CH=CHCH2CH=CH(CH2)4COOH 
cis-,cis-,cis-,cis-5,8,11,14- 
Icosatetraenoic acid 
Arachidonic acid 
(ARA) 
20:4(Δ5,8,11,14) CH3(CH2)4CH=CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)3COOH 
cis-,cis-,cis-,cis-,cis-
5,8,11,14,17- 
Eicosapentaenoic acid 
Eicosapentaenoic acid 
(EPA) 
20:5(Δ5,8,11,14,17) CH3CH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)3COOH 
cis-,cis-,cis-,cis-,cis-
4,7,10,13,16,19- 
Docosahexaenoic acid 
Docosahexaenoic acid 
(DHA) 
22:6(Δ4,7,10,13,16,19) CH3CH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CHCH2CH=CH(CH2)2COOH 
(Adapted from Lehninger et al., 2005; Prasad, 1996). 
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1.3.2 Lipid functions 
Lipids fulfill three general functions: (i) they serve as an efficient source of 
energy; (ii) they form cell membranes that contain bipolar lipids such as 
glycerophospholipids and sphingolipids; and (iii) they serve as messengers during 
cellular signal transduction (van Meer et al., 2008). An additional function, related to 
membrane lipid organization, has been proposed (Escribá et al., 2008; Escribá et al., 
1997; Escribá et al., 1995). Lipids by themselves can induce the organization of 
membrane lipids into microdomains with different structure that act as spatial/temporal 
platforms that control the interaction of cell signaling proteins and tune the type and 
extent of messages propagated into the cells. This function of membranes will be 
addressed later in the present work. 
First, because of their relatively reduced state, lipids are used for energy storage 
in LDs, which are cytosolic organelles present in all cell types, consisting of a 
hydrophobic core of TAG and cholesteryl esters, surrounded by a monolayer of 
phospholipids and cholesterol with associated proteins. De novo formation of LDs is 
tightly connected to the endoplasmic reticulum (ER) but the molecular mechanism 
involved in this process remains unsolved (Digel et al., 2010; Walther & Farese, 2009). 
LDs are considered storage organelles for energy generation and membrane-building 
blocks (fatty acids and sterols), although new roles in protein storage and sorting have 
been proposed recently (Welte, 2007). In the last years, LDs have been recognized as 
highly relevant for widespread and serious human diseases like diabetes type II, 
hepatosteatosis and atherosclerosis (Digel et al., 2010). 
Second, cell membranes are formed by polar lipids, mainly organized in bilayer 
structures with a hydrophobic and a hydrophilic region. The propensity of the 
hydrophobic moieties to self-associate (entropically driven by water), and the tendency 
of the hydrophilic moieties to interact with aqueous environments and with each other, 
constitute the physical basis of the spontaneous formation of membranes. This 
fundamental principle of amphipathic lipids is a c hemical property that possibly 
enabled the first cells to segregate their internal constituents from the external 
environment. This same principle is recapitulated within the cell to produce discrete 
organelles (van Meer et al., 2008).  
Finally, lipids can act as first and second messengers in signal transduction and 
molecular recognition processes. These include Cer, C1P, Sph and S1P, which are 
potent messenger molecules involved in the regulation of cell growth and apoptosis; 
DAG and inositol phosphate derivatives (PIPs) are involved in calcium-mediated 
activation of protein kinase C and other phenomena; prostaglandins are one type of 
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fatty-acid derived eicosanoid involved in inflammation and immunity; and steroid 
hormones such as estrogen, testosterone and cortisol, which modulate a wide range of 
functions such as reproduction, metabolism and blood pressure (The LIPID MAPS–
Nature Lipidomics Gateway, www.lipidmaps.org). 
 
1.3.3 Membrane lipid structure 
The fluid mosaic model of the structure of cell membranes proposed by Singer 
and Nicolson (1972), implied an homogeneous lateral distribution of the bulk of lipids. 
This model proved to be a very useful hypothesis in explaining many, but certainly not 
all, phenomena taking place in biological membranes. However, new experimental data 
has allowed the extension of the model, showing additional structural and functional 
aspects of membrane organization (Vereb et al., 2003). Therefore, according to the 
extended model, the mosaic is configured not only by different proteins on membranes, 
but also by (i) the different protein and lipid composition of outer and inner leaflets of 
the plasma membrane, (ii) regions enriched in certain protein and lipid species, and (iii) 
local (domain-restricted) membrane functions provided by the discrete localization of 
membrane proteins and lipids and by the lipid polymorphism (Figure 1-1; Escribá et al., 
1997). 
Hence, one essential feature of membranes is the asymmetric distribution of 
lipids and proteins both laterally and between the two bilayer leaflets. Whereas the 
plasma, Golgi, and endosomal membranes display an asymmetric lipid distribution; in 
the ER, where most lipids are synthesized, lipids are symmetrically distributed between 
the two leaflets. In the plasma membrane, for example, choline-containing lipids such as 
PC and SM, as well as GSLs are enriched in the non-cytosolic (external leaflet and 
luminal side), whereas PS and PE are enriched in the cytosolic leaflet. Minor lipids such 
as PI and PA are predominantly in the cytosolic leaflet, where they participate in cell 
signaling (Figure 1-3; Devaux & Morris, 2004). Maintaining the differences in lipid 
composition between organelles and between the two leaflets of individual organelle 
membranes requires selectivity and directionality, which are provided by various 
transport mechanisms. In this regard, membrane lipids may be subject to two kinds of 
movement: flip–flop across the membrane from one to another monolayer and diffusion 
out of the membrane into the aqueous phase, followed by insertion into another 
membrane (Holthuis & Levine, 2005). Within the same membrane, lipids are 
transported to or segregated into one of the two leaflets of the membrane by virtue of 
their chemical structure or by the action of enzymes called flippases, whose function is 
to favor (energy-independent, mainly in the ER) or force the movement (energy-
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dependent, mainly at the plasma membrane) of specific lipids between the two leaflets 
of the membrane (van Meer et al., 2008). Some lipids are transported by vesicular 
pathways, as in the case of SM that cannot flip and travels in the luminal leaflet of the 
vesicles. The asymmetric distribution of lipids has important functional consequences. 
For example, when exposed on the cell surface, PS acts as susceptibility signal for 
phagocytosis and as a p ropagation signal in blood coagulation. The loss of 
transmembrane lipid asymmetry and the concomitant exposure of PS to the external 
milieu also occurs upon induction of programmed cell death (apoptosis; Fadok et al., 
1992). 
 
Figure 1-3. Asymmetric distribution of glycerophospholipids between the inner and 
outer monolayers of erythrocyte plasma membrane (Lehninger et al., 2005). 
 
The lateral asymmetry is achieved by lateral diffusion in the two-dimensional 
plane of the membrane and the subsequent differentiation of membrane regions (basal, 
lateral, apical) and specialized membrane microdomains such as lipid rafts, caveolae, 
coated pits, synaptosomes, etc. (Escribá, 2006; Lingwood & Simons, 2010). Within 
such domains there is not only an enrichment of particular lipids and proteins, but their 
rotational movement may be different from that of molecules in other domains. In this 
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regard, fluidity is one of the most important biophysical properties of membrane lipids 
and together with the cross-sectional area, electric charge, surface packing, molecular 
weight and nonlamellar-phase propensity, contribute to the curvature stress in 
biomembranes (Escribá, 2006). Membrane fluidity depends on the phase behavior of the 
lipids, which are not covalently bound in membranes but rather interact dynamically to 
form transient arrangements whose stability can vary. Biological membrane lipids can 
exist in multiple possible phase states (Figure 1-4). All lamellar states are the most 
relevant to cell biomembranes, where lipids can adopt fluid and solid phases, which are 
characterized by a d ifferent spatial arrangement and motional freedom of each lipid 
with respect to its neighbors (Figure 1-4B; van Meer et al., 2008). The fluidity of 
individual lipid molecules changes with the temperature. This response is known as the 
phase behavior of the bilayer. At a given temperature a lipid bilayer can exist in either a 
liquid or a solid phase. All lipids have a ch aracteristic melting temperature (Tm) at 
which they undergo a transition from the gel to liquid phase and this temperature is 
affected by the acyl-chain length and unsaturation degree. Non-bilayer lipid phases, 
such as hexagonal and cubic phases (not shown), may relate to transient biomembrane 
events, such as membrane fusion, fission and pore formation. 
The fluid lamellar phase called liquid disordered (ld), is currently acknowledged 
as the structure found in most membrane regions. In ld structures, the hydrocarbon 
chains that form the membrane core, exhibit a high level of mobility as illustrated in 
Figure 1-4B (Escribá, 2006). Under different conditions, lipids can organize into more 
ordered bilayers, such as the solid ordered (so) or gel structure. As indicated above, the 
degree of fatty acyl chains saturation influences the physical properties of the 
compound that contains them. Thus, SM contains long, saturated (or trans-unsaturated) 
hydrocarbon chains, with high Tm, so that SM-rich mixtures tend to form these so 
phases. However, biomembrane glycerophospholipids contain mainly cis-unsaturated 
hydrocarbon chains, with low Tm, thus they are abundant in liquid phases. Within the 
membrane glycerophospholipids, PC self-organizes spontaneously as a planar bilayer, 
less tightly than SM, in which each PC has a nearly cylindrical molecular geometry, 
with the lipidic tails facing each other and the polar headgroups interfacing with the 
aqueous phase (Vance & Vance, 1996). In the liquid-ordered (lo) phase, the acyl chains 
of lipids are extended and tightly packed as in the gel phase, but they have a higher 
degree of lateral mobility. Generally, the lo phase represents lipid rafts in model 
membranes, since lipid rafts segregate from the rest of the membrane, forming defined 
domains. Sterols by themselves do not form bilayer phases, but together with a bilayer-
forming lipid, they can organize into lo phases, regulating their fluidity (Castro et al., 
2009). However, not all sterols have the ability to induce the formation of lo phases or 
lipid rafts. While cholesterol is responsible for the lo domain formation in mammals and 
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ergosterol in yeast, some other sterols such as zymosterol do not form lo domains 
(Megha et al., 2006). Membrane rafts are defined as small (10-200 nm), heterogeneous, 
highly dynamic, sterol- and sphingolipid enriched domains that compartmentalize 
cellular processes. Small rafts can sometimes be stabilized to form larger platforms 
through protein-protein and protein-lipid interactions (Lingwood & Simons, 2010; Pike, 
2006). 
 
Figure 1-4. Membrane lipid structure. 
Examples of lipid shapes and their influence on membrane structure. (A) (a) and (b) GPs in which the polar 
head group and the fatty acid chains have similar sizes adopt a cylindrical shape in membranes (solid circles 
symbolize the polar head groups; wavy lines represent the fatty-acid chains). Lipids with a small polar head 
have a molecular shape that resembles a truncated cone. They induce a negative curvature strain, favoring the 
reorganization of membranes into inverted micelles and HII phases in general. Lipids with a bulky polar head 
and only one acyl chain have a molecular shape similar to an inverted cone and induce a positive curvature 
strain in membranes (HI phases). PLA2, phospholipase A2; LPAT, lysophospholipid acyl transferases. c) The 
two steps of membrane fusion: left, during stalk formation, two adjoining membranes merge their outer 
leaflets producing a negatively curved monolayer region (red) that is facilitated by cone-shaped lipids; right, 
widening of the stalk generates a fusion pore that is lined by a positively curved monolayer region (blue). (B) 
Lipid phases in membranes. All membrane phase behaviors that have been observed are characteristic of the 
corresponding lipids. S, the order parameter of a segment of acyl chain; and DT, the translational diffusion 
coefficient (Adapted from Escribá, 2006; Piomelli et al., 2007; van Meer et al., 2008). 
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Non-lamellar prone glycerophospholipids add versatility to lipid structures. 
Lipid curvature stress controls the organization of lipids into different types of 
hexagonal phases (HI and HII; Figure 1-4A). Lipids with a small polar headgroup, such 
as PE, have a molecular shape that resembles a t runcated cone. These lipids induce a 
negative curvature strain, which favors the reorganization of membranes into inverted 
micelles (HII phases). The inclusion of PE in PC bilayers imposes a cu rvature stress 
onto the membrane, which is used for budding, fission and fusion (Piomelli et al., 
2007). Non-bilayer lipids like PE and CL may also be used to accommodate membrane 
proteins, which may stabilize the bilayers, and modulate their activities. Lipids with a 
bulky polar head and only one acyl chain (e.g. lysophospholipids) have a molecular 
shape that is similar to an inverted cone and induce a p ositive curvature strain in 
membranes. In this case, they favor the formation of tubular (HI) or spherical micelles. 
In this context, lipid hydrolases, such as PLA2 convert phospholipids into conical (fatty 
acid) and inverted conical (lysophospholipid) products, whereas fatty acid transferases 
such as lysophospholipid acyl transferases catalyze the opposite reaction. 
 
1.3.4 Lipid metabolism 
The ER and Golgi apparatus together constitute the endomembrane compartment 
in the cytoplasm of eukaryotic cells, where not only lipids but also membrane-bound 
proteins and secretory proteins are synthesized (Fagone, 2009). The ER produces the 
bulk of the structural glycerophospholipids, such as PC, PE, PI, PS and PA; as well as 
cholesterol, Cer (which is the precursor for complex sphingolipids) and significant 
levels of TAG and cholesteryl esters (Figure 1-5; van Meer et al., 2008). 
For the biosynthesis of glycerolipids, glycerophospholipids and cholesterol 
esters, fatty acids first need to be activated as acyl-coenzyme A (CoA), produced by one 
of several long-chain or very-long-chain acyl-CoA synthases (Coleman et al., 2002; 
Kornberg & Pricer, 1953). Then, acyl-CoA can be used as donors, to form glycerolipids 
and glycerophospholipids by a de novo pathway (Kennedy pathway) or be modified by 
a remodeling pathway (Lands’ cycle) to generate membrane asymmetry and diversity. 
This remodeling pathway involves the rapid turnover of the sn-2-acyl moiety of 
glycerophospholipids by the concerted and coordinated actions of PLA2 and 
lysophospholipid acyltransferases (Lands, 2000; Shimizu et al., 2006). It is worth to 
mention that saturated fatty acids (SFA) are usually esterified at the sn-1-position, 
whereas unsaturated acyl groups are esterified at the sn-2-position (Shindou & Shimizu, 
2009). 
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In the de novo pathway, 1-acyl-sn-glycerol-3-phosphate (lysophosphatidate, 
LPA) is first formed from glycerol 3-phosphate by the glycerol-3-phosphate 
acyltransferase (GPAT), which attaches a fatty acyl moiety to the sn-1 position (Figure 
1-6; Coleman & Lee, 2004; Shindou & Shimizu, 2009). Next, LPA is converted to PA 
by the acyl-CoA:1-acylglycerol-sn-3-phosphate acyltransferase (AGPAT, also called 
lysophosphatidate acyltransferase or LPAAT), which attaches a fatty acyl moiety to the 
sn-2 position. GPAT and AGPAT activities are associated with the ER and the 
mitochondria (Athenstaedt & Daum, 1999). In the ER, PA is metabolized into two types 
of glycerol derivatives. By the phosphatidic acid phosphatase enzymes (PAP), PA is 
dephosphorylated to yield DAG, which is then converted to TAG, PC and PE. The other 
glycerol derivative is cytidine diphospho-DAG (CDP-DAG), which is transformed into 
the acidic phospholipids PI, PG and CL (Heacock & Agranoff, 1997). The GPAT and 
AGPAT association with the mitochondria indicates that these activities provide the PA 
precursor (CDP-DAG) for the synthesis of PG and CL located at the same site. CL is 
present only in the mitochondria, where it is absolutely required for energy production, 
and its synthesis is restricted to the inner mitochondrial membrane (Schlame et al., 
2000). Approximately 45% of the phospholipid in mitochondria (mostly PE, PA and 
CL) is autonomously synthesized by the organelle (Fagone, 2009; van Meer et al., 
2008). In turn, PA can be synthesized from DAG by diacylglycerol kinase, which is 
believed to generate a PA as a signaling molecule rather than a p recursor for TAG 
biosynthesis (Martelli et al., 2002). 
PC is the most abundant glycerophospholipid species in mammalian cells, 
(~50% of glycerophospholipid mass), and it is synthesized in the ER and Golgi 
apparatus (Figure 1-5). Two biosynthetic pathways are available for PC synthesis and 
are located in different endomembrane domains. The Kennedy pathway is the 
predominant route to PC in most cells, and the final step is catalyzed either by the 
bifunctional diacylglycerol choline/ethanolamine phosphostransferase (CEPT), which is 
located in the ER, or alternatively by the diacylglycerol choline phosphostransferase 
(CPT), which is located in the Golgi apparatus (Henneberry et al., 2002; Vance et al., 
1997). Both the CEPT and the CPT use DAG and CDP-choline to form PC. The rate-
limiting step for PC synthesis is catalyzed by the amphitropic CTP:phosphocholine 
cytidylyltransferase α (CCT), which is found in the nucleus in most cell types, 
immediately upstream of CEPT and CPT, and it translocates from a s oluble nuclear 
location to the nuclear membrane in response to activators of the CDP-choline pathway 
(Henneberry et al., 2002). Phosphatidylethanolamine N-methyltransferase (PEMT) 
converts PE to PC and is associated with mitochondria-associated membranes. PEMT is 
generally considered to be a liver-specific enzyme although there is PE methylation 
activity (1% or less of that recovered from rat liver microsomes) in various other cells 
1 Introduction 
23 
and tissues (Vance & Ridgway, 1988). PE is the second most abundant 
glycerophospholipid species (~25% of glycerophospholipid mass), and its de novo 
synthesis can be catalyzed by CEPT using CDP-ethanolamine, located in the ER. PE 
can also arise from head-group exchange with PS in the ER as mediated by 
phosphatidylserine synthase 2 (PSS2) or in the mitochondria by PS decarboxylation, 
mediated by phosphatidylserine decarboxylase.  
 
Figure 1-5. Lipid synthesis and steady-state composition of cell membranes. 
The lipid composition of different membranes varies throughout the cell. Lipid composition data (shown in 
graphs) are expressed as a percentage of the total glycerophospholipid in mammals (blue) and yeast (light 
blue). The molar ratio of cholesterol and ergosterol to glycerophospholipid is also included. The figure shows 
the site of synthesis of the major glycerophospholipids (blue) and lipids that are involved in signaling and 
organelle recognition pathways (red). It should be appreciated that the levels of signaling and recognition 
lipids are significantly below 1% of the total glycerophospholipid, except for Cer (van Meer et al., 2008). 
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By contrast with PC and PE, PS is synthesized in the ER or the Golgi apparatus 
through head-group exchange of already-made PC and PE as catalyzed by PSS1 and 
PSS2, respectively (Vance, 2008). PI is also synthesized in the ER by the CDP-
diacylglycerol-inositol 3-phosphatidyltransferase, and its conversion into highly 
phosphorylated forms, which play critical roles in signaling and membrane vesicle 
trafficking, occurs outside the ER (Antonsson, 1997). Phosphoinositides identify 
endocytic membranes and allow them to recruit proteins from the cytosol that are 
involved in this process. A dedicated system of kinases and phosphatases produces and 
hydrolyses specific phosphoinositides, including phosphatidylinositol-(4,5)-
bisphosphate (PI(4,5)P2) in the plasma membrane, phosphatidylinositol-trisphosphate 
(PI3P) on early endosomes, phosphatidylinositol-(3,5)-bisphosphate (PI(3,5)P2) on late 
endosomes and PI4P on the (trans)-Golgi network (Di Paolo & De Camilli, 2006). 
Plasmalogen synthesis occurs in peroxisomes. Among plasmalogens, 
plasmenylethanolamine is the most abundant and it is also the precursor of 
plasmenylcholine (Fagone, 2009). 
TAGs are also synthesized in the ER and in the plasma membrane either by the 
Kennedy pathway or the MAG pathway (Yen et al., 2008). While the glycerol 
phosphate pathway is present in most cells, the MAG pathway is found in specific cell 
types, such as enterocytes, hepatocytes, and adipocytes, where it may participate in the 
reesterification of hydrolyzed TAG. In the final reaction of both pathways, a fatty acyl-
CoA and DAG are covalently bound to form TAG. This reaction is catalyzed by acyl-
CoA:diacylglycerol acyltransferase (DGAT) enzymes (Weiss et al., 1960). Newly 
synthesized TAGs are thought to be released into the associated lipid bilayer, where 
they are channeled into cytosolic LDs or, in cells that secrete TAG, to nascent 
lipoproteins. TAGs are the main energy store and, through a lipase-catalyzed reaction, 
can be reconverted to DAG as a precursor for the synthesis of complex lipids (Coleman 
& Lee, 2004). DAG can also act as a substrate for DAG lipases that hydrolyze the fatty 
acid in position 1 or 2, generating MAG. DAG lipases are also strongly linked to 
signaling functions. For example, in platelets, in response to thrombin their combined 
action with phospholipase C (PLC) facilitates the release of arachidonic acid, an 
intermediate in thromboxane and prostaglandin synthesis (Smith et al., 1991). 
 
  
 
Figure 1-6. Integrated metabolic pathways of glycerolipids and glycerophospholipids. See footnote on next page1.
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In addition to the de novo synthesis, three alternative pathways can generate 
DAG through the action of sphingomyelin synthase (SMS), PLC and phospholipase D. 
In the last two pathways, DAG generation is highly dependent on extracellular 
stimulation, and DAG generated by these mechanisms is not usually consumed for 
metabolic purposes (Carrasco & Merida, 2007). The principal effect of DAG on 
responsive proteins, such as protein kinase C (PKC), is considered to be protein 
translocation to membranes, mediated by its direct binding to the C1 domain (Yang & 
Kazanietz, 2003) and regulation of membrane curvature (Goñi & Alonso, 1999). 
Considering the numerous metabolic pathways in which DAG is implicated, cells must 
rigorously control the production and clearance of DAG to guarantee a p ermanent 
reservoir of this lipid. 1 
The mammalian Golgi also specializes in sphingolipid synthesis, and produces 
SM, GlcCer, lactosylceramide (LacCer) and higher-order GSLs, all of which are 
primarily destined for export to the plasma membrane (Futerman & Riezman, 2005). 
The production of sphingolipids is reviewed in Chapter 3. Although the plasma 
membrane is not involved in autonomous synthesis of its structural lipids, numerous 
reactions for either synthesizing or degrading lipids that are involved in signaling 
cascades have been described for this organelle, such as the SM-Cer cycle (Di Paolo & 
De Camilli, 2006). Plasma membranes are also enriched in sterols (Figure 1-5), which 
are packed together with sphingolipids at a higher density than glycerophospholipids 
and confer to the membrane higher resistance to mechanical stress.  
                                                           
1 Figure1-6. The scheme shows the de novo synthesis of glycerolipids and glycerophospholipids (Kennedy 
pathway) and the remodeling pathway (Lands cycle) indicated by orange arrows. The names of the enzymes 
are in red: GPAT, Glycerol-3-phosphate acyltransferase; AGPAT, 1-acyl-sn-glycerol-3-phosphate 
acyltransferase; PAP (LPP), Phosphatidic acid phosphatase (Lipid phosphate phosphohydrolase); CEPT, 
Diacylglycerol choline/ethanolamine phosphotransferase; CPT, Diacylglycerol choline phosphotransferase; 
MGAT, Acyl-CoA:monoacylglycerol acyltransferase; DGAT, Acyl-CoA:diacylglycerol acyltransferase; 
MGL, Monoacylglycerol lipase; DGL, Diacylglycerol lipase; TGL, triacylglycerol lipase; PEMT, 
Phosphatidylethanolamine N-methyltransferase; PSS1/2, Phosphatidylserine synthase; PSD, 
Phosphatidylserine decarboxylase; CDS, Phosphatidate cytidylyltransferase; CDIPT (PIS), CDP-
diacylglycerol--inositol 3-phosphatidyltransferase; CLS, Cardiolipin synthetase; PGS, 
Phosphatidylglycerophosphate synthase; DGK, Diacylglycerol kinase; PLC, Phospholipase C; PLD, 
Phospholipase D; CK, Choline kinase; EK, Ethanolamine kinase; CCT, CTP-phosphocholine 
cytidylyltransferase; PLA2, Phospholipase A2; LPLAT (LPCAT, LPEAT, LPSAT, LPIAT, LPGAT, 
LCLAT), lysophospholipid acyltransferases. PLC and PLD act on every glycerophospholipid, although in the 
picture is only shown for some of them. The names of the lipid species are in blue: G3P, glycerol-3-
phosphate; LPA, lysophosphatidic acid; PA, phosphatidic acid; CDP-DAG, CDP-diacylglycerol; 1,2-DAG, 
1,2-diacylglycerol; MAG, monoacylglycerol; TAG, triacylglycerol; PC, phosphatidylcholine; LPC, 
lysophosphatidylcholine; PE, phosphatidylethanolamine; LPE, lysophosphatidylethanolamine; PE-NMe, 
methylphosphoethanolamine; PS, phosphatidylserine, LPS, lysophosphatidylserine; PI, phosphatidylinositol; 
LPI, lysophosphatidylinositol; PIPs, phosphatidylinositol phosphates; PGP, phosphatidylglycerol phosphate; 
PG, phosphatidylglycerol; CL, cardiolipin; LCL, lysocardiolipin. Lipid structures were obtained from Sud et 
al, 2006. 
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Many aspects of the glycerophospholipid metabolism and function in the 
cytoplasm are recapitulated in the nucleus (Irvine, 2003). The nuclear envelope contains 
the large bulk of nuclear lipids, which, in addition to providing structural support and 
isolation of nuclear functions, are also the source of numerous signaling reactions. 
Recent studies have shown that endonuclear loci are also the source of numerous 
phospholipid signaling reactions, in agreement with their detection in chromatin, 
nucleolus, and nuclear matrix (Ledeen & Wu, 2008). These include metabolic cycles 
involving SM-Cer, Cer-Sph, glycerophospholipid acylation-deacylation, and PLC-
mediated breakdown of phosphoinositides (Ledeen & Wu, 2004). SM, the most 
represented lipid in chromatin with respect to microsomes and nuclear membranes, is 
localized near to newly synthesized RNA, and appears to protect RNA from RNase 
digestion. SM increases during the differentiation process and apoptosis, while an 
increase of sphingomyelinase, with a concomitant decrease in SM, is observed at the 
beginning of S-phase of the cell cycle in rat hepatocytes; indicating a possible role in 
stabilizing the DNA double helix (Albi & Viola Magni, 2004; Cascianelli et al., 2008).  
Fatty acid oxidation is the process by which fatty acids are degraded in living 
organisms. In animal cells, fatty acids are degraded both in mitochondria and 
peroxisomes. The initial event is the activation of fatty acids by esterification with CoA. 
The degradation of the resultant fatty acyl-CoA thioesters proceeds by a cyclic process 
named β-oxidation (Schulz, 2004). Passage through one cycle of β-oxidation produces 
fatty acids that are shortened by two carbon atoms and yields acetate in the form of 
acetyl-CoA. Repetitive cycling through β-oxidation results in the complete degradation 
of fatty acids, releasing energy that drives the formation of ATP by oxidative 
phosphorylation. α-Oxidation occurs in peroxisomes and is the process that results in 
the oxidative removal of the first carbon atom, the carboxyl group, of a fatty acid or 
carboxylic acid to yield CO2 and a fatty acid or carboxylic acid shortened by one carbon 
atom. Substrates of peroxisomal oxidation are the CoA derivatives of fatty acids and 
carboxylic acids that are poorly or not at all taken up by mitochondria as, for example 
very long-chain fatty acids, methyl-branched carboxylic acids like phytanic acid, and α- 
hydroxylated fatty acids, among others. It is worth to mention that while α-oxidation 
was extensively studied for phytanic acid (Jansen & Wanders, 2006), very little was 
done with hydroxylated fatty acids (Foulon et al., 2005). Once they are chain-shortened 
by one carbon atom they can be degraded by β-oxidation (Schulz, 2004). 
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1.4 Lipid alterations in cancer 
There are several signaling pathways that are deregulated in cancer cells and can 
be summarized by six essential alterations in the cell’s physiology, and that collectively 
dictate malignant growth: self-sufficiency in growth signals, insensitivity to growth-
inhibitory (antigrowth) signals, evasion of programmed cell death (apoptosis), limitless 
replicative potential, sustained angiogenesis, and tissue invasion and metastasis 
(Hanahan & Weinberg, 2000). Similar to regulation of gene expression, changes in the 
presence and levels of membrane lipid species have been described in several human 
pathologies, associated either with adaptive responses or with the aetiology of the 
disease. In this regard, numerous studies have shown that the lipid composition of 
tumor cell membranes is altered with respect to non-tumor cells (Table 1-2). This area 
of study has received little attention in cancer research, mainly because structural and 
functional concepts of lipid alterations in cancer are more difficult to understand than 
the functional role of certain proteins and their genes in defining cancer cell phenotypes. 
Although thus far it has not been shown a common pattern of alterations characteristic 
for different kinds of tumors, certain cancer-induced lipid profile changes have been 
described and should possess some diagnostic value (Hendrich & Michalak, 2003). 
In this context, a hallmark of cancer cells is the constitutive activation of the 
fatty acid biosynthetic pathway, which produces SFA and monounsaturated fatty acids 
(MUFA) to sustain the increasing demand of new membrane phospholipids with 
appropriate acyl composition (Kuhajda, 2006; Rashid et al., 1997; Swinnen et al., 
2000). In this regard, the increased levels of oleic acid, detected in several tumors, are 
related to the activation of the fatty acid synthesis (Igal, 2010). The enzyme responsible 
for the oleic acid synthesis is the stearoyl-CoA desaturase (SCD) and its role in cancer 
is discussed in chapter 4. 
Gangliosides, which are membrane-bound glycosphingolipid molecules, are 
frequently aberrantly expressed in tumors (Hettmer et al., 2005). Ganglioside antigens 
on the cell surface, act as immunosuppressors; and certain gangliosides, such as GD3 or 
GM2, promote tumor-associated angiogenesis (Birkle et al., 2003). The reduced levels 
of Cer that were found in some types of cancer could be related to its pro-apoptotic role 
(Riboni et al., 2002). The role of ceramides in cancer is discussed in chapter 3. One 
lipid alteration highly connected to the genetic alterations found in cancer, is the 
elevated levels of PI(3,4,5)P3 formed by the activation of phosphatidylinositol 3-kinase 
(PI3K) that was observed in several tumors and contribute to oncogenesis (see below; 
Samuels et al., 2004). In the present study, we showed that SM levels are markedly 
reduced in cancer cells, ranging between one third and one half the levels found in 
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normal cells (Castagnet et al., 2005; Merchant et al., 1991b), suggesting that this 
change might be relevant for tumorigenesis. 
Table 1-2. Lipid composition alterations in cancer cells. 
Tumor type/Cell type Lipid alteration Reference 
Human neuroblastoma and small 
cell lung carcinoma 
Aberrant ganglioside (GM1 and 
GM2) containing high levels of 
hydroxyl fatty acids  
(Ladisch et al., 1989; Nilsson et 
al., 1986) 
Human ovarian tumors Increased sulfated glycolsphingo-
lipid expression. 
(Kiguchi et al., 1992; Liu et al., 
2010) 
Human neuroblastoma Aberrant ganglioside glycolsyla-
tion: Increased GD2 expression. 
(Hettmer et al., 2005) 
Human glioma Altered PUFA composition: 
reduced DHA (22:6n-3) and 
increased linoleic acid (18:2n-6). 
(Martin et al., 1996) 
Human head and neck squamous 
cell carcinoma (HNSCC)  
Downregulation of C18:0-Cer. (Koybasi et al., 2004) 
Human astrocytomas (low grade 
and high grade malignancy) 
Decreased total Cer levels. (Riboni et al., 2002) 
Human prostate cancer Cholesterol accumulation. (Di Vizio et al., 2008; Freeman & 
Solomon, 2004) 
Human breast, colon, esophageal 
Cancer 
Altered phospholipid profile (e.g. 
reduced SM). 
(Merchant et al., 1993; Merchant 
et al., 1991a; Merchant et al., 
1991b) 
Human ovarian tumors Activation of choline phospho-
lipid metabolism. 
(Iorio et al., 2005) 
Mice brain tumors Abnormalities in CL content or 
composition. 
(Kiebish et al., 2008) 
Human ovarian, colon, prostate 
and lung carcinomas, malignant 
melanoma and glioblastoma-
astrocytoma cell lines compared 
to different human fibroblast cell 
lines 
Increased oleic acid, reduced 
stearic acid, DHA. 
(Meng et al., 2004c) 
Plasma, Red Blood Cells or 
platelets from cancer patients 
  
Pancreatic and non-small lung 
cancer 
Reduced n-3 fatty acid levels. (Zuijdgeest-van Leeuwen et al., 
2002) 
Non-small lung cancer Reduced linoleic acid (LA, 18:2n-
6). 
(de Castro et al., 2009) 
Breast, prostate, liver, pancreas, 
colon and lung cancer 
Increased oleic acid and decreased 
stearic acid; reduced DHA in 
relation to ALA. 
(Mikirova et al., 2004; Pala et al., 
2001) 
non-Hodgkin lymphoma Abnormal fatty acid profile: 
higher levels of palmitic (16:0), 
oleic (18:1n-9) and arachidonic 
acids (20:4n-6); reduced levels of 
LA (18:2n-6), EPA (20:5n-3) and 
DHA (22:6n-3). 
(Cvetkovic et al., 2010) 
Colorectal cancer Reduced n-6 fatty acids. (Baro et al., 1998) 
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Therefore, because the type and/or composition of membrane lipids are altered in 
several pathologies, and important cellular functions occur within or around 
membranes, Membrane Lipid Therapy (see below) might have potential use for the 
treatment of several illnesses. 
In the present work, a h uman glioma cell line was used as the main model 
system, thus, a brief description of brain tumors and the specific genetic alterations that 
they contain are indicated below. Brain and other central nervous system tumors 
represent about 2% of all cancers and they account for about 2% of all cancer-related 
deaths (Ferlay et al., 2008). Brain tumors have a poor prognosis and poor survival rates, 
around 20% (Wrensch et al., 2002), indicating the great therapeutic needs for the 
treatment of this condition (Schwartzbaum et al., 2006). The only established risk factor 
for glial and meningeal neoplasms is the exposure to therapeutic or high-dose ionizing 
radiation and is determined by genetic factors (DeAngelis, 2001). The standard 
treatment for a primary brain tumor is surgery, radiotherapy and chemotherapy, mainly 
with temozolomide (Temodar;Chandana et al., 2008; Stupp et al., 2005). However the 
use of temozolomide only provides a modest increase in life span (ca. 10 weeks) to 
patients with glioma.  
There are several types of brain tumors, classified by the World Health 
Organization based on their cellular origin and histologic appearance (Louis et al., 
2007). Neuroglial tumors account for more than 80% of primary brain tumors and 
derive from astrocytes, oligodendrocytes, or ependymal cells. In addition, gliomas are 
divided into four grades, according to the malignancy of the tumor. Glioblastoma 
multiforme is the most common type of glioma, the most aggressive one and is 
associated with very poor survival (Schwartzbaum et al., 2006). High-grade (malignant) 
glial neoplasms can arise either alone (primary glioblastoma) or from a preexisting low-
grade tumor (secondary glioblastoma; DeAngelis, 2001; Schwartzbaum et al., 2006). 
The most frequent genetic alteration found in glioma is the loss of heterozygosity 
of chromosome 10q, which contains functional copies of tumor suppressor genes 
(Fujisawa et al., 2000). A key signaling pathway in the development of primary 
glioblastomas is the EGFR/PTEN/Akt/mTOR pathway. In fact, EGFR amplification has 
been identified as a g enetic hallmark of glioblastomas (Kleihues & Sobin, 2000). 
Activated EGFR transduces a mitotic signal (Arteaga, 2002), recruiting PI3K to the cell 
membrane. PI3K phosphorylates PI(4,5)P2 to PI3P, which activates downstream 
effector molecules such as Akt (protein kinase B) and mTOR; resulting in cell 
proliferation and increased cell survival by blocking apoptosis (Ohgaki & Kleihues, 
2007). Apoptosis can be elicited in cells through two major routes, an extrinsic route 
initiated through activation of cell surface receptors such as TNF and Fas; and an 
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intrinsic route that is activated by permeabilization of the outer mitochondrial 
membrane via pro-apoptotic stimuli (MacFarlane & Williams, 2004). Both pathways 
converge on caspases, which are responsible for executing subsequent steps in the 
apoptotic program. PTEN (phosphatase and tensin homology), whose gene is located at 
10q23.3, inhibits the PI3P signal, thereby inhibiting cell proliferation (Teng et al., 
1997). In addition, the signaling pathway Ras/MAPK is also activated in many gliomas 
(Tatevossian et al., 2010). Indeed, high levels of active Ras-GTP are found in advanced 
astrocytomas (Guha et al., 1997). Ras-GTP phosphorylates Raf kinase, which 
phosphorylates MEK, which phosphorylates ERK, which enters the nucleus and 
phosphorylates nuclear transcription factors that induce the expression of genes 
promoting cell cycle progression, such as cyclin D1 (Furnari et al., 2007). 
The cell cycle involves a series of events which result in DNA duplication and 
cell division. The cell cycle is divided into two stages: mitosis (M), the process of 
nuclear division; and interphase, the interlude between two M phases. Interphase 
includes the first gap phase (G1), the DNA replication phase (S) and the second gap 
phase (G2). Cells in G1 can, before commitment to DNA replication, enter a resting (or 
quiescent) state called G0, which accounts for most of the non-growing, non-
proliferating and differentiated (mature) cells in the human body. The progression from 
one stage to the next is carefully controlled by the sequential formation, activation and 
subsequent degradation or modification of a series of cyclins and their partners, the 
cyclin-dependent kinases (CDKs), a family of serine/threonine protein kinases that are 
activated at specific points of the cell cycle. Transition from one stage to the next is 
regulated at a number of checkpoints which prevent premature entry into the next phase 
of the cycle (Macdonald et al., 2004; Vermeulen et al., 2003).  
The retinoblastoma protein (pRb) and p53 regulate the cell cycle primarily by 
governing the G1 to S phase transition, are major targets of inactivating mutations in 
glioblastomas. The absence of these cell cycle guardians renders tumors particularly 
susceptible to inappropriate cell division driven by constitutively active mitogenic 
signaling effectors, such as PI3K and MAPK. In its hypophosphorylated state, pRb 
blocks proliferation by binding and inhibiting the proliferation inducing transcription 
factors E2F, which prevents the expression of genes essential for progression from G1 
into S phase (Sherr & McCormick, 2002). Upon mitogenic stimulation, the activation of 
the MAPK cascade leads to the association of the CDK4/cyclin D1 complex that 
phosphorylates pRB, thereby releasing active E2F. In turn, p16INK4a binds to CDK4, 
inhibits the CDK4/cyclin D1 complex and, therefore, the G1 to S transition (Sherr & 
Roberts, 1999). In glioblastomas, disruption of the p16INK4a gene occurs through 
homozygous deletion (Kleihues & Sobin, 2000). The p53 tumor suppressor is a 
transcription factor that prevents the propagation of cells with unstable genomes, 
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predominantly by halting the cell cycle in the G1 phase or instigating a program of 
apoptosis or proliferative arrest (Vousden & Lu, 2002). Loss of p53, through either 
point mutations that prevent DNA binding or loss of chromosome 17p, is a frequent and 
early event in the pathological progression of secondary glioblastomas (Furnari et al., 
2007; Ichimura et al., 2004). 
 
Figure 1-7. Signaling pathways altered in human gliomas. 
Most of the molecular entities in the Ras/MAPK and PI3K/Akt have been seen mutated in 
human gliomas. The greater the number of genes mutated, the higher the degree of 
malignancy of the glioma. This figure shows these signaling pathways, as well as its relation 
with the cell cycle machinery (cyclin/CDK, Rb/E2F, p27kip1, p16INK4b, etc). The boxes 
indicate the genes more frequently mutated in human primary glioblastoma (pGBM, red), 
secondary glioblastoma (sGBM, blue) or both (green) (Adapted from Ohgaki & Kleihues, 
2007). 
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1.5 Membrane Lipid Therapy 
Previous works showed that the membrane lipid structure influences cell 
signaling (Escribá et al., 1997; Escribá et al., 1995; Vogler et al., 2004). Thus, for 
example, the presence of the nonlamellar-prone lipid PE favors the binding of 
heterotrimeric Gi proteins and Gβγ dimmers to model membranes, whereas Gαi subunit 
prefers lamellar structures. Consequently, the association of both G protein coupled 
receptors and G proteins to the plasma membrane makes them susceptible to their lipid 
environment so that lipid-protein interactions are crucial to their function. Furthermore, 
the types and relative abundance of lipids in the membrane not only control numerous 
functions but also regulate the localization and activity of membrane proteins (Vogler et 
al., 2004). Thus, molecules that interact with membrane lipids and modify the 
composition and structure of cell membranes can change the localization and/or activity 
of membrane proteins. The net result of these effects is the modulation of certain 
signaling pathways that reverse the pathological state. 
Due to this participation in cellular activities, membrane lipids might constitute 
targets for drugs whose pharmacological effects would be associated with the 
modulation of the composition, structure and physicochemical properties of membranes, 
as states the Membrane Lipid Therapy (Escribá, 2006). Indeed, G proteins, PKC and 
heat shock proteins are among the proteins regulated by membrane-lipid therapy and the 
therapeutic agents used can inhibit cell proliferation or induce apoptosis and cell 
differentiation (Escribá, 2008).  
In this context, it was demonstrated that the antitumor effect of anthracyclines 
and the ensuing modifications in cell signaling, involved interactions with the plasma 
membrane without unspecific interactions with other cell targets (Escribá et al., 1995; 
Triton & Yee, 1982). Based on these results, 2-hydroxy-9-cis-octadecenoic acid 
(2OHOA), patented and registered as Minerval®, was designed rationally (Figure 1-8). 
A first approach showed that 2OHOA binds to membranes and modifies the biophysical 
properties of the lipid bilayer in model membranes (Barceló et al., 2004; Martínez et al., 
2005b). 
Further studies demonstrated that 2OHOA induces cell cycle arrest in human 
lung adenocarcinoma cells by causing, both in vitro and in vivo PKC translocation to the 
plasma membrane and by downregulating the expression of certain cyclins, CDKs, E2F-
1 and dihydrofolate reductase (DHFR), a protein directly involved in DNA synthesis 
(Lladó et al., 2009; Martínez et al., 2005a; Martínez et al., 2005b). Interestingly, DHFR 
downregulation is also involved in the effect of 2OHOA on human leukemia cells, 
where it induces ligand-independent Fas receptor (FasR) capping and apoptosis (Lladó 
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et al., 2010). In addition, cell cycle arrest was followed by cancer cell differentiation in 
human glioma cells, as a result of the translocation of Ras to the cytosol and the 
subsequent inhibition of the ERK (MAPK) pathway. These effects in turn contribute to 
the inactivation of the cyclin/CDK/RB/E2F-1/DHFR and PI3K/Akt pathways. 
Moreover, increased expression of the cyclin/CDK inhibitors p21Cip1 and p27Kip1 caused 
further reductions in the phosphorylation of Rb and triggered autophagic cell death 
(Marcilla-Etxenike et al., 2011; Terés et al., 2011). 
Despite the potency of 2OHOA against cancer, it is a safe non-toxic compound 
with IC50 values in non-tumor IMR90 fibroblasts cells 30 to 150-fold greater than in 
tumor cells (Lladó et al., 2010). This lack of toxicity was confirmed by GLP (Good 
Laboratory Practice) studies showing that the minimum lethal dose is greater than 3,000 
mg/kg and that no undesired side effects were observed at therapeutic doses (Martínez 
et al., 2005a; Terés et al., 2011).  
 
Figure 1-8. Structure of oleic acid and 2-hydroxyoleic acid (Minerval®). 
 
Despite all our current knowledge on the importance of the plasma membrane in 
2OHOA action against cancer and its impact on membrane associated signaling 
pathways, the regulatory effects of 2OHOA on the composition of cancer cell 
membranes are not fully understood. Until now, it has not been determined whether 
2OHOA incorporates itself in cell membranes and tissues, as a free fatty acid; or if it is 
incorporated into other lipids classes, or even if it modulates lipid composition at 
another level. Therefore, the aim of this study was to investigate the effects of 2OHOA 
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on the composition and structure of human glioma (and other types of cancer and 
normal) cells, and related molecular events involved in the biosynthesis and metabolism 
of membrane lipids. 
 
1.6 Aim of the study 
Taking into account all the facts exposed above, the main goal of the present 
study was to investigate the molecular lipid alterations induced by 2OHOA and its 
potential relationship with its mechanism of action. In order to do so, our approach was: 
 To analyze the effect of 2OHOA on the phospholipid and sphingolipid 
composition of human cancer cells; 
 To analyze the metabolic fate of 2OHOA and its effect on fatty acid 
composition of human cancer cells; 
 To investigate the molecular bases of the main changes induced by 
2OHOA in cancer cell membrane composition; 
 To determine the impact of cancer cell membrane alterations induced 
by 2OHOA on the biophysical properties of model membranes and; 
 To analyze the effect of 2OHOA treatments on the lipid composition of 
mice tissues. 
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2 SM and Sphingomyelin Synthase (SMS) in 2OHOA’s 
effect against cancer 
2.1 Sphingolipids 
Sphingolipids were originally named by J.L.W. Thudichum in 1884 due to their 
enigmatic nature. Apparently, Thudichum spent much of his spare time thinking about 
the sphinx of Greek mythology, and so named the compounds that he isolated after the 
sphinx because of the mystery of their function. Sphingolipids have become the focus of 
renewed attention because they are an unusually versatile class of membrane lipid that, 
besides providing mechanical stability, have important roles in molecular signaling and 
sorting as well as in cell recognition (Tafesse & Holthuis, 2010). As is the case for all 
membrane lipids, sphingolipids are amphipathic molecules that have both hydrophobic 
and hydrophilic properties, albeit to varying extents. The hydrophobic region consists of 
a sphingoid long chain base with a dozen of structural variants, normally sphingosine, 
dihydrosphingosine (dhSph, also called sphinganine) or phytosphingosine, to which a 
fatty acid is attached by an amide bond to carbon 2 (Futerman & Riezman, 2005). 
The de novo biosynthetic pathway for sphingoid bases and complex 
sphingolipids is depicted in Figure 2-1. The first steps in sphingolipid biosynthesis 
involve formation of the sphingoid base by the condensation of L-serine and palmitoyl-
CoA, a reaction catalyzed by Serine-palmitoyl transferase (SPT), generating 3-
ketodihydrosphingosine, which is then reduced to dhSph by 3-ketosphinganine 
reductase. This is followed by N-acylation of dhSph to form dihydroceramide (dhCer), 
by sphinganine N-acyl transferase, also called ceramide synthase (CerS). At this point, 
the dhCer undergoes desaturation by dhCer desaturase (the cis 4–5 double bond is 
inserted in mammals) to generate Cer. All these reactions occur on the cytosolic surface 
of the ER. 
A family of six mammalian CerS has been described (Table 2-1), each of them 
with a high specificity toward the acyl-CoA chain length used for N-acylation of the 
sphingoid base, using either dhSph, derived from the biosynthetic pathway, or Sph, 
derived from sphingolipid recycling (Levy & Futerman, 2010; Stiban et al., 2010). 
 
  
 
Figure 2-1. Scheme of sphingolipid metabolism. See footnote on next page2.
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Thus, CerS are responsible for the fatty acid composition of Cer. Evidence is 
currently emerging that different CerS, and consequently Cer containing specific fatty 
acids, play different roles in mediating specific biochemical events and thus specific 
roles in the cell’s physiology (Hannun & Obeid, 2011).2In this context, in one of the 
earliest studies to examine molecular Cer species involved in cell responses, it was 
observed that triggering of the B-cell receptor in lymphocytes induced a biphasic 
elevation in Cer (Kroesen et al., 2001). The early phase -minutes/hours- consists 
primarily of de novo synthesis of C16-Cer and preceded the onset of activation-induced 
cell death. The late phase involves accumulation of C24-Cer after cell death activation. 
Among the various Cer, only C18-Cer is selectively downregulated in head and neck 
cancer tissues (Koybasi et al., 2004). In a r ecent study, CerS5 and CerS6 have been 
implicated in mediating cytotoxic responses to ionizing radiation whereas CerS2, 
probably acting in mitochondria, offered partial protection (Mesicek et al., 2010). 
Similarly, CerS5 and CerS6 are also implicated in the generation of Cer by the salvage 
pathway, which are necessary for regulating membrane permeability in the programmed 
cell death execution phase in MCF-7 breast cancer cells in response to UV radiation 
(Mullen et al., 2011). In addition, the first study to demonstrate biological activities for 
the dhCer class showed that autophagy was induced in prostate cancer cells treated with 
C2-dhCer (Zheng et al., 2006). Taken together, these studies on CerSs not only 
implicate each of these enzymes in the formation of specific Cer and perhaps in specific 
compartments, but also they clearly suggest Cer-species-specific functions.   
Table 2-1. Comparison of human CerS features. 
Name Acyl chain-length 
Specificity 
Tissue mRNA expression profile 
CerS1 C18 Brain, skeletal muscle, testis 
CerS2 C20-C26 Widely expressed, acts as housekeeping 
CerS3 C22-C26 Testis, skin 
CerS4 C18-C20 Low expression levels in all tissues 
CerS5 C16 Low expression levels in all tissues 
CerS6 C14 and C16 Low expression levels in all tissues 
(Adapted from Levy & Futerman, 2010; Stiban et al., 2010). 
                                                           
2 Figure 2-1. The scheme shows metabolic pathways for sphingolipids including the de novo pathway in the 
ER, the sphingomyelinase (SMase) pathway at the plasma membrane and the salvage pathway in the 
lysosomes. The names of the biosynthetic enzymes are in red and the names of the sphingolipid species are in 
blue. Dash lines represent minor pathways (Adapted from Bartke and Hannun, 2009; Kitatani et al, 2008; 
Menaldino et al, 2003; and Merrill, 2002). 
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Subsequently, Cer is delivered to the Golgi apparatus where it is  converted to 
SM or GlcCer, by SM Synthase (SMS) or GlcCer Synthase, respectively. As the 
hydrophobic nature of Cer prevents its spontaneous transfer through the cytosol, it must 
travel from the ER to the Golgi apparatus by facilitated mechanisms (Venkataraman & 
Futerman, 2000). The transport of Cer to the Golgi complex occurs either through 
vesicular transport, which delivers Cer for the synthesis of GlcCer, or through the action 
of the transfer protein CERT, which specifically delivers Cer for SM synthesis 
(Fukasawa et al., 1999). CERT specifically extracts ceramide from the ER and contains 
a pleckstrin homology (PH) domain to allow its targeting to the Golgi apparatus 
(Futerman & Hannun, 2004; Hanada et al., 2003; Hannun & Obeid, 2008). GlcCer 
synthase catalyzes the transfer of glucose from UDP-glucose to Cer. This enzyme 
resides in the cis Golgi and has its active site oriented toward the cytosol (Futerman & 
Riezman, 2005). After translocation to the Golgi lumen, GlcCer is converted to more 
complex GSLs. FAPP2 was recently identified as an essential component of the GSLs 
synthetic machinery, as it mediates non-vesicular transport of GlcCer from its site of 
synthesis at the early Golgi to distal Golgi compartments, where most of the enzymes 
involved in complex GSLs assembly are located (D'Angelo et al., 2007). 
SM production involves the enzymatic transfer of a phosphocholine head group 
from PC to the primary hydroxyl of Cer, yielding DAG in the process (Figure 2-2; 
Huitema et al., 2004). The enzyme catalyzing this reaction, phosphatidylcholine: 
ceramide choline-phosphotransferase, or SMS, occupies a central position in 
sphingolipid and glycerolphospholipid metabolism. Since the enzyme is also able to 
catalyze the reverse reaction, the formation of PC and Cer from SM and DAG (van 
Helvoort et al., 1994), it h as considerable biological potential as a regulator of pro-
apoptotic factor Cer and mitogenic factor DAG (Huitema et al., 2004; Tafesse et al., 
2006). Two SMS isoforms with close structural similarities and a 57% sequence 
homology have been described to date, SMS1 and SMS2. SMS1 is mostly associated 
with the Golgi apparatus, and SMS2 is mainly distributed to the plasma membrane and 
to a lesser extent to the perinuclear region (Huitema et al., 2004). Both enzymes have 
the active site facing the exoplasmic leaflet of the membranes and while the Golgi 
enzyme would be responsible for generating the bulk of cellular SM, the second enzyme 
may serve a principal role in signal transduction at the plasma membrane. Remarkably, 
a difference in substrate preference between both isozymes has been described. Thus, 
SMS1 uses PC as a substrate, whereas SMS2 can use PE and PC (Ternes et al., 2009). 
SMS1 and SMS2 are uniformly distributed among mammalian tissues, and are encoded 
by ubiquitously expressed genes (Huitema et al., 2004). In addition to SMS1 and 
SMS2, there is a third SMS-related (SMSr) protein that synthesizes Cer 
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phosphoethanolamine, a SM analog. This enzyme is localized to the ER and controls 
Cer homeostasis in the ER (Vacaru et al., 2009). 
 
Figure 2-2. Scheme of the enzymatic reaction regulated by SMS. 
SM synthase catalyzes the transfer of the phosphorylcholine moiety from one molecule of PC to one molecule 
of Cer. This leads to the formation of one molecule of SM and one of DAG. 
Once synthesized, SM and complex GSLs are transported to the plasma 
membrane via vesicular trafficking. There, SM can be metabolized to Cer either by 
acidic sphingomyelinase (aSMase), on the outer leaflet of the membrane, or by neutral 
sphingomyelinase (nSMase), which resides on the inner leaflet of the bilayer (Bartke & 
Hannun, 2009). Currently, seven distinct SMase have been identified based on their 
preferred optimal pH for activity, subcellular localization, and dependence on cations 
(Goñi & Alonso, 2002; López Jiménez, 2008). From the plasma membrane, 
sphingolipids may be recirculated through the endosomal pathway, also called the 
salvage or recycling pathway (Kitatani et al., 2008). Thereby, SM and GlcCer are 
metabolized to Cer in the lysosomal compartment by aSMase and glucosidases, and Cer 
is then degraded by acid Ceramidase (CDase) to form Sph (Futerman & Hannun, 2004; 
Futerman & Riezman, 2005). Due to its ionizable positive charge, the salvaged Sph is 
able to leave the lysosome and shows adequate solubility in the cytosol to move 
between membranes, including the ER where it would be available for recycling 
(Kitatani et al., 2008). These bases serve also as substrates for sphingosine kinases that 
form sphingosine-1-phosphate (S1P; Figure 2-1). 
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Cer functions both as a key player in cell signaling and as the precursor of more 
complex sphingolipids (Merrill, 2002). As bioactive molecules, sphingolipid 
metabolites have been recognized as important modulators of cell survival, cell growth, 
migration and angiogenesis, and therefore have an important role in cancer progression. 
Cer and Sph are mostly anti-proliferative or pro-apoptotic, regulating cell responses 
such as growth arrest, senescence, apoptosis, and recently, it has been shown that they 
also participate in autophagy; but they can be reversibly converted to ceramide-1-
phosphate (C1P) by ceramide kinase and to S1P by sphingosine kinase, respectively 
(Figure 2-1; Oskouian & Saba, 2010). C1P promotes growth and counteracts apoptotic 
stimuli, by activating cPLA2 and inhibiting aSMase in a cel l-dependent manner 
(Gómez-Muñoz, 2006; Gómez-Muñoz et al., 2004). S1P also functions as a growth and 
survival factor, acting as a ligand for a family of G protein-coupled receptors, as well as 
a second messenger (Cuvillier et al., 1996; Spiegel & Milstien, 2003). 
Diverse cellular and environmental stresses such as chemotherapeutics (Bose et 
al., 1995), heat shock (Jenkins et al., 2002), ischemia-reperfusion (Yu et al., 2007), UV 
radiation (Rotolo et al., 2005), and ionizing radiation (Truman et al., 2005), stimulate 
the generation of Cer. This Cer, produced either by the de novo biosynthetic (Uchida et 
al., 2003), the SMase (Haimovitz-Friedman et al., 1994) or recycling metabolic 
pathways (Jin et al., 2008), triggers activation of signals affecting intrinsic and extrinsic 
apoptotic pathways and the cell cycle control, while simultaneously inhibiting signaling 
events that promote cell growth and survival mediated by the AKT pathway (Oskouian 
& Saba, 2010). In contrast to other sphingolipids, which contain a hydrophilic region 
such as phosphate in the case of S1P and C1P, phosphorylcholine in SM, and sugar 
residues in GSLs, Cer has a minimal hydrophilic region comprising two OH groups 
(Futerman & Hannun, 2004). Because Cer is highly hydrophobic, it tends to reside in 
the membranes where it is generated unless it is transported, thus Cer can exert their 
primary actions at the membrane level, acting only on membrane related proteins, either 
permanently or transiently linked to the membrane. This may occur in two different 
ways: 1) on proteins lacking specific Cer binding sites, Cer may act by inducing 
localized changes in the biophysical properties of the membrane bilayer, for example, 
increase in lipid chain order and the formation of Cer-enriched membrane platforms, 
which can in turn modify enzyme activities, for example by concentrating and 
oligomerizing membrane receptors (Cremesti et al., 2001; Gulbins & Kolesnick, 2003; 
Kolesnick et al., 2000; Stancevic & Kolesnick, 2010). Cer can also induce 
permeabilization of mitochondria membranes, releasing the cytochrome c, and leading 
to activation of the caspase-dependent apoptotic pathway (Siskind et al., 2002; Siskind 
et al., 2006). 2) Cer may bind to specific sites in the target protein, thereby modulating 
their activity. Among the proteins that contain ceramide-binding sites are proteins that 
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are transiently bound to membranes, such as Cer-activated protein kinase (Bourbon et 
al., 2000; Yao et al., 1995); and proteins without known membrane binding capacity, 
such as Cer-activated protein phosphatase 2 (Dobrowsky & Hannun, 1993). 
The fact that sphingolipids are implicated in such important processes for the 
cell, points towards the need of a fine regulation mechanism. In fact, the balance 
between the relative levels of the bioactive sphingolipids, Cer, Sph, S1P and C1P, has 
been proposed to act as a ‘rheostat’ to determine the fate of the cell with respect to 
survival (Ruvolo, 2003; Zheng et al., 2006). Recently, Orm proteins were identified as 
essential components of the sphingolipid rheostat that allows cells to fine-tune 
sphingolipid synthesis according to their needs. These experiments demonstrated that 
Orm proteins form a co nserved complex with SPT that is regulated by a 
phosphorylation cycle of Orm proteins relieving their inhibitory activity when 
sphingolipid production is disrupted (Breslow et al., 2010). 
The sphingolipid metabolism rheostat can also be deregulated by defects in 
enzymes and proteins required for lysosomal catabolism that lead to inherited diseases, 
the lysosomal storage diseases. Indeed, human diseases caused by alterations in the 
metabolism of sphingolipids or GSLs are mainly disorders of the degradation of these 
compounds. Table 2-2 shows some examples of lysosomal storage diseases, which can 
be classified according to the stored substances, as sphingolipidoses, 
mucopolysaccharidoses, mucolipidoses, glycoprotein and glycogen storage diseases. 
However, in most lysosomal diseases more than one compound accumulates and in 
some disorders for various reasons the stored material can be rather heterogeneous 
(Ballabio & Gieselmann, 2009; Kolter & Sandhoff, 2006; Kolter & Sandhoff, 2010). As 
a result of the growing amount of accumulating material, a v ariety of pathogenic 
cascades are activated such as altered calcium homeostasis, oxidative stress, 
inflammation, altered lipid trafficking, autophagy, endoplasmic reticulum stress, and 
autoimmune responses, and subsequently to cell death (Vitner et al., 2010).  
In this chapter, we show that 2OHOA activated SMS isozymes, inducing a rapid 
increase in the membrane levels of SM. In addition, the use of various 2OHOA 
analogues showed that this effect was strongly associated with the fatty acid structure. 
Because the plasma membrane is the first cell structure 2OHOA encounters, SMS 
activation could be one of the first molecular events associated with its antitumor 
effects. Significantly, SM accumulation specifically occurred in cancer cells but not in 
non-cancer cells and SMS pharmacological inhibition reversed the effects of 2OHOA 
on the cell cycle. These results might explain why 2OHOA acts specifically against 
cancer cells and therefore, induces no undesired side effects at therapeutic doses. In 
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addition, the sustained activation of SMS provoked a deregulation of the whole 
sphingolipid metabolism.  
Table 2-2. Examples of lysosomal storage diseases. 
Disease Defective protein Main storage material Altered pathways 
GM1 gangliosidosis β-Galactosidase GM1  a, b, c, d, e, f. 
GM2 gangliosidosis 
(Sandhoff) 
β-Hexosaminidase  
A and B 
GM2  a, c, d, e, f 
Gaucher β-Glucosidase 
or saposin C activator 
GlcCer a, c, e, f 
Fabry α-Galactosidase A Globotriaosyl- 
Ceramide 
a, f 
Niemann-Pick Type 
A and B 
Sphingomyelinase SM c, e, f 
Niemann-Pick Type C NPC1 and 2 Cholesterol 
and sphingolipids 
a, b, c, d, e, f 
Farber Ceramidase Ceramide e 
a, oxidative stress; b, ER stress and UPR; c, altered calcium homeostasis; d, autophagy; e, inflammation; 
f, altered lipid trafficking (Adapted from Ballabio & Gieselmann, 2009; Vitner et al., 2010). 
 
2.2 Results 
2.2.1 2OHOA inhibited cell viability and downregulated DHFR levels in 
human U118 glioma cells.  
Previous studies from our group have shown that 2OHOA induces apoptosis in 
human leukemia cells (Jurkat) or cell cycle arrest in human lung adenocarcinoma 
(A549) cells. Interestingly, in both cell lines 2OHOA downregulates DHFR, a protein 
required for DNA synthesis and cell proliferation (Lladó et al., 2009). Here, we 
evaluated the capacity of 2OHOA to diminish the viability of human U118 glioma cells 
using the XTT method and evaluating its effect on DHFR levels. In this context, 
2OHOA (0-1000 μM; 48 h) reduced the viability of human U118 glioma cells in a 
concentration dependent manner (Figure 2-3A-B). In addition, 2OHOA (200 μM, 48 h) 
induced a marked decrease in DHFR protein levels (69.7%) in U118 cells while it had 
no such effect in non-tumor human lung fibroblast (MRC-5) cells (Figure 2-3C). These 
results extend previous studies, for the first time showing that 2OHOA has a distinct 
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effect on DHFR in tumor and non-tumor cells (Lladó et al., 2010; Lladó et al., 2009; 
Martínez et al., 2005b). 
 
Figure 2-3. 2OHOA inhibited cell viability and downregulates DHFR levels in U118 cells. 
(A) Representative phase-contrast micrographs (40 × magnification) of U118 cells in the presence (200 μM, 
48 h) or absence (control) of 2OHOA. (B) Cell viability assessed by the MTT assay. (C) DHFR protein levels 
in MRC-5 and U118 cells after treatment with 2OHOA (200 μM, 48 h) were determined by immunoblotting. 
Results are expressed as percentage of untreated cells and represents mean ± SEM, n=3. The asterisks indicate 
a significant effect of the treatment as compared with the control (**P < 0.01). 
 
2.2.2 2OHOA specifically augmented SM mass in cancer cells. 
Because lipid composition is usually altered in various human pathologies, 
including cancer, we investigated the impact of 2OHOA (200 μM, 72 h) on U118 cells 
phopholipid mass and composition. After extraction, lipids were separated by thin layer 
chromatography (TLC) and the phospholipid mass was determined by measuring the 
lipid phosphorus content of the different bands. Treatments with 2OHOA induced a 
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marked increase in SM mass (4.6-fold) that was accompanied by a decrease in PE and 
PC mass (57% and 30%, respectively; Table 2-3). In addition, while PS mass decreased 
43%, PI mass remained unchanged. Despite these changes, the total phospholipid 
content was essentially unaffected by 2OHOA.  
Table 2-3. Phospholipid mass changes in control and treated U118 cells. 
 Control 2OHOA 
  Mean ± SEM  Mean ± SEM 
SM  42 ± 4  193 ± 16*** 
PC  249 ± 16  176 ± 13*** 
PS  70 ± 3  40 ± 5*** 
PI  36 ± 2  31 ± 6 
PE  106 ± 8  46 ± 3*** 
Total PL  463 ± 79  486 ± 38 
U118 cells were treated with 2OHOA (200 µM, 72 h). Total lipid extracts were separated by TLC as 
described in Experimental procedures, Values are expressed as mass (nmol/mg protein) and represent mean ± 
SEM, n = 4–5. The asterisks indicate a significant effect of the treatment as compared with the control (***P 
< 0.001). 
To determine whether the observed changes in lipid composition were associated 
with the effects of 2OHOA against cancer, we further analyzed the effect of 2OHOA on 
the glycerophospholipid composition in human leukemia (Jurkat) cells, non-small cell 
lung cancer (A549) cells, an additional human glioma cell line (1321N1), and in non-
tumor (MRC-5) cells. Exposure to 2OHOA (200 μM, 24 h) significantly increased the 
SM content of cancer cells (2.4-fold in Jurkat cells, 2.2-fold in 1321N1 cells, 2.7-fold in 
A549 cells) but not that of MRC-5 cells (Figure 2-4). The complete 
glycerophospholipid profile of these cell lines is depicted in Figure A 1. Therefore, 
these data not only revealed the ability of 2OHOA to regulate the glycerophospholipid 
composition of tumor cells but also, they indicated that this effect was specific to cancer 
cells. Interestingly, all the cancer cells studied here had approximately half the SM 
content of the non-tumor MRC-5 cells, suggesting a relevant role for this lipid in 
tumorigenesis (see below).  
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Figure 2-4. 2OHOA increased SM levels in different cancer cells but not in non-tumor MRC-5 cells. 
SM content in different cells lines (MRC-5, U118, Jurkat, 1321N1 and A549 cells) after treatment with 
2OHOA (200 μM, 24 h). SM levels were determined by HPTLC analysis and expressed as percentage of total 
phospholipids. Values represent the mean ± SEM, n = 3–5. The asterisks indicate a s ignificant effect of the 
treatment as compared with the control (**P < 0.01; ***P < 0.001). 
To study the effects of 2OHOA on SM accumulation in depth, we investigated 
the effect of the duration of treatment and of the 2OHOA concentration on U118 cells. 
First, cells were treated with 2OHOA (200 μM) for 2, 6, 12, 24, 48 and 72 h (Figure 
2-5A) and after 6 h exposure, the increase in SM content was already significant when 
compared to control cells. Then, we evaluated the effect of different 2OHOA 
concentrations (25-400 μM, 24 h) on SM content. A concentration as low as 25 μM was 
sufficient to produce a significant increase in SM content (Figure 2-5C). Thus, the effect 
of 2OHOA on SM content was concentration-dependent, and it was maximal at 200 
μM. Accordingly, the levels of PC and PE decreased with time and concentration in a 
similar way to the increases in SM content (Figure 2-6).  
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Figure 2-5. 2OHOA increased SM levels in a time- and concentration-dependent manner in U118 cells. 
(A) SM content after treatment with 2OHOA (200 μM) at different times in U118 cells. (B) Representative 
HPTLC analysis of total lipid extracts from control and treated (200 μM, 72 h) U118 cells. (C) SM content 
after treatment with 2OHOA (24 h) at different concentrations in U118 cells. In all cases SM levels were 
determined by HPTLC analysis and expressed as percentage of untreated cells. Values represent the mean ± 
SEM, n = 3–5. The asterisks indicate a significant effect of the treatment as compared with the control (*P < 
0.05; **P < 0.01; ***P < 0.001). 
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Figure 2-6. 2OHOA decreased PC and PE in U118 cells. 
(A) PC and (B) PE content after treatment with 2OHOA (200 μM) at different times. (C) PC and (D) PE 
content after treatment with 2OHOA (24 h) at different concentrations. PC and PE levels were determined by 
HPTLC analysis and expressed as percentage of untreated cells. Values represent the mean ± SEM, n = 3–5. 
The asterisks indicate a significant effect of the treatment as compared with the control (*P < 0.05; ***P < 
0.001).  
We used a n umber of 2OHOA analogues to investigate the structural bases 
underlying the regulatory effects of 2OHOA on SM accumulation in U118 glioma cells 
(200 μM, 24 h). We focused our study on the effect of the fatty acid length, the presence 
and number of double bonds and the substitution at C-2. The failure of oleic acid 
(18:1n-9) and 2-methyloleic acid (2Me-18:1n-9) to significantly increase SM levels 
indicated that the presence of the hydroxyl group at C-2 is crucial for SM accumulation. 
In addition, we assessed the effects of 2-hydroxystearic acid, (2OH-18:0), 2-
hydroxylinoleic acid, (2OH-18:2n-6), 2-hydroxy-α-linolenic acid (2OH-18:3n-3), 2-
hydroxy-γ-linolenic acid, (2OH-18:3n-6), 2-hydroxyarachidonic acid (2OH-20:4n-6), 2-
hydroxyeicosapentaenoic acid (2OH-20:5n-3) and 2-hydroxydocosahexaenoic acid 
(2OH-22:6n-3) on U118 cells. SM levels only increased when cells were treated with 
18-carbon fatty acids containing a hydroxyl moiety at C-2 and at least one double bound 
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(Figure 2-7). Therefore, SM accumulation induced by 2OHOA appeared to be a highly 
structure-related phenomenon.  
 
Figure 2-7. SM accumulation was dependent on the fatty acid structure. 
(A) Structures of the compounds used to study the structural bases underlying the SM accumulation. The fatty 
acid structure was obtained from the LIPID MAPS database and was drawn as CPK spheres with Jmol, an 
open-source Java viewer for chemical structures in 3D (http://www.jmol.org/). 18:1n-9, oleic acid (a); 2Me-
18:1n-9, 2-methyloleic acid (b); 2OH-18:0, 2-hydroxystearic acid (c); 2OH-18:1n-9, 2-hydroxyoleic acid (d); 
2OH-18:2n-6, 2-hydroxylinoleic acid (e); 2OH-18:3n-3, 2-hydroxy-α-linolenic acid (f); 2OH-18:3n-6, 2-
hydroxy-γ-linolenic acid (g); 2OH-20:4n-6, 2-hydroxyarachidonic acid (h); 2OH-20:5n-3, 2-
hydroxyeicosapentaenoic acid (i); 2OH-22:6n-3, 2- hydroxydocosahexaenoic acid (j). (B) SM content after 
treatment with different fatty acids (200 μM, 24 h) in U118 cells. SM levels were determined by HPTLC 
analysis and expressed as percentage of untreated cells. Values represent the mean ± SEM, n = 3–5. The 
asterisks indicate a significant effect of the treatment as compared with the control (*P < 0.05; **P < 0.01).  
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Nuclear phospholipids, either in the membrane or associated with chromatin 
(e.g., SM), regulate DNA synthesis and cell cycle progression (Albi & Magni, 1999; 
Albi et al., 2003). Thus, an increase in SM, through its direct association with 
chromatin, would hamper DNA unfolding, which is necessary for its duplication. Given 
that 2OHOA impairs glioma cell proliferation and induces SM accumulation, we 
analyzed its influence on nuclear lipid composition. When nuclear lipid extracts were 
analyzed by high performance TLC (HPTLC), a marked increase in SM (2.0-fold) was 
also observed in nuclei of treated cells when compared with nuclei of control cells 
(Figure 2-8), consistent with our results in total cell extracts. Nevertheless, SM 
accumulation occurred mainly at plasma membrane level as it was demonstrated by 
incubating cells with lysenin, a SM specific binding protein (Figure 2-9; Yamaji et al., 
1998). 
 
Figure 2-8. 2OHOA increased nuclear SM levels in U118 human glioma cells. 
(A) Nuclear SM content after treatment with 2OHOA (200 μM, 24 h). (B) Representative HPTLC analysis of 
nuclear lipid extracts from control and treated (200 μM, 24 h) U118 cells. SM levels were determined by 
HPTLC analysis and expressed as percentage of untreated cells. Values represent the mean ± SEM, n = 3–5. 
The asterisks indicate a significant effect of the treatment as compared with the control (*P < 0.05; **P < 
0.01; ***P < 0.001). 
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Figure 2-9. Visualization of 2OHOA-induced plasma membrane SM accumulation by lysenin staining.  
Representative confocal microscope micrographs of U118 cells labeled with lysenin in the absence (control) 
or presence of 2OHOA (200 µM, 72 h). Cells were fixed and incubated with lysenin as is described in the 
Experimental procedures section. 
 
2.2.3 2OHOA activated both the SMS1 and SMS2 isozymes.  
De novo SM synthesis involves numerous reactions that commence with the 
condensation of palmitic acid and L-serine by SPT and that end with the transfer of the 
phosphocholine moiety from PC to the primary alcohol of a Cer by SMS isozymes 
(Figure 2-2; Huitema et al., 2004). Consequently, the accumulation of SM induced by 
2OHOA could be due to the regulation of various enzymes (Figure 2-1). However, the 
rapid increase in SM (Figure 2-5A) in addition to the decrease in PC content observed 
in our experiments (Table 2-3 and Figure 2-6) suggested that SMS was the molecular 
target for 2OHOA. Thus, we assessed SMS activity in cultured U118 cells using the 
fluorescent Cer analogue, NBD-C6-Cer (NBD-Cer, 3 μM, 3 h), in the absence or 
presence of 2OHOA (200 μM, 24 h). When cell lipids were extracted and separated by 
HPTLC in order to detect the newly synthesized NBD-C6-SM (NBD-SM), SMS 
activity in the presence of 2OHOA was 3.6-fold greater than that of control (untreated) 
cells (Figure 2-10A-B).  
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Figure 2-10. 2OHOA activated SMS isozymes in U118 cells. 
(A) Effect of duration of treatment on NBD-SM levels. Cells were incubated with NBD-Cer (3 μM, 3 h) and 
treated with 2OHOA (200 μM) for different times. (B) Representative TLC analysis of total lipid extracts 
from control and treated (200 μM, 72 h) U118 cells incubated with NBD-Cer. (C) In vitro SMS activity assay. 
Cell homogenates (100 μg protein) were incubated with NBD-Cer (0.1 μg/μl) for 2 h at 37ºC in the presence 
(200 μM) or absence of 2OHOA. (D) SMS1 and SMS2 isoforms activation was determined by a cell surface 
SMS assay. Control and treated cells (200 μM, 6 h) were incubated for 3 h at 0ºC with NBD-Cer (5 μM) in 
BSA-containing medium. Then, lipids were extracted from cells and medium. In all cases NBD-SM formation 
was determined HPTLC. Values represent the mean ± SEM, n = 3. The asterisks indicate a significant effect 
of the treatment as compared with the control (*P < 0.05; **P < 0.01). 
Because 2OHOA can rapidly enter the cells, as it was detected by gas 
chromatography (Figure 2-11), we investigated the effect of exposing cells incubated 
with NBC-Cer (3 μM, 3 h) to 2OHOA (200 μM) for 5, 15, and 60 min. SMS activity 
increased 85.5% after 5 min in the presence of 2OHOA, indicating that it has an 
extremely rapid effect on SMS. This rapid response and the highly fatty acid structure-
dependency described above suggested the possibility that 2OHOA directly interacts 
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and activates SMS. To address this possibility we carried out an in vitro SMS activity 
experiment. Thus, cells were homogenized with the zwitterionic detergent CHAPS (8% 
w/v) in order to disrupt cell membranes and the post-nuclear supernatant was incubated 
with NBD-C6-Cer (0.1 μg/μl) and 2OHOA (200 μM) for 2 h. In these in vitro 
conditions, 2OHOA increased SMS activity 80.5% (Figure 2-10C), indicating 
altogether a rapid and direct interaction between the drug and the enzyme.  
 
Figure 2-11. Detection of 2OHOA by gas chromatography in total cell lipid extracts. 
(A) Gas chromatograms showing the detection of 2OHOA in total cell lipids extracts. Green line, 2OHOA 
standard; blue line, control cells and red lines, 2OHOA treated cells (200 µM, 72 h). (B) Time-dependent 
accumulation of 2OHOA, each color line corresponds to different times of treatment (200 µM). Total lipids 
were transmethylated in acidic conditions as described in the Experimental procedures section.  
Having established that 2OHOA activates SMS, we studied next whether this 
effect might be selective for one of the SMS isoforms (Huitema et al., 2004). By 
adapting a procedure published previously (Tafesse et al., 2007), we found that both 
SMS1 and SMS2 isozymes were activated (2-2-fold and 1.8-fold, respectively), 
indicating that 2OHOA is a general SMS activator (Figure 2-10C). Moreover, there 
were no significant differences in SMS1 and SMS2 protein and mRNA expression in 
control and 2OHOA-treated cells (200 μM, 24 h; Figure 2-12), showing that the 
increase in SM mass was exclusively due to the specific activation of SMS isozymes by 
2OHOA, and not to increased SMS expression. 
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Figure 2-12. Effect of 2OHOA on SMS protein and mRNA levels in U118 cells. 
(A) Effect of 2OHOA on SMS protein levels as determined by quantitative immunoblotting (a representative 
immunoblot is also shown). (B) Effect of 2OHOA on SMS mRNA expression. U118 cells were incubated in 
the presence (200 µM, 24 h) or absence (control) of 2OHOA. Values are expressed as percentage of control 
and represent the mean ± SEM, n = 4. 
 
2.2.4 Inhibition of SMS by D609 reversed the effect of 2OHOA on the cell 
cycle progression in cancer cells 
2OHOA induces cell cycle arrest by increasing the proportion of cells in the 
G0/G1 phase (Lladó et al., 2010; Martínez et al., 2005a). To demonstrate the importance 
of SMS activation in the effect of 2OHOA against cancer, we examined how the 
inhibition of SMS expression, using specific small interference RNA (siRNA), and the 
inhibition of SMS activity, using the enzyme inhibitor D609, affected the cell cycle 
progression. Both experiments were initially done on U118 and A549 cells. Since both 
the silencing and the pharmacological inhibition worked better on A549 cells, the latter 
were selected to continue with these experiments. 
First, A549 cells were treated for 48 h with non-silencing siRNA (Scramble, 75 
nM), SMS1 (50 nM), or SMS2 (25 nM) siRNAs or both, in the presence or absence of 
2OHOA (200 µM, 24 h). After treatment, SM levels were determined by TLC while the 
effect of SMS knockdown on the cell cycle was evaluated by flow cytometry. As 
expected, in the absence of 2OHOA, SMS1 and SMS2 siRNAs, both individually or 
combined, reduced SM content by 50-60% compared to non-silenced cells (Scramble). 
However, in all cases, 2OHOA still induced an increase in SM content, probably by 
activating the remaining SMS (Figure 2-13C). In agreement with the cell surface assay 
previously shown (Figure 2-10), these results indirectly confirmed that 2OHOA 
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activated both SMS1 and SM2 enzymes. Because of this remaining SMS activity, 
2OHOA was able to induce cell cycle arrest in the double-silenced cells (Figure 2-13A-
B), since the distribution of cells in the G1 phase shifted from 54.3 ± 0.1% in the 
absence to 70.4 ± 1.7% cells in the presence of 2OHOA.  
 
Figure 2-13. 2OHOA induced SM accumulation and cell cycle arrest despite SMS1 and SMS2 
downregulation by siRNA. 
Effect of SMS knockdown by siRNA on cell cycle progression. (A) Representative histograms of control 
(untreated) and treated cells with 2OHOA (200 µM), exposed to specific SMS1 and SMS2 siRNA and non-
specific All Star siRNA sequence (Scramble siRNA). DNA content of A549 cells was measured by flow 
cytometry after a 48 h exposure to siRNA in the presence or absence of 2OHOA (200 µM, 24 h). (B) Bar 
graphs show the percentage of A549 cells in Sub-G1, G1, S and G2/M phases with respect to the total cell 
number; (C) Effect of SMS knockdown on SM content in A549 cells. SM content was determined by TLC as 
described in the Experimental Procedures section. Values represent the mean ± SEM, n = 2. 
Second, A549 cells were treated with D609 (350 µM, 17 h ), the only 
pharmacological SMS inhibitor known (Gonzalez-Roura et al., 2002; Li et al., 2007; 
Meng et al., 2004b). When A549 cells were exposed to 2OHOA (200 µM, 16 h) in the 
presence or absence of D609, the effect of 2OHOA on SM levels was reversed from 
172.1 ± 13.1% in the absence to 118.3 ± 20.1% in the presence of D609 compared to 
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control with D609 (117.8%). These results indicated that 2OHOA was not able to exert 
its effect on SMS, suggesting that D609 affected the interaction between 2OHOA and 
SMS. Indeed, the distribution of cells in the G1 phase of the cell cycle shifted from 50.7 
± 5.0% in the absence to 40.5 ± 4.1% cells in the presence of D609 (values compared to 
control with D609 30.1 ± 1.4%, Figure 2-14), showing that SMS inhibition diminishes 
2OHOA capability to induce cell cycle arrest. Therefore, these results indicate that SMS 
activation, and the subsequent accumulation of SM, plays an important role in the 
effects of 2OHOA against non-small cell lung adenocarcinoma cells growth. 
 
Figure 2-14. Inhibition of SMS by D609 diminished 2OHOA effect on the cell cycle progression. 
Effect of SMS pharmacological inhibition on cell cycle progression. (A) Representative histograms of control 
(untreated) and treated cells with 2OHOA (200 µM, 16 h) or with D609+2OHOA (350 µM, 17 h) are shown. 
DNA content of A549 cells was measured by flow cytometry after a 16 h exposure to 2OHOA (200 µM) in 
the presence or absence of D609 (350 µM). (B) Bar graphs show the percentage of A549 cells in in Sub-G1, 
G1, S and G2/M phases with respect to the total cell number. (C) Effect of SMS inhibition on SM content in 
A549 cells. SM content was determined by TLC as is described in the Experimental procedures section. 
Values represent the mean ± SEM, n = 3. The asterisks indicate a significant effect of the treatment as 
compared with the control (*P < 0.05; ***P < 0.001). In this case, § indicates a significant effect of the 
inhibition as compared with the treatment (§§ P < 0.01). 
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2.2.5 Impact of SMS activation on the sphingolipid rheostat 
In order to sustain the large increase in SM over the time, cells exposed to 
2OHOA must have a pool of Cer available. Three pathways individually or coordinately 
contribute to Cer synthesis, leading to the generation of Cer signaling and subsequent 
modulation of downstream cell responses: the de novo pathway, the salvage pathway, 
and the SMase pathway (Kitatani et al., 2008).  
Considering the rapid effect that 2OHOA had on SMS and the ensuing SM 
accumulation, we investigated the impact of 2OHOA over a wide range of exposure 
times (200 μM, 0.5-72 h) on U118 cells sphingolipid mass and composition, by mass 
spectrometry (MS). Consistently, while at short times (0.5-6 h) there were no significant 
changes; most of the sphingolipids were significantly affected after a 72 h exposure to 
2OHOA. Thus, while Cer and GlcCer increased 1.9-fold and 1.2-fold, respectively; 
LacCer decreased 28.6% in treated cells when compared to controls (Figure 2-15A-C). 
Regarding the sphingoid bases, Sph and dhSph increased 1.7-fold and 4.4-fold, 
respectively, when compared to non-treated cells (Figure 2-15E-F). Sph increase was 
further confirmed by HPLC (Figure A 3). It should be noted that whereas free dhSph is 
mostly generated by de novo sphingolipid biosynthesis, free Sph appears to derive 
exclusively from the turnover of complex sphingolipids (Figure 2-1). Thus, all Sph 
should be considered a product of hydrolysis of complex sphingolipids and then Cer 
(Kitatani et al., 2008). Therefore, these results indicate the de novo synthesis of Cer 
(through dhSph accumulation) and the salvage pathway (through Sph accumulation) 
were both activated by 2OHOA. Furthermore, this analysis showed a time-dependent 
accumulation of dhSM (Figure 2-15D), which derives metabolically from dhSph.  
The MS analysis allowed a detailed characterization of the molecular species of 
every class of lipid analyzed, which showed that indeed, 2OHOA profoundly remodeled 
the sphingolipid fatty acid profile (Figure 2-16). The most consistent change was the 
increase in C16- and C22-containing sphingolipid species in all the sphingolipids. Thus, 
after 72 h of treatment, C16-Cer, C16-GlcCer and C16-dhSM increased 2.2-fold, 3.0-
fold and 7.8-fold, respectively. Similarly, C22-Cer, C22-GlcCer and C22-LacCer 
increased 5.4-fold, 3.2-fold and 2.2-fold, respectively. Interestingly, the most abundant 
species in U118 control cells, C24 (24:0 and 24:1), were not affected (in Cer) or even 
reduced (in GlcCer and LacCer). 
Even though the accumulation of sphingolipids was consistent after an exposure 
of 72 h to 2OHOA, some significant changes were already detected after 24 h. 
2 SM and SMS in 2OHOA’s effect against cancer 
59 
 
Figure 2-15. 2OHOA affected U118 cells sphingolipid composition. 
U118 cells were exposed to 2OHOA for different times (200 µM, 0.5-72 h) and then lipids were extracted and 
analyzed by mass spectrometry. (A) Total Cer mass; (B) Total GlcCer mass; (C) Total LacCer mass; (D) 
Total dhSM mass; (E) Sph mass; (F) dhSph mass. Values represent the mean ± SEM, n = 3-4. The asterisks 
indicate a significant effect of the treatment as compared with the control (*P < 0.05; **P < 0.01; ***P < 
0.001). 
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Figure 2-16. 2OHOA modulated the sphingolipids molecular species profile. 
U118 cells were exposed to 2OHOA (200 µM, 72 h) and then lipids were extracted and analyzed by mass 
spectrometry. (A) Cer species mass; (B) GlcCer species mass; (C) LacCer species mass; (D) dhSM species 
mass. Values represent the mean ± SEM, n = 3. The asterisks indicate a significant effect of the treatment as 
compared with the control (*P < 0.05; **P < 0.01; ***P < 0.001). 
Each CerS has a high specificity toward the acyl-CoA chain length used for N-
acylation of the sphingoid base, thus, being responsible for the fatty acid composition of 
Cer (Table 2-1). For this reason, we determined if there was a correlation between CerS 
mRNA levels and Cer acyl chain lengths in control cells, comparing the distribution of 
Cer subspecies with that of the relative levels of CerS mRNA. Indeed, CerS2, which 
mainly synthesizes C24 species, was the most abundant enzyme, followed by CerS5 and 
CerS4, which synthesize C16 and C18-C20, respectively (Figure 2-17 A). CerS1 and 
CerS6 were extremely low and CerS3 was almost undetected, in agreement with its high 
tissue specificity for testis and skin. Despite the large increase in C16- and C18-
containing sphingolipids, no significant differences in CerS5 and CerS1 mRNA 
expression in 2OHOA-treated cells were observed when compared to control (200 μM, 
72 h; Figure 2-17B). The origin for the specific accumulation of C16-containing 
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sphingolipids is under research and may involve direct or indirect enzyme activation by 
2OHOA. 
 
Figure 2-17. CerS mRNA levels in U118 cells. 
(A) RNA was extracted from U118 control (untreated) cells and the levels of the different CerS were analyzed 
by qRT-PCR as described in Experimental Procedures. (B) Effect of 2OHOA on CerS1 and CerS5 mRNA 
expression. U118 cells were incubated in the presence (200 µM, 72 h) or absence (control) of 2OHOA. Values 
are expressed as percentage of control and represent the mean ± SEM, n = 4. 
Considering the indirect evidence that both the de novo synthesis and the salvage 
pathway were activated by 2OHOA, we further investigated both pathways. Activation 
of the de novo pathway can be detected selectively by pulse labeling with radioactive 
precursors, such as palmitate or serine, which are the substrates of the SPT, the first 
enzyme in this pathway (Figure 2-1). Thus, U118 cells exposed to 2OHOA for 6 and 24 
h were pulse-labeled with [H3]-palmitic acid for 5 min prior to extraction. Then, lipids 
were separated by TLC and quantified by liquid scintillation counting. [H3]-Cer content 
increased upon exposure to 2OHOA for 6 h and 24 h (7.8-fold and 5.6-fold, 
respectively; Figure 2-18), indicating that indeed the de novo synthesis pathway was 
activated. Interestingly, in agreement with the rapid activation of the SMS shown in the 
previous sections, [H3]-SM content also increased after 2OHOA treatment (2.7-fold 
after 6 h and 3.4-fold after 24 h). Finally, the detection of increased levels of [H3]-
LacCer and [H3]-cerebrosides provided further evidence for the activation of this 
pathway. 
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Figure 2-18. 2OHOA induced de novo Cer synthesis. 
U118 cells exposed to 2OHOA for 6 h (A) and 24 h (B) were pulse-labeled with [H3]-palmitic acid for 5 min. 
Then, the radioactive lipids were separated by TLC and quantified by liquid scintillation counting. 
Cerebrosides include GlcCer+GalCer; [H3]SP, [H3]sphingolipids. Values represent the mean ± SEM, n = 3. 
The asterisks indicate a significant effect of the treatment as compared with the control (*P < 0.05; **P < 
0.01; ***P < 0.001). 
We further studied this aspect by incubating control and treated (200 µM, 24 h) 
cells with different NBD-C6sphingolipid analogs (3 µM, 3 h), NBD-Cer, NBD-SM and 
NBD-C6-GlcCer (NBD-GlcCer; Figure 2-19). When cell lipids were analyzed in order 
to detect the synthesized NBD-sphingolipid products, results showed that 2OHOA 
significantly altered the sphingolipid metabolism. Thus, when cells were incubated with 
NBD-Cer, in addition to NBD-SM, an increased formation of NBD-GlcCer was 
observed, 5.9-fold and 11.6-fold, respectively. Similarly, when cells were incubated 
with NBD-SM, an increased formation of NBD-Cer (2.7-fold) and NBD-GlcCer (3.0-
fold) was observed. Finally, after NBD-GlcCer incubation, NBD-Cer and NBD-SM 
formation increased 4.6-fold and 5.3-fold, respectively (Figure 2-19). Altogether these 
experiments demonstrated that all enzymes participating in the sphingolipid turnover 
were activated after 24 h of treatment. 
Collectively, the experiment with radioactive- and fluorescent-labeled lipids 
provided further evidence that both the de novo synthesis and the salvage pathway were 
activated; indicating that 2OHOA completely altered the sphingolipid metabolism. 
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Figure 2-19. 2OHOA altered the turnover of sphingolipids in U118 cells. 
(A) Representative TLC of lipid extracts from control and 2OHOA treated cells (200 µM, 24 h) incubated 
with NBD-Cer (B), NBD-SM (C) and NBD-GlcCer (D) (3 µM, 3 h). After incubation, lipids were extracted 
and analyzed by TLC. NBD-C6-SP, NBD-C6-sphingolipids; AU, arbitrary units of fluorescence intensity. 
Values represent the mean ± SEM, n = 3. The asterisks indicate a significant effect of the treatment as 
compared with the control (*P < 0.05; **P < 0.01; ***P < 0.001). 
The breakdown of sphingolipids for recycling Sph takes place in the acidic 
compartments of the cells, the late endosomes and lysosomes (Kolter & Sandhoff, 2010; 
Tettamanti, 2004; Tettamanti et al., 2003). Taking this into account, further evidence 
supporting the salvage pathway activation was obtained by staining the lysosomes with 
Lysosensor, a fluorescent probe that labels the acidic organelles. After 72 h of exposure, 
we observed that 2OHOA (200 µM) induced the accumulation of lysosomes (Figure 
2-20), in agreement with the observed increase of sphingolipids at this time. Finally, an 
ultrastructural study also revealed that exposure to 2OHOA (200 µM, 72 h) induced the 
appearance of unidentified intracellular membranous, myelin-like bodies (Figure 2-21), 
probably constituted by the accumulated sphingolipids, such as SM.  
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Figure 2-20. 2OHOA increased the number of lysosomes. 
Representative micrographs of control and 2OHOA treated cells (200 µM, 72 h) labeled with Lysosensor, as 
explained in the Experimental procedures section. Scale bar =100 µM. 
 
2.3 SMS activation induced by 2OHOA led to deregulation of 
the sphingolipid metabolism 
Our first aim was to investigate the effects of 2OHOA on the composition of 
non-cancer and cancer cell membranes and the relationship of the induced changes with 
its activity against tumors. In the present work, we demonstrated that 2OHOA induces 
marked changes in the lipid composition of cancer cells that can in part explain its 
specificity against cancer and its mechanism of action. Thus, treatment of human 
glioma U118 cells with 2OHOA increased the SM mass 4.6-fold, while it decreased the 
PC and PE mass by 30 and 57%, respectively (Table 2-3). This effect of 2OHOA on 
SM accumulation was time- and concentration-dependent (Figure 2-5). Moreover, 
similar changes were observed in other glioma, leukemia and lung cancer cell lines 
(Jurkat, 1321N1 and A549 cells), while no such differences in phospholipid 
composition were observed in non-tumor MRC-5 cell membranes (Figure 2-4). These 
results reflect 2OHOA’s specificity against cancer cells and its failure to produce the 
toxic effects of other anticancer drugs. The incapacity to produce relevant effects on 
non-tumor MRC-5 cells could be due to the fact that these cells already contain high 
levels of SM such that SMS activation cannot further increase the amount of this lipid in 
membranes. Interestingly, in different normal tissues, higher SM levels have been found 
when compared to their tumors counterparts (Merchant et al., 1992; Merchant et al., 
1993; Merchant et al., 1995; Merchant et al., 1991b). Consequently, these results 
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highlight the potential role of the plasma membrane in the malignant transformation of 
many cancer cells and reinforce the importance of regulating its lipid composition. 
 
Figure 2-21. 2OHOA induced the appearance of myelin-like bodies and the formation of lipid droplets. 
(A-C) U118 were exposed to 2OHOA for 72 h, fixed and processed for electron microscopy. Magnification: 
20500 ×. Arrows, myelin-like bodies; LDs, lipid droplets. (D) Structures formed in Niemann-Pick disease 
caused by SM accumulation due to a deficiency of SMase. Cortical endothelial cell is filled with concentric 
membranous bodies and parallel palisaded lamellar bodies ("zebra bodies" - inset). E, erythrocyte; N, nucleus 
of endothelium; arrow, basal lamina. Scale bar = 2 µm (Human neocortex; Spacek, 2004). 
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SM and DAG are products of SMS, while PC and PE are substrates (Huitema et 
al., 2004; Ternes et al., 2009). Since 2OHOA increased the former and decreased the 
latter, we investigated the effects of 2OHOA on this enzyme. The effect of 2OHOA on 
DAG levels and metabolism is described in the next chapter. 2OHOA augments SMS 
activity (Figure 2-10A) whereas it has no effect on SMS mRNA and protein levels 
(Figure 2-12). Interestingly, activation of SMS by 2OHOA turned out to be extremely 
rapid and sustained, probably due to a direct interaction between 2OHOA and SMS. 
This direct interaction would explain the structural relationship between the fatty acid 
structure and SMS activation (Figure 2-7). Indeed, we found that the 2-hydroxy moiety, 
18 C atoms and at least one double bond in the fatty acid structure, were crucial to 
induce SM accumulation, 2OHOA being the most efficient molecule. The in vitro SMS 
activation in the presence of 2OHOA offers further evidence of the direct binding of 
this compound to the enzyme (Figure 2-10C). Considering that the metabolism of PC, 
PE and PS is interconnected (Figure 1-6), it is worth to mention that the increase in SM 
content (151 nmoles/mg protein) was similar to the total decrease in PC, PE and PS 
together (163 nmoles/ mg protein; Table 2-3). 
Here, we showed that 2OHOA can activate both SMS1 and SMS2 (Figure 
2-10D), probably due to the high structural similarity of these isoforms. Moreover, 
2OHOA rapidly enters the cell so that after a few minutes, both SMS1 and SMS2 are 
exposed equally to the drug (Figure 2-11). SMS2 activation, would be consistent with 
the rapid activation of the SMS (Figure 2-10A), since the catalytic site of this enzyme is 
exoplasmic (Huitema et al., 2004). Finally, additional evidence supporting SMS1 and 
SMS2 activation was obtained by using the specific interference RNA. Upon SMS1 or 
SMS2 knockdown, 2OHOA was still able to induce SM accumulation indicating that it 
activated both SMS isozymes. To our knowledge, 2OHOA is the first specific and direct 
activator of SMS. 
Upon SMS activation induced by 2OHOA, newly synthesized SM mainly 
accumulates in the plasma membrane (Figure 2-9). In addition, 2OHOA may enter the 
nucleus, which would provoke the increases in SM as a result of the activation of 
chromatin-associated or perinuclear SMS (Figure 2-8). Interestingly, increased SMS 
activity has been related to a decrease in DNA synthesis in rat hepatocytes (Albi et al., 
2003), which is consistent with previous studies showing that 2OHOA induces cell 
cycle arrest in cancer cells (Martínez et al., 2005a; Martínez et al., 2005b).  
Some studies suggest that SMS inhibition and the ensuing Cer accumulation are 
associated with the cell cycle arrest (Tafesse et al., 2007) or cell death (Lafont et al., 
2010; Separovic et al., 2007) in different tumor cell lines. However, recent studies show 
that reduced SM synthesis causes resistance to certain apoptosis-inducing drugs, such as 
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the lipopolysaccharide or the alkyl-lysophospholipid edelfosine (Ding et al., 2008; Van 
der Luit et al., 2007). On the other hand, increased SM membrane content appears to 
enhance Fas- and TNF-α induced apoptosis through the efficient clustering of FasR, or 
by increasing TNF-α receptor exposure at the plasma membrane (Ding et al., 2008; 
Miyaji et al., 2005). Analogously, decreased SM levels protect THP-1 derived 
macrophages from LPS-induced apoptosis (Miyaji et al., 2005). For all these reasons, 
the physiological significance of SMS goes beyond the mere regulation of Cer levels 
since SM modulates the biophysical properties of lipid rafts and the activity of the 
proteins they contain (Milhas et al., 2010). In this context, our results demonstrated the 
important role that SMS activation plays in 2OHOA antitumor mechanism attributing 
pro-apoptotic properties to the large and sustained SMS activation (Barceló-Coblijn & 
Martin et al, 2011). All these controversial results clearly point to a complex scenario, 
where the effect of SMS activation on cell fate would depend on, among other factors, 
the cell line, the type and intensity of the stimuli (Milhas et al., 2010) and even on the 
specific pool of regulated Cer (Hannun & Obeid, 2011; Senkal et al., 2010). Our current 
understanding of the role of SMS activation in the mechanism of 2OHOA against 
cancer is discussed in chapter 6. 
In order to sustain the large increase in SM, a pool of Cer must be available to 
the cells. Cer may be synthesized de novo or recycled through the salvage pathway 
(Kitatani et al., 2008). Our results indicated that indeed both pathways were activated 
by 2OHOA. In this regard, total Cer and GlcCer mass increased 1.9- and 1.2-fold, 
respectively, upon 72 h of treatment. In a similar way, Sph and dhSph mass increased 
1.7- and 4.4-fold, respectively, providing the first evidence that both pathways were 
activated because while dhSph is mostly generated by de novo sphingolipid 
biosynthesis, Sph appears to derive exclusively from the turnover of complex 
sphingolipids (Figure 2-1; Kitatani et al., 2008). It is worth to point out that increased 
SM was detected before any of the increased sphingolipids, suggesting that the 
sphingolipid accumulation is driven by the sustained increase in SM. Interestingly, the 
MS analysis showed that dhSM was particularly affected, increasing its content 4.6-fold 
after a 72 h exposure to 2OHOA. One possible explanation for this result could be that 
in order to maintain the large and sustained SMS activation, cells channel dhCer 
directly into the synthesis of dhSM bypassing the last step in the Cer synthetic pathway. 
However, the fact that dhCer desaturase could be inhibited by 2OHOA cannot be ruled 
out. In fact, inhibition of its function with siRNA along with the subsequent 
accumulation of endogenous dhCer, and possibly more complex dh-sphingolipids, leads 
to the cell cycle arrest in human neuroblastoma (SMS-KCNR) cells (Kraveka et al., 
2007). 
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Further evidence about the deregulation of the sphingolipid metabolism was the 
accumulation of C16- and C22-containing sphingolipids (Cer, dhSM and GlcCer; 
Figure 2-16). Interestingly, C16-Cer is associated with the induction of apoptosis in 
Ramos B-cells (Kroesen et al., 2001). When the amount of the fatty acyl-species was 
correlated with the mRNA levels of the CerS in control cells, CerS2, which synthesizes 
C20‑C26‑Cer (Table 2-1), was the most abundant CerS (Figure 2-17A). This would 
explain why C24-containing sphingolipids were the most abundant species in U118 
cells. Furthermore, previous works established CerS2 as the most ubiquitously 
expressed of all the CerS isoforms with the broadest tissue distribution (Laviad et al., 
2008). Particularly, CerS2 was found to have the highest expression of all CerS 
isoforms in oligodendrocytes and Schwann cells (Becker et al., 2008). Despite all these 
results, a differential effect induced by 2OHOA over the expression of CerS that 
synthesize the C16 and C18 species was not observed (Figure 2-17B). Interestingly, 
these fatty acid species, 16:0 and 18:0, also increased in glycerophopsholipids, as it will 
be shown in the next chapter.  
Upon activation of SMS, with the ensuing SM accumulation induced by 
2OHOA, the turnover of sphingolipids would be stimulated, as it was demonstrated by 
different means: i) by the metabolic labeling of cells with NBD-sphingolipids, and the 
consequent formation of different NBD-products induced by 2OHOA (Figure 2-19); ii) 
by a pulse-labeling experiment that showed the activation of the de novo Cer synthesis 
after 6 a nd 24 h of exposure to 2OHOA (Figure 2-18); and iii) by staining the 
lysosomes, where the recycling of sphingolipids occurs, showing that these acidic 
vesicles accumulated after a 72 h exposure to 2OHOA (Figure 2-20). In addition, the 
formation of unidentified myelin-like bodies was observed, probably related to the 
sphingolipid accumulation due to the sustained activation of SMS (Figure 2-21). These 
bodies reminded of the membranous bodies formed in Niemann-Pick disease caused by 
deficiency of SMase (Figure 2-21D). Finally, this accumulation of sphingolipids may 
account for the increased number of lysosomes observed after treatment. This result is 
in agreement with the 2OHOA-induced autophagy demonstrated in glioma cells 
(Marcilla-Etxenike et al., 2011; Terés et al., 2011), which is a h allmark of several 
sphingolipid metabolism disorders (Table 2-2). Autophagy is a vacuolar, self-digesting 
mechanism responsible for removal of long lived proteins and damaged organelles. 
Autophagosomes fuse with lysosomes for degradation of their cargo by lysosomal 
hydrolases. Aside from its role in survival during stress conditions, autophagy can also 
serve as a p rogrammed cell death mechanism, with impairment of autophagosome-
lysosome fusion or overinduction of autophagy leading to autophagosome accumulation 
and cell death (Vitner et al., 2010). 
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In conclusion, this chapter provides new insights into the antitumor molecular 
mechanism of action for 2OHOA and demonstrates its specificity against tumor cells 
via SMS activation that results in a r obust increase in SM mass. To sustain this 
activation, the whole sphingolipid metabolism is altered, both the de novo synthesis and 
the salvage pathway, inducing a kind of sphingolipidoses that would contribute to the 
effect of 2OHOA against cancer.  
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3 SCD1 inhibition was involved in the 2OHOA’s 
antitumor mechanism 
3.1 Stearoyl-CoA Desaturases 
The processes of cell growth, proliferation and survival require the formation of 
new membranes, which implies the production of new lipids with an appropriate 
molecular composition. A basic step in the synthesis of lipids is the formation of 
saturated (SFA) and monounsaturated (MUFA) fatty acids, the major fatty acid species 
in mammalian cells (Igal, 2010). De novo fatty acid synthesis involves three key 
enzymes, ATP citrate lyase (ACL), acetyl-CoA carboxylase (ACC) and fatty-acid 
synthase (FAS). ACL catalyzes the conversion of citrate to acetyl-CoA, thus connecting 
glycolysis to lipogenesis; ACC carboxylates acetyl-CoA to form malonyl-CoA, which 
is further converted by FAS to long-chain fatty acids (Mashima et al., 2009). As 
building blocks of glycerolipids, glycerophospholipids, and cholesteryl esters, these 
fatty acids are fundamental constituents of membrane structures, vital pools of 
metabolic energy and important mediators/signals that regulate many cellular activities 
(Igal, 2010). 
Stearoyl-CoA desaturase (SCD) is the rate-limiting enzyme in the biosynthesis 
of MUFAs. Also known as fatty acyl-CoA delta-9 desaturase, this ER-resident enzyme 
catalyzes the introduction of the first double bond in the cis delta-9 position (between 
carbons 9 a nd 10) of several saturated fatty acyl-CoAs, mainly palmitoyl-CoA and 
stearoyl-CoA, to yield palmitoleoyl- and oleoyl-CoA, respectively (Figure 3-1). This 
reaction catalyzed by SCD, also requires NADPH, cytochrome b5 reductase, and 
cytochrome b5 in the presence of molecular oxygen (Enoch et al., 1976). Based on 
recent isotope kinetic data of the plant desaturase, the current hypothesis for the 
desaturation reaction is that the enzyme removes hydrogen atoms starting with the one 
at the C-9 position, followed by the removal of the second hydrogen atom from the C-
10 position. Fatty acid desaturation is an oxidation reaction and requires molecular 
oxygen and two electrons. However, oxygen itself is not incorporated into the fatty acid 
chain but is released in the form of water (Ntambi & Miyazaki, 2004). The human 
SCD1 gene is ubiquitously expressed, with highest levels in brain, liver, heart and lung 
(Zhang et al., 1999). 
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Figure 3-1. A simplified pathway for the synthesis of monounsaturated fatty acids and their 
incorporation into glycerolipids and glyerophospholipids.  
Stearate can be reconverted to palmitate by β-oxidation. SCD1, stearoyl-CoA desaturase 1; FAS, fatty acid 
synthase; ACC, acetyl-CoA carboxylase (Kim & Ntambi, 1999). 
Oleic acid is the preferred substrate for acyl-CoA:cholesterol acyltransferase and 
DGAT, the enzymes responsible for cholesteryl ester and TAG synthesis, respectively. 
Thus, the regulation of SCD is very diverse and could affect a v ariety of key 
physiological variables, including insulin sensitivity, metabolic rate, adiposity, 
atherosclerosis and cancer. In order to support continuous cell proliferation, cancer cells 
coordinate the activation of lipid biosynthesis and the signaling networks that stimulate 
this process. In fact, elevated expression and activity of SCD1 have been detected in 
several types of cancers and cancer cells. Moreover, the essential role of SCD1 in 
cancer cell mitogenesis was unambiguously demonstrated by recent work in which 
suppression of SCD1 by genetic and pharmacological means led to a slower rate of cell 
proliferation and decreased survival in different types of cancer cells (Fritz et al., 2010; 
Li et al., 1994; Scaglia et al., 2005; Scaglia et al., 2009).  
Excessive content of long chain fatty acids, especially SFA, triggers 
programmed cell death in a p rocess known as lipid mediated toxicity or lipoapoptosis 
(Schaffer, 2003). The protective action of SCD1 against SFA-mediated apoptosis was 
observed in non-transformed mammalian cells in which overexpression of SCD1 
blocked the induction of programmed cell death by palmitic acid (Listenberger et al., 
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2003). TAG accumulation in response to acute lipid overload represents an initial 
cellular defense against lipotoxicity. Induction of lipid droplets (LDs) with exogenous 
fatty acids can be regarded as a simple channeling of excess material into neutral lipids 
that are stored in LDs (Listenberger et al., 2003). However, the fact that different fatty 
acids induce different types of LDs suggests a more complex scenario. 
 
Figure 3-2. Anatomy of a lipid droplet. 
The structural features of a lipid droplet. The surface is formed by a monolayer of polar 
lipids (e.g., phospholipids and sterols) and a variety of proteins, whereas the core contains 
nonpolar lipids (e.g., sterol esters and triacylglycerols). The proteins include DGAT2, 
Rab18, perilipin, and CTP:phosphocholine cytidylyltransferase (CCT); the rate-limiting 
enzyme in phosphatidylcholine synthesis. Several hypothetical mechanisms for how proteins 
interact with the lipid droplet are shown, including amphipathic α helices, embedding of 
hydrophobic regions directly in the droplet, and lipid anchors (Adapted from Krahmer et al., 
2009). 
As it was mentioned in the Introduction section, LDs are key cellular organelles 
involved in lipid storage and mobilization (Figure 3-2). Most cells in culture form LDs 
whenever there is lipid availability from the medium. When maintained in serum-
deprived conditions, cells are practically devoid of LDs, which appear upon addition of 
complete serum, containing lipoproteins and increase in number and size when free 
fatty acids are supplemented at nontoxic concentrations (Gubern et al., 2008). A number 
of proteins associated with LDs have been characterized over the years. Among them, 
the best known is the perilipin-adipophilin-TIP47 family of proteins, termed collectively 
PAT (Brasaemle, 2007; Kimmel et al., 2010; Miura et al., 2002). Adipophilin, also 
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called adipose differentiation-related protein (ADRP), is a constitutive PAT protein, 
which is degraded in the absence of LDs, and therefore expression levels of this protein 
reflect the mass of stored neutral lipids (Brasaemle et al., 1997). Unlike perilipin, which 
is specific for adipocytes and steroidogenic cells, ADRP is expressed ubiquitously 
(Brasaemle et al., 2000). 
In addition, exogenously added fatty acids, indeed, can be incorporated into 
glycerolipids and glycerophospholipids either by acylation of glycerophosphate to 
phosphatidic acid, through de novo synthesis via the Kennedy pathway (Kennedy, 
1961), or by remodeling of de novo synthesized glycerophospholipids via deacylation-
reacylation (Lands, 1958) or the MAG-pathway in the case of glycerolipids (Figure 
1-6). Most mammalian cells continually synthesize, remodel, transport and degrade 
glycerophospholipids and glycerolipids. Whether a fatty acid is incorporated into 
glycerolipids and glycerophospholipids by the de novo or remodeling pathways can 
depend on its structure (Schmid et al., 1995). In particular, hydroxyl fatty acids have 
been exclusively found in sphingolipids (Hama, 2010). Thus, part of the metabolic fate 
of 2OHOA is revealed in this chapter. 
In this chapter we show that 2OHOA remodeled the fatty acid profile of tumor 
cells, being the most notorious changes the decrease in oleic acid, the increase in stearic 
acid and the incorporation of 2OHOA into different lipid classes. In addition, the 
decrease in oleic acid and the increase in stearic acid were linked to the SCD1 inhibition 
induced by 2OHOA. Finally, the analysis of the neutral lipid fraction showed an 
increase in the formation of DAG, free fatty acids (FFA) and TAG levels, with the 
ensuing formation of LDs.  
 
3.2 Results  
3.2.1 2OHOA induced reduction of oleic acid content in cancer cells 
In the previous chapter we have demonstrated how 2OHOA affects 
glycerophospholipid composition of tumor cells. In this chapter, we analyzed the effects 
of 2OHOA on tumor cell fatty acid composition. Thus, human glioma (U118) cells were 
first treated with 2OHOA at 200 µM for 72 h. After extraction, lipids were separated by 
TLC, and PE and PC fractions were collected, transesterified in basic conditions and 
analyzed by gas chromatography.  
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Table 3-1. Effect of 2OHOA on fatty acid composition of individual phospholipid of human glioma 
U118 cells. 
 
 
U118 cells were treated with 2OHOA (200 µM, 72 h). After treatment, lipids were extracted and analyzed by 
TLC. The PC and PE fractions were converted to FAME and analyzed by gas chromatography. Values are 
expressed as mole% and represent mean ± SD, n = 4-5. The asterisks indicate a significant effect of the 
treatment as compared with the control (*P < 0.05; **P < 0.001; ***P < 0.001). 
We observed a profound effect on the PE and PC fatty acid composition upon 
2OHOA treatment (Table 3-1). Particularly, oleic acid (18:1n-9), which is structurally 
related to 2OHOA, was reduced 44% in PC and 55% in PE. This decrease accounted for 
most of the reduction in MUFA, 39% and 49%, in PC and PE, respectively, together 
with cis-vaccenic acid (18:1n-7), reduced by 24% in PC and 32% in PE. In contrast, 
SFA increased 42% in PC and 66% in PE. PC SFA included primarily palmitic acid 
(16:0) and stearic acid (18:0), which increased 37% and 55%, respectively; while PE 
SFA increase was mainly due to 18:0 (94%). In addition, total PUFA levels increased 
2.5-fold in PC, but only 17% in PE. Within total PUFA, n-3 increased 3.1-fold while n-
6 increased 2.0-fold in PC. These changes affected, in both phospholipids, the n-3 to n-6 
FAME 
PC PE 
Control 2OHOA Control 2OHOA 
 Mean ± SD  Mean ± SD  Mean ± SD  Mean ± SD 
16:0  32.3 ± 1.4  44.4 ± 2.8***    4.4 ± 0.9    1.7 ± 0.3*** 
18:0    7.2 ± 0.2  11.2 ± 0.5***  15.5 ± 0.5  30.2 ± 0.6*** 
18:1n-9  42.1 ± 0.6  23.7 ± 1.1***  33.2 ± 1.9  14.8 ± 0.4*** 
18:1n-7  13.0 ± 0.5    9.8 ± 0.6***    9.5 ± 0.4    6.4 ± 0.2*** 
20:3n-6    0.5 ± 0.2    1.1 ± 0.1***    2.7 ± 0.6    2.7 ± 0.2 
22:0    0.8 ± 0.1    1.7 ± 0.3***    3.5 ± 0.9    7.0 ± 1.0*** 
20:4n-6    0.8 ± 0.2    1.6 ± 0.2***  12.6 ± 0.3    9.7 ± 0.3*** 
20:5n-3    0.3 ± 0.2    0.4 ± 0.1    3.0 ± 0.4    1.4 ± 0.2*** 
22:5n-3    0.5 ± 0.2    1.9 ± 0.4**    8.5 ± 0.7  12.9 ± 0.3*** 
22:6n-3    0.6 ± 0.2    2.2 ± 1.0*    7.2 ± 1.9  13.1 ± 0.5*** 
SFA  40.3 ± 1.2  57.3 ± 2.1***  23.4 ± 0.7  38.9 ± 1.1*** 
MUFA  56.2 ± 0.6  34.1 ± 1.8***  42.7 ± 2.3  21.4 ± 0.6*** 
PUFA    3.5 ± 0.9    8.6 ± 1.4***  33.9 ± 2.7  39.7 ± 1.4*** 
n-3    1.4 ± 0.5    4.4 ± 1.2***  18.6 ± 2.5  27.4 ± 1.0** 
n-6    2.1 ± 0.4    4.2 ± 0.4***  15.3 ± 0.8  12.3 ± 0.4*** 
n-3/n-6    0.6 ± 0.16    1.1 ± 0.28*    1.2 ± 0.17    2.2 ± 0.02*** 
3 SCD1 is inhibited by 2OHOA 
76 
ratio, which increased 66% in PC and 82% in PE. In a s imilar way, oleic acid level 
decreased and palmitic acid increased in total lipid extracts (Table A 3). 
To further study the fatty acid profile remodeling induced by 2OHOA, U118 
cells were treated for 12, 24, 48 and 72 h at 200 µM and the PC and PE the fatty acid 
composition was analyzed (Figure 3-3). In this context, oleic acid was significantly 
reduced in treated cells at all times in both glycerophospholipids, with a concomitant 
increase in stearic acid. Interestingly, oleic acid levels in control (untreated) cells 
increased with time (ca. 31% at 12 h to 42% at 72 h in PC and ca. 20% at 12 h to 33% at 
72 h in PE) while remained constant in treated cells (ca. 24% in PC and ca. 14% in PE). 
On the contrary, stearic acid content followed the opposite pattern. While it d id not 
change in control cells (ca. 7% in PC and ca. 14% in PE), it increased in treated cells 
(ca. 9% at 12 h to 11% at 72 h in PC and ca. 19% at 12 h to 30% at 72 h in PE). 
 
Figure 3-3. Time dependent changes in fatty acids induced by 2OHOA in U118 cells. 
U118 cells were treated in the presence or absence of 2OHOA (200 µM, 12-72 h). After treatment lipids were 
extracted and analyzed by TLC. PC (A and C) and PE (B and D) fractions were converted to FAME in basic 
conditions and analyzed by gas chromatography. The bar graphs show the oleic acid content (A, B); and the 
stearic acid content (C, D). Values are expressed as mole% and represent mean ± SD, n= 4-5. The asterisks 
indicate a significant effect of the treatment as compared with the control (*P < 0.05; ***P < 0.001). 
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To determine whether the observed changes in fatty acid composition occurred 
in other tumor cells, we analyzed the effect of 2OHOA on the fatty acid composition in 
human non-small cell lung cancer (A549) cells and an additional line of human glioma 
(SF767) cells (Figure 3-4). After 2OHOA treatment (200 µM, 72 h), Oleic acid 
decreased 52% in PC and 41% in PE, while stearic acid increased 2.7-fold in PC and 
62% in PE, in A549 cells. Likewise, oleic acid was reduced 17% in PC and 40% in PE, 
while stearic acid increased 19.2% only significantly in PE, in SF767 cells. Altogether, 
these results indicated that the effect on fatty acid composition was not dependent on 
the particular type of tumor. The complete fatty acid profile of SF767 and A549 cells is 
shown in the appendix (Table A 1 and Table A 2, respectively). 
 
Figure 3-4. 2OHOA reduced oleic acid content in different cancer cells. 
Different cancer cells (U118, SF767 and A549) were treated with 2OHOA (200 µM, 72 h). Lipids were 
extracted and separated by TLC. PC (A and C) and PE (B and D) fractions were converted to FAME in basic 
conditions and analyzed by gas chromatography. The bar graphs show the oleic acid content (A, B), and the 
stearic acid content (C, D). Values are expressed as mole% and represent mean ± SD, n= 4-5. The asterisks 
indicate a significant effect of the treatment as compared with the control (***P < 0.001). 
 
3 SCD1 is inhibited by 2OHOA 
78 
3.2.2 2OHOA was incorporated into different lipid classes 
The presence of 2OHOA in total lipid extracts has been already shown (Figure 
2-11), but it remained to be determined if it stayed as a FFA or if it was incorporated 
into any lipid fraction. TLC analysis of control and 2OHOA treated U118 cells (200 
µM, 24 h) allowed the detection of free 2OHOA. Interestingly, 2OHOA’s RF (Ratio of 
Front) was considerably different than the RF of FFA (Figure 3-6). Despite these 
results, part of 2OHOA could still be incorporated into lipids. In order to detect 
2OHOA, lipid extracts were analyzed by mass spectrometry (MS), as hydroxyl fatty 
acids are not transesterified in the basic conditions used in the previous fatty acid 
analysis (Barceló-Coblijn et al., 2010). Thus, U118 cells were treated with 200 µM 
2OHOA for a wide range of incubation times (0.5 – 72 h) and it was observed that at 
least part of the 2OHOA was primarily incorporated into glycerophospholipids and 
glycerolipids TAG and DAG (Figure 3-5 and Figure 3-7).  
 
Figure 3-5. Mass spectra from glycerolipids containing 2OHOA. 
U118 cells were treated in the presence or absence of 2OHOA (200 µM, 24 h). After treatment lipids were 
extracted and analyzed by LC/MS. The peak corresponding to 893.0 represents TAG containing OH-52:2 and 
the peak corresponding to 628.8 represents DAG containing OH 34:1. The spectra are normalized to the 
highest peak in both control and treated sample. 
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Figure 3-6. 2OHOA remained in part as a free fatty acid. 
U118 cells were exposed to 2OHOA (200µM) for 24 h. Then, lipids were extracted and analyzed by TLC. (A) 
Representative HPTLC for neutral lipids, separated in petroleum ether/diethyl ether/acetic acid (75:25:1.3 by 
vol) (Marcheselli, 1988). (B) Representative separation by TLC (Kuerschner et al., 2005). After running two-
thirds of the separation distance in chloroform/ethanol/water/triethylamine (35:40:9:35, by vol.), the plates 
were dried and subsequently separated in isohexane/ethylacetate (5:1, by vol) for the full distance. 
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Figure 3-7 clearly shows the time-dependent accumulation of 2OHOA into the 
glycerophospholipid fraction with the highest incorporation into PC (30.1% ± 0.3%) 
and PE (29.0% ± 0.7%) after 72 h. 2OHOA was also incorporated, although to a lesser 
extent, into PS (11.7% ± 0.47%) and PI (13.4% ± 1.3%). Interestingly, 0.5 h o f 
treatment was sufficient to observe a significant incorporation of 2OHOA into PC, 
while for PE, 6 h of treatment were needed. In the case of PS and PI, its incorporation 
was significant after 24 h of treatment. These results not only indicate that 2OHOA was 
replacing its analogue oleic acid but they can also support that the kinetics of fatty acid 
incorporation depends on the particular glycerophospholipid. 
 
Figure 3-7. 2OHOA was incorporated into the glycerophospholipid fraction. 
U118 cells were treated in the presence or absence of 2OHOA (200 µM, 0.5-72 h). After treatment lipids were 
extracted and analyzed by LC/MS. Values are expressed as % of total fatty acids and represent mean ± SEM, 
n= 3-4. Line plots show PC (A), PE (B), PS (C) and PI (D) OH-species content. The asterisks indicate a 
significant effect of the treatment as compared with the control (*P < 0.05; **P < 0.01; ***P < 0.001). 
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3.2.3 2OHOA inhibited SCD1 
The severe decrease in oleic acid in addition to the increase in stearic acid 
(Figure 3-4 and Figure 3-3), not only in the glycerophospholipid fraction but also in the 
total lipid extract (Table A 3), clearly suggested that the rate of Δ9-desaturation could 
be affected. For this reason, we evaluated the effect of 2OHOA on SCD1 activity, by 
measuring the conversion of exogenous [H3]-palmitic acid (16:0) into MUFA. Thus, 
control and treated cells (200 µM, 48 h) were incubated with [H3]-palmitic acid for 6 h. 
After incubation, lipids were extracted; transesterified in basic conditions, and FAME 
were then separated by argentation TLC. The MUFA spot was scraped and radioactivity 
was measured by scintillation counting. Figure 3-8 shows that [H3]-MUFA levels were 
reduced 48% in treated cells compared to control cells, indicating that SCD1 was 
significantly inhibited by 2OHOA. 
These results indicate that the SCD1 inhibition, in addition to the incorporation 
of 2OHOA into the glycerophospholipid fraction, are the main processes driving the 
profound fatty acid remodeling induced by 2OHOA.  
 
Figure 3-8. 2OHOA inhibited SCD1. 
Control and treated (200 µM, 48 h) U118 cells were labeled with [H3]-palmitic acid (0.25 µCi/ 
60 mm petri dish) for 6 h. Conversion of [H3]-palmitic acid to [H3]-MUFA was measured 
following the separation of FAME on TLC plates impregnated with silver nitrate and 
determination of radioactivity as indicated in the Experimental procedures section. Values 
represent the mean ± SEM, n= 3-4. The asterisks indicate a significant effect of the treatment as 
compared with the control (**P < 0.01). 
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3.2.4 2OHOA affected neutral lipid composition 
Because 2OHOA was also incorporated into the glycerolipids TAG and DAG, 
we next studied the effect of 2OHOA on these lipids. Lipid extracts from control and 
2OHOA treated U118 cells (200 µM) at different times were analyzed by HPTLC. 
Results showed that although TAG levels increased at all times they followed a cyclic 
pattern (Figure 3-9). Thus, the increases in TAG peaked after 12 h and 48 h of treatment 
(6.7-fold and 8.5-fold, respectively), while after 24 h and 72 h the increases were more 
modest (2.6-fold and 2.4-fold, respectively). This increase in TAG after treatment was 
further confirmed by mass spectrometry (Figure A 4). In addition, similar increases in 
TAG levels were observed in A549 and SF767 cells (Figure A 5).  
 
Figure 3-9. 2OHOA induced TAG accumulation in U118 cells. 
U118 cells were exposed to 2OHOA (200 µM) for different times. Lipids were 
extracted and neutral lipids were analyzed by HPTLC as explained in the 
Experimental procedures section. Results are means ± SEM, n=3. The asterisks 
indicate a significant effect of the treatment as compared with the control (**P < 
0.01). 
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Figure 3-10. Representative phase-contrast micrographs (100 × magnification) of U118 cells exposed to 
2OHOA or OA (200 μM, 24 h). 
 
The observation of treated cells by phase contrast microscopy showed the 
presence of white round vesicles of unknown nature (Figure 3-10). Taking into account 
that 2OHOA induced increases in TAG levels, we explored the possibility that these 
vesicles could be LDs. Exposure to oleic acid (OA, 100 µM, 2 h) was used as a positive 
control, as it is  well established that OA induces the formation of LDs (Gubern et al., 
2008). As it can be observed in Figure 3-11, after the exposure to 2OHOA (200 µM, 24 
h), there was an increased number of LDs with an increased total area and particle 
average size in comparison to control cells. Interestingly, when compared to cells 
exposed to OA, the number of particles and the total area were smaller, while the 
particle average size was bigger (Figure 3-11A-D). These results suggested that 
2OHOA was metabolized differently than OA, inducing, after a longer period of 
exposure, less but larger LDs. Finally, the formation of LDs was confirmed by the 
presence of ADRP analyzed by western blot (Figure 3-12) and by electron microscopy 
(Figure 2-21). 
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Figure 3-11. 2OHOA induced lipid droplet formation. 
U118 cells were treated in the absence (Control) or presence of 2OHOA (200 µM, 24 h) or OA (100 µM, 
2 h). (A) After treatment cells were fixed and stained with Nile Red (green for LDs) and Hoescht (blue 
for nuclei). The presence of LDs was quantified by fluoresce microscopy with ImageJ analysis of total 
particle/cell (B), total LDs area/cell (C) and average size (D) in 9 micrographs from each experimental 
condition. Bar scale = 100 µM. Results are means ± SEM of three experiments, each carried out with 
triplicate determinations. The asterisks indicate a significant effect of the treatment as compared with the 
control (***P < 0.001). In this case, § indicates a significant effect of OA compared with 2OHOA 
treatment (§§§ P < 0.001). 
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Figure 3-12. 2OHOA induced ADRP formation. 
Western blot of ADRP in total cell extracts under the three experimental conditions. U118 cells 
were treated in the absence (Control) or presence of 2OHOA (200 µM, 24 h) or OA (100 µM, 2 
h). Results are means ± SEM of three independent experiments carried out by triplicate. The 
asterisks indicate a significant effect of the treatment as compared with the control (**P < 0.01; 
***P < 0.001). 
Hitherto, we have described the effect of 2OHOA on TAG levels. In addition, 
the analysis of the neutral lipid separation led to additional information. Thus, 
cholesterol mass increased 1.3-fold after 72 h of treatment and FFA levels (which did 
not include 2OHOA, Figure 3-6) increased 3.1-fold and 2.3-fold, after 24 h and 48 h of 
treatment, respectively. The 1,2-DAG levels increased 2.5-fold only after 24 h  of 
treatment. Finally, the TLC analysis showed the presence of a band of unknown nature. 
Consistently, similar changes were found in A549 and SF767 glycerolipid composition 
(Figure A 5).  
As it was previously indicated, PC is the donor of the phosphocholine group, 
which is transferred by SMS onto the primary hydroxyl group of Cer, generating DAG 
as an additional product of the reaction (Huitema et al., 2004; Ternes et al., 2009). 
Interestingly, DAG levels did not follow the same increase pattern as SM (Figure 2-5), 
probably because, as a crucial signaling lipid, the increased DAG production is 
compensated by channeling it into TAG formation or into its degradation to MAG. To 
address this issue, control and 2OHOA treated cells (200 µM, 24 h) were incubated with 
the fluorescent phospholipid analogues NBD-C6-PC (NBD-PC) or NBD-C6-PE (NBD-
PE; 3 µM, 4 h), which contain the NBD-fluorescent moiety at the sn-2 position of the 
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glycerol backbone. The analysis of lipids by TLC revealed new insights on the effect of 
2OHOA on lipid metabolism (Figure 3-14). First, it was demonstrated that 2OHOA 
increased the formation of NBD-DAG. Interestingly, the increase was larger when cells 
had been incubated with NBD-PE than with NBD-PC. In addition, the TLC analysis 
showed that 2OHOA activated the conversion of NDB-PE to NBD-PC, which 
confirmed the interconnection between PE and PC metabolism, suggested in the 
previous chapter (Figure 2-6). Second, the TLC analysis showed that NBD-DAG was 
probably being degraded to NBD-MAG, since no NBD-TAG could be detected. 
 
Figure 3-13. 2OHOA affected U118 neutral lipid composition. 
U118 cells were treated in the presence or absence of 2OHOA (200 µM, 12-72 h). After treatment lipids were 
extracted and analyzed by TLC. (A) Free fatty acids (FFA); (B) Cholesterol (Cho); (C) DAG. Values are 
OD/mg protein and are expressed as % of control and represent mean ± SD, n= 4-5. The asterisks indicate a 
significant effect of the treatment as compared with the control (*P < 0.05; **P < 0.01; ***P < 0.001). 
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Figure 3-14. DAG from PC was converted into MAG. 
Control and treated cells (2OHOA, 200µ, 24 h) were incubated with NBD-C6-PC or NBD-C6-PE for 3 h. 
After incubation, lipids were extracted and analyzed by TLC. (A) Separation was achieved by using two 
solvent system (Kuerschner et al., 2005). Thus, after running two-thirds of the separation distance in 
chloroform/ethanol/water/triethylamine (35:40:9:35, by vol.), plates were dried and subsequently separated in 
isohexane/ethylacetate (5:1, by vol) for the full distance. (B) Neutral lipids were separated in petroleum 
ether/diethyl ether/acetic acid (75:25:1.3 by vol) (Marcheselli, 1988). The image contrast was saturated for a 
better visualization of minor bands (image on right side of the panel indicated by an arrow).  
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3.3 2OHOA incorporation into glycerolipids and 
glycerophospholipids provoked a profound fatty acid 
remodeling 
In the previous chapter it was demonstrated that 2OHOA affects the 
glycerophospholipid composition of different cancer cells (U118, A549, 1321N1, Jurkat 
and SF767), but it d oes not affect the non-tumor MRC-5 cells. Specifically, 2OHOA 
treatment strongly augmented SM mass, while a loss of PE and PC was observed. In 
this chapter, based on the fatty acid nature of 2OHOA, we demonstrated that 2OHOA 
profoundly remodeled the fatty acid profile of cancer cells. Among the fatty acids, oleic 
acid, a structural analogue to 2OHOA, was the most affected by the treatment, 
decreasing significantly in the main membrane lipids PC and PE in the cell lines studied 
(U118, SF767 and A549 cells). While in PC the reduction in oleic acid was between 20-
50%, in PE it was between 40-60%, depending on the cell line (Table 3-1 and Figure 
3-4). This is a very significant reduction, considering that oleic acid is the most 
abundant fatty acid in these cell lines. In order to explain this reduction two possibilities 
were explored: its substitution by 2OHOA and the potential inhibition of SCD1, which 
would consequently inhibit the synthesis of oleic acid. 
MS analysis of the glycerophospholipid fraction revealed that 2OHOA was 
mainly incorporated into the major glycerophospholipids fractions PC and PE, and to a 
lesser extent into PS and PI, indicating that indeed 2OHOA could be replacing oleic 
acid. In fact, taking into account the glycerophospholipid composition (Table 2-3), 
2OHOA would account for ca. 15% of the total fatty acids composition, becoming one 
of the most abundant fatty acids in membranes from glioma treated cells. It is worth 
mentioning that 2OHOA was also incorporated into the glycerolipid fraction, mainly 
into TAG and DAG, while no incorporation into sphingolipids was detected. The latter 
was somehow unexpected since endogenous hydroxyl fatty acids have been found 
almost exclusively as N-acyl chains within the Cer moiety of a variety of sphingolipids 
while there is no evidence in the literature supporting the incorporation of hydroxyl 
fatty acids into glycerophospholipids in mammals (Hama, 2010). This difference may 
rely on the exogenous nature of 2OHOA. Thus, upon activation of 2OHOA by its 
conversion to 2OHOA-CoA (Foulon et al., 2005), 2OHOA would be incorporated into 
the DAG-pathway and consecutively into the Kennedy-pathway (Kennedy, 1961). 
Moreover, it could also be subjected to a rapid turnover of the acyl moiety (probably the 
sn-2) of glycerophospholipids (Hishikawa et al., 2008; Lands, 1958). Therefore, these 
results would be the first evidence of the incorporation of hydroxyl fatty acids into 
glycerolipids and glycerophospholipids. 
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It is well documented that various tumors undergo exacerbated endogenous fatty 
acid biosynthesis irrespective of the levels of extracellular lipids (Kuhajda, 2006; 
Rashid et al., 1997; Swinnen et al., 2000). In contrast, most adult normal tissues, even 
those with high cellular turnover, preferentially use circulating fatty acids for the 
synthesis of new structural and signaling lipids (Mashima et al., 2009). That is why 
noncancer cells do not have relevant requirements of de novo lipid synthesis, and 
therefore, normal cells are not sensitive to inhibition of this pathway (Fritz et al., 2010). 
In addition, it is known that cancer cells and tumors usually have elevated oleic acid and 
lower stearic acid content than their normal non-tumor counterparts (Mikirova et al., 
2004), leading to the possibility of considering the oleic acid/stearic acid ratio as a 
tumor marker (Cvetkovic et al., 2010; Meng et al., 2004c).  
In this context, previous studies show a strong functional association of SCD1 
activity with membrane lipid synthesis in neoplastic cells (Scaglia et al., 2005; Scaglia 
& Igal, 2008). Accordingly, the induction of apoptosis with etoposide and Cer led to the 
downregulation of SCD1 activity and expression, accompanied by a decrease in oleic 
acid and an increase in stearic acid (Ariyama et al., 2010; Fritz et al., 2010; Scaglia & 
Igal, 2005). This chapter showed that SCD1 activity decreased by ca. 50% upon 
2OHOA treatment, suggesting that the SCD1 inhibition could be an additional factor 
contributing to the effect of 2OHOA on the cell cycle. At least two possibilities, may 
explain the observed SCD1 inhibition. First, SCD1 could be inhibited by oleic acid 
released induced by substitution for 2OHOA, as oleyl-CoA is a good competitive 
inhibitor of the desaturase enzyme (Enoch et al., 1976). Second, because of the Δ9 
insaturation present in 2OHOA, and their high structural similarity, SCD1 could 
recognize it as an end product, inhibiting consequently its activity.  
Although it requires further investigation, SCD1 could be a therapeutic target for 
2OHOA as this enzyme was identified as a target for inducing cytotoxicity and cell 
death in a r ecent study, where a siRNA library against 3,700 genes was screened in 
several cancer cells (Morgan-Lappe et al., 2007). Remarkably, SCD1 was one of the 
three main targets identified in this screening, confirming that this enzyme is a crucial 
factor for cancer cell survival. Potent and specific small molecule inhibitors of SCD1 
activity have been recently discovered and if, as observed in in vitro studies, the anti-
growth effect of SCD1 inhibition proves to be selective for cancer cells, this may open 
an interventional window for SCD1 inhibitors in cancer treatment (Koltun et al., 2009). 
The analysis of neutral lipid showed that 2OHOA induced increases in TAG and 
FFA levels while DAG levels remained constant (except at 24 h). It is known that TAG 
accumulation may be a general metabolic phenomenon in response to increased cellular 
levels of unsaturated fatty acids. Thus, exogenous OA supplied in the media leads to 
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TAG synthesis in CHO cells and mouse embryonic fibroblasts (Gubern et al., 2008; 
Listenberger et al., 2003). Therefore, 2OHOA-induced accumulation of TAG may have 
a similar explanation, because part of 2OHOA was channeled to TAG synthesis, which 
could also be influenced by the oleic acid hydrolyzed from the glycerophospholipids. In 
any case, the increase in TAG levels would contribute to the formation of LDs. The 
difference between OA and 2OHOA in their capacity to stimulate LDs formation 
indicated that despite their high structural similarity, 2OHOA is differentially 
metabolized when compared to OA. 
The robust increase in SM was not accompanied by a s imilar effect on DAG 
levels, despite that the latter is the second product of the reaction catalyzed by SMS. 
This result was not completely unexpected because, considering the important role of 
DAG in cell signaling, its metabolism is very active in cells. However, the increased 
formation of DAG was demonstrated by incubating cells with NBD-PC and NBD-PE 
(Figure 3-14). In addition, these experiments suggested that part of the newly 
synthesized DAG may be converted into MAG, allowing glioma cells to maintain DAG 
within appropriate levels. In this context, alternative pathways that lead to DAG 
metabolization to promptly compensate for its accumulation may be expected. 
To sum up, the results of this chapter not only helped to elucidate part of 
2OHOA fate but also revealed what would be an additional aspect of its molecular 
mechanism of action, which would involve a profound fatty acid remodeling and SCD1 
inhibition. Finally, we have shown that 2OHOA, oleic acid released from the 
glycerophospholipids, or both, induced TAG accumulation with the consequent 
formation of LDs. 
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4 2OHOA affected the biophysical properties of 
membranes 
4.1 Membrane biophysics and fluorescence spectroscopy 
As it was previously mentioned in the Introduction, cellular membranes are 
complex and dynamic systems, defined by specific lipid-lipid and lipid-proteins 
interactions that can induce the formation of lipid microdomains. There are many 
different types of membrane domains in the plasma membrane, and perhaps the entire 
membrane should be viewed as a mosaic of microdomains (Maxfield, 2002). The most 
actively studied type of lipid domains are lipid rafts, which are thought to consist of 
sphingolipid–cholesterol-enriched and (unsaturated) PC-depleted domains (de Almeida 
et al., 2009). One approach to study such a complex system with different phases, 
properties and proportion is fluorescence spectroscopy. 
This technique allows obtaining dynamical information of biological systems 
due to its intrinsic sensitivity and the time-scale of fluorescence emission together with 
the time-resolution of detection. Fluorescence measurements can be classified into two 
types: steady-state and time-resolved (Lakowicz, 2006). 
Steady-state measurements are those performed with constant excitation and 
emission. The sample is illuminated with a continuous beam of light, and the 
fluorescence intensity is measured. When fluorescence intensity is obtained as a 
function of the emission wavelength, an emission spectrum is recorded. When using 
polarized light, steady-state fluorescence anisotropy, a widely used steady-state 
parameter, can be obtained (see below).  
For time-resolved measurements the sample is exposed to a pulse of light, whose 
width is typically shorter than the decay time of the sample. This intensity decay is 
recorded with a high-speed detection system that allows the intensity or anisotropy to be 
measured on the nanosecond timescale. In this case, several types of parameters can be 
used, such as fluorescence lifetimes, anisotropy decays and time-resolved emission 
spectra, the two latter out of the scope of this thesis. Because these parameters depend 
on different characteristics of the probe environment, like polarity or microviscosity, 
they can report the appearance of new phases which otherwise would not be detected. 
By combining these parameters with the direct observation of heterogeneities through 
imaging techniques, fluorescence methods with time resolution are one of the 
potentially most useful tools to study lipid domains and rafts (de Almeida et al., 2009).  
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Anisotropy measurements are based on the principle of photoselective excitation 
of fluorophores by polarized light (Figure 4-1). Fluorophores preferentially absorb 
photons whose electric vectors are aligned parallel to the transition moment of the 
fluorophore. The transition moment has a defined orientation with respect to the 
molecular axis. In an isotropic solution, the fluorophores are oriented randomly. Upon 
excitation with polarized light, the probability of excitation is maximal for fluorophore 
molecules whose absorption transition dipole is parallel to the electric vector of the 
excitation, and is zero for those molecules which have the transition moment 
perpendicular to the polarization of the excitation light. This selective excitation results 
in a partially oriented population of fluorophores (photoselection), and in partially 
polarized fluorescence emission, which also occurs with the light polarized along a 
fixed axis in the fluorophore. Thus, the fluorescence anisotropy is defined by (r), 
⊥
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,        (Equation 3) 
where I|| and I ⊥  are the fluorescence intensities of the vertically (||) and 
horizontally ( ⊥ ) polarized emission, when the sample is excited with vertically 
polarized light. The anisotropy is a dimensionless quantity that is independent of the 
total intensity of the sample, because the difference (I|| – I⊥) is normalized by the total 
intensity, which is defined as IT = I|| + 2I⊥. Rotational diffusion, limited by the viscosity 
and fluidity of the membranes, changes the direction of the transition moments and is 
one common cause of depolarization (Figure 4-2). Anisotropy measurements reveal the 
average angular displacement of the fluorophore that occurs between absorption and 
subsequent emission of a photon. This angular displacement is dependent upon the rate 
and extent of rotational diffusion during the lifetime of the excited state. In addition, the 
rate of rotational diffusion depends not only on the size and shape of the rotating 
molecule, but also on viscosity and temperature. Therefore, the same probe, i.e., with 
the same size and shape, will display very different average angular displacements 
whether it is incorporated in a highly packed environment with high viscosity, or in a 
less restrictive towards rotation and more fluid one. Thus, the anisotropy of a membrane 
probe reflects the fluidity and order of the membrane. 
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Figure 4-1. Schematic diagram for measurements of fluorescence anisotropies (Lakowicz, 2006). 
 
 
Figure 4-2. Rotational motions inducing depolarization of fluorescence. 
The ϴ angle between Mo, the absorption transition moment and E, the electric vector of the 
excitation light, accounts for the photoselection effect. The absorption and emission (M) transition 
moments are assumed to be parallel and the angular displacement between them (ω) is due to 
molecular rotation (Valeur, 2001). 
Time-resolved experiments are often performed through direct measurements in 
the time domain, in which a short pulse of light excites the sample, and the subsequent 
fluorescence emission is recorded as a function of time. This is generally achieved using 
time-correlated single photon counting, which uses electronics to detect single-photon 
events at a detector. By repeating many start-stop signals, a histogram of single-photon 
counts in discrete time channels is obtained (Figure 4-3). In a microheterogeneous 
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medium the decay of a fluorophore is not usually described by a s ingle exponential 
function but by a complex decay with several components: 
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Where αi and τi are the normalized amplitude and lifetime of component i, 
respectively. Then, it is useful to describe the fluorescence kinetics through a parameter 
named mean or average lifetime, given by 
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For a decay described by a sum of exponentials, where αi is the normalized pre-
exponential and τi the lifetime of the decay component i. Thus, the mean lifetime is the 
average amount of time a fluorophore remains in the excited state following excitation. 
As exemplified below, fluorescence lifetime is in certain cases highly dependent on the 
environment of the probe and potentially very useful in membrane biophysical studies. 
It should also be highlighted that time resolved techniques have the advantage of not 
evaluating the total intensity, so they are much less biased by the known problems 
associated to steady-state data such as light scattering, or error in probe concentration. 
Most lipids do not display intrinsic fluorescence, thus the application of 
fluorescence spectroscopy to this kind of studies requires the labeling of the bilayer with 
an extrinsic fluorophore (membrane probe). Membrane probes include fluorescent 
molecules similar to natural lipids, such as 1,6-diphenyl-1,3,5-hexatriene (DPH) and 
their derivatives having the same chromophore, for example the cationic 
trimethylamino-DPH (TMA-DPH), which are the most widely used. Important 
information about the membrane can be also obtained using linear conjugated polyene 
fluorescent fatty acids such as all-trans-9,11,13,15-octadecatetraenoic acid, known as 
trans-parinaric acid (t-PnA) and all-trans-8,10,12,14,16-octadecapentaenoic acid (de 
Almeida et al., 2009). 
In this work, two probes that have different phase partitioning behavior were 
used, DPH and t-PnA (Figure 4-4). DPH incorporates parallel to the acyl chains of the 
phospholipids and it distributes indistinctly between ld and lo phases, but is excluded 
from Cer-rich gel phase (de Almeida et al., 2003; Lentz, 1993; Silva et al., 2006; Silva 
et al., 2007). 
4 2OHOA affected the biophysical properties of membranes
95
Figure 4-3. Data obtained by the single-photon timing technique with TRFA data 
processor.
Sample: solution of POPC:POPE:PSM:Cholesterol with t-Pna at 24°C. Excitation wavelength: 
320 nm; observation wavelength: 404 nm. Reference: scattering solution (Ludox). Number of
channels: 1024; χ2=1.4.
On the other hand, t-PnA presents a h igh preference for lo and Cer-rich gel 
phase, where it displays an increased fluorescence quantum yield and therefore is an 
exceptional reporter of these phases (de Almeida et al., 2009). Due to the trans-
configuration of its double bonds, t-Pna is not only one of the few probes that has a 
preference for lo phases, but in addition it is  the only probe that displays a strong 
preference for the gel phase. Moreover, t-Pna does not have a tendency to aggregate and
consequently, does not affect significantly the organization of the lipid bilayer. Thus,
the fluorescence properties of this probe are particularly sensitive to the changes 
undergone in the lo domains or the lipid rafts. Consequently, by combining these two 
membrane probes complementary information is obtained. In addition, the quantum 
yield of the probes, i.e. the number of emitted photons relative to the number of 
absorbed photons, behaves differently. Thus, whereas the DPH quantum yield is not 
strongly sensitive to the presence of either type of phase, t-PnA presents quantum yield 
values and fluorescence lifetime components that are typical of each phase. The 
fluorescence intensity decay of t-PnA (Equation 4) is usually described by the sum of 
several exponentials, each one with a cer tain fluorescence lifetime component. As the 
mean fluorescence lifetime depends on the squares of the lifetime components, it is very 
sensitive to changes undergone in the long lifetime component (τlong). In addition, the 
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τlong of this probe is specifically due to the ordered domains, such as the lo (lipid rafts) or 
the so (gel) phases, directly reflecting the composition and acyl chain packing of those 
domains (Aresta-Branco et al., 2011). The fact that for both probes the fluorescence 
anisotropy is high in the gel and low in the fluid state, together with the previously 
mentioned differences, allows for a detailed characterization of the lipid phases that are 
formed in the system under investigation (Castro et al., 2007). In addition, for both 
probes, the chromophore is buried in the hydrophobic core of the lipid bilayer, 
providing direct information on acyl chain packing. Thus, the results can be interpreted 
without taking into consideration biophysical complexities on the lipid-water 
interface/lipid headgroup region or interactions with extra membrane molecules or 
domains of membrane proteins (Aresta-Branco et al., 2011). 
 
Figure 4-4. Probes used in this study for fluorescence spectroscopy (Valeur, 2001). 
 
 
4.2 Results 
4.2.1 Effect of the SM increase on the biophysical properties of model 
membranes 
As a first approach to understand the consequences that the dramatic changes in 
phospholipid composition observed after treatment of U118 cells with 2OHOA (200 
µM) would have on membrane biophysical properties, we prepared membrane model 
systems with compositions mimicking the major alterations observed in SM, PC, PE 
and cholesterol levels (Table 4-1). The mixtures used in this study met the criteria for 
formation of raft-like domains (Marsh, 2009). By using this set of lipids, the changes in 
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artificial membrane lipid composition reflected the alterations induced by the treatment 
on the different lipid headgroups content, rather than in the acyl chain, which are 
analyzed in the next section. These liposomes were then labeled with either t-PnA or 
DPH. 
Table 4-1. Mole fractions of the lipids used to mimic 2OHOA action on membrane lipid composition.  
 
 
12 h  24 h  48 h 72 h  
 
Control 2OHOA Control 2OHOA Control 2OHOA Control 2OHOA 
PSM 5.3 15.0 6.8 20.3 8.4 26.8 10.1 30.9 
POPC 40.6 39.9 36.2 29.4 39.7 32.3 42.4 32.5 
POPE 22.6 17.1 23.6 19.0 22.9 15.0 23.2 10.7 
Cho 31.5 28.0 33.4 31.3 28.9 25.9 24.3 25.9 
Values were calculated according to the experimental values for phospholipid and cholesterol composition 
obtained during the time-dependent incubation of U118 cells in the presence or absence of 2OHOA (200 
µM;Figure 2-5 and Figure 2-6) and are expressed as mole%. Cho, Cholesterol. 
 
As mentioned above, the steady-state fluorescence anisotropy of DPH (DPH 
<r>; Equation 3) is a parameter that reflects the global order of the acyl chains of the 
lipid bilayer membrane (de Almeida et al., 2003). For liposomes resembling 48 and 72 
h treated cell membranes, DPH <r> was higher than that of liposomes mimicking 
control (untreated) cell membranes (Figure 4-5A), indicating an increase in the general 
lipid order. Figure 4-5B shows that changes in phospholipid composition clearly 
induced an increase in t-PnA τlong values indicating that the lo domains became more 
ordered and more compact. The mean fluorescence lifetime (Equation 5) of t-PnA (τ) 
paralleled the long lifetime component (Figure 4-5C). This suggests that the major 
changes in phospholipid composition occurred at the lo domains, and not in the 
disordered ones. Because the cholesterol mole fraction did not change severely (Table 
4-1), it is reasonable to explain this increase in the lipid bilayer order through a SM-
enrichment of the lo domains, which was expected taking into account the changes 
observed in lipid composition. 
To interpret quantitatively the results obtained we mapped the compositions 
studied in a p hase diagram, which are available for ternary lipid mixtures (Marsh, 
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2009). The best diagram to represent the liposomes used in the present study is the 
ternary lipid system POPC/PSM/Cholesterol at 23ºC (de Almeida et al., 2003). It was 
considered that POPE is equally distributed between PC and SM and the mole fractions 
were thus recalculated (Table 4-2).  
 
Figure 4-5. 2OHOA-induced phospholipid composition changes lead to significant biophysical 
alterations in model membranes. 
(A) Steady state fluorescence anisotropy, <r>, of DPH; (B) Long lifetime component of the mean fluorescent 
lifetime, <τ>long, of t-Pna. (C) The mean fluorescence lifetime <τ> (Eq. 5) of t-PnA. All these measurements 
were done on PC:PE:SM:Cholesterol MLVs at 24ºC; (D) Ternary phase diagram of POPC/PSM/Cholesterol 
at 23ºC including the compositions of liposomes mimicking control (squares) or treated (balls) cells 
recalculated in Table 4-2. The fraction of ld and lo domains were calculated using the diagram tie-line and the 
lever rule (Marsh, 2009). The gray region represents the raft region (ld+lo). All the experimental points are 
within this region which is the physiologically relevant of the phase diagram. The region around them is 
shaded to stress out the average behavior. The black to white lines represent the lo to ld molar ratios in each 
case. The black arrows on the PSM axis show the increase in SM content of the non-raft (small arrow) and of 
the raft fraction of the membrane (large arrow). It can be clearly seen that the raft fraction is much more SM-
enriched upon 2OHOA treatment. MM: model membrane mimicking the lipid composition of control and 
2OHOA treated cells (200 µM, 12-72 h). Values represent the mean ± SD, n=3. The asterisks indicate a 
significant effect of the treatment as compared with the control (**P < 0.01; ***P < 0.001). 
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Then, these compositions were mapped in the ternary phase diagram (Figure 
4-5D), and the fraction of ld and lo domains was calculated using the diagram tie-line 
and the lever rule (Marsh, 2009). From the calculations, it was concluded that the lo 
phase fraction may increase ca. 5-10 mole% upon 2OHOA treatment, but the SM 
content of the lo domains can increase by more than 15 mole%, i.e., virtually all of the 
SM induced by the treatment is incorporated into lo domains, from where POPC and 
even cholesterol could be depleted. This is in agreement with the preceding results, 
where the observed increase in the global order of the bilayer membrane (Figure 4-5A) 
could be mainly explained by a much higher order and packing of the lo domains 
(Figure 4-5B), rather than by a marked increase in their relative abundance. 
Table 4-2. Recalculated lipid mole fractions mapped in the phase diagram.  
 
 
12 h 24 h 48 h 72 h 
 
Control 2OHOA Control 2OHOA Control 2OHOA Control 2OHOA 
SM 16.6 23.5 18.6 29.8 19.9 34.3 21.7 36.3 
PC 51.9 48.4 48.0 38.9 51.2 39.8 54.0 37.8 
Cho 31.5 28.0 33.4 31.3 28.9 25.9 24.3 25.9 
The lipid mole fractions were calculated considering the system a ternary mixture of PC/SM/Cholesterol in 
order to compare with the published phase diagram. Values are expressed as mole%. Cho: Cholesterol. 
4.2.2 Effect of 2OHOA on the biophysical properties of cell membranes 
In this section we focused not only on the changes induced by 2OHOA in the 
phospholipid headgroups but also in the acyl-chain remodeling described in chapter 3, 
as well as in the changes in sphingolipids described in chapter 2. To do this, we 
analyzed the biophysical properties of liposomes reconstituted from total lipid extracts 
obtained from control and treated U118 cells, labeled with either t-PnA or DPH. For 
simplification, from now on and within this chapter, “liposomes reconstituted from total 
lipid extracts” will be referred to as “lipid extracts”. 
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Figure 4-6. 2OHOA induced a decrease of the global membrane order while the lo domains became 
more ordered in reconstituted liposomes. 
DPH anisotropy, <r> (A), t-Pna long lifetime component, <τ>long (B) and t-Pna mean fluorescence lifetime, 
<τ> (C) of lipid extracts from control and treated cells (200 µM, 24, 48 and 72 h) reconstituted into liposomes. 
Values represent the mean ± SEM, n= 3. The asterisks indicate a significant effect of the treatment as 
compared with the control (*P < 0.05; **P < 0.01; ***P < 0.001). 
 
Contrary to what it was observed with artificial membranes in the previous 
section, DPH <r> decreased when compared to control lipid extracts at all times of 
treatment, indicating a general decrease of the membrane global order (Figure 4-6A). 
As shown in Figure 4-6 B, changes in lipid composition induced an increase in t-PnA 
τlong indicating that the lo domains became more ordered and more compact, in 
agreement with the observations in artificial membranes. It is usually considered that, at 
room temperature, the lipid phase is lo if its t-PnA τlong value is below 30 ns, and it is a 
gel phase when this value is over 30 ns (de Almeida et al., 2009). In these experiments, 
t-PnA τlong value was generally below 30 ns for the controls, indicating the presence of 
sphingolipid-cholesterol enriched domains (lipid rafts). However, the value was always 
much longer than 30 ns in the treated samples, indicative of a possible sphingolipid-
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enriched gel-like phase. In addition, the mean fluorescence lifetime (Equation 5) of t-
PnA (τ) showed a t rend that paralleled the long lifetime component (Figure 4-6 C), 
indicating that the increased lipid packing of the lo domains is the major factor affecting 
t-PnA fluorescence lifetime. The opposite behavior of t-PnA (τ) compared to the DPH 
<r>, also indicated that the lo and ld domains of the membrane were differently affected 
by 2OHOA. 
 
4.2.3 Partition of free 2OHOA partially explained the changes in the 
biophysical properties of membranes 
Considering the results of the previous sections, the next question raised was 
whether the partition of free 2OHOA into membranes could explain the differences 
observed between artificial membranes and lipid extracts DPH <r> values. To address 
this issue, large unilamellar vesicles (LUVs) mimicking the composition of control and 
treated cells after a 24 h treatment (Table 4-1), were prepared and incubated with or 
without 2OHOA (5 or 20 mole%) for 1 h before the measurements. As it was explained 
in the Experimental procedures section, 5 mole% would represent the concentration of 
2OHOA most commonly used in this study, i.e., 200 µM. Here, model membranes 
(MM) mimicking the composition of control cells incubated with 2OHOA (C + 5/20 
mole% 2OHOA) would reflect the initial situation of a treatment, i.e., when 2OHOA 
first encounters cells, while MM mimicking the composition of treated cells incubated 
with 2OHOA (T+ 5/20 mole% 2OHOA) would represent the composition of lipid 
extracts at the end of the 24 h treatment. 
In agreement with the results obtained with artificial liposomes, DPH <r> of 
MM mimicking treated cells (T) was higher than that of control cells (C; Figure 4-7A-
B). When 5 mole% of 2OHOA was added, DPH <r> decreased only in MM mimicking 
treated cells (T + 5 mole% 2OHOA), although this value was still higher than that of 
MM mimicking control cells. These results indicated that the partition of free 2OHOA 
decreased the global order of the acyl chains of glycerophospholipids. Consistently, the 
reduction in DPH <r> was more pronounced when 20 mole% of 2OHOA was added to 
the MM (T + 20 mole% 2OHOA; Figure 4-7 B). Nevertheless, the addition of 2OHOA 
to MM did not reduce DPH <r> to the extent observed for lipid extracts (Figure 4-6 A). 
Therefore, the partition of free 2OHOA into membranes may only partially explain the 
decrease in DPH <r> observed for lipid extracts. This discrepancy may be due to: i) the 
changes in other fatty acids; ii) the differences in lipid composition between MM and 
lipid extracts; and iii) the difference between 2OHOA as free fatty acid or incorporated 
into glycerophospholipids. 
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Figure 4-7. Partition of free 2OHOA explained in part the effects on the biophysical properties 
of the membranes. 
(A-B) Steady state fluorescence anisotropy, <r>, of DPH; (C-D) Long lifetime component of the 
mean fluorescent lifetime, <τ>long, of t-Pna. (E-F) The mean fluorescence lifetime <τ> (Eq. 5) of t-
PnA. All these measurements were done on PC:PE:SM:Cholesterol mixtures at 24ºC with or without 
the addition of 2OHOA (5 mole%, A, C, E; and 20 mole%, B, D, F); All the experiments were 
performed with LUVs mimicking the 24 h lipid composition of Control (C) and Treated (T) cells. 
The asterisks indicate a significant effect as compared with the control (*P < 0.05; **P < 0.01; ***P 
< 0.001). In this case, § indicates a significant effect of the addition of 2OHOA (T + 2OHOA) as 
compared with the composition of treated cells (T) (§P < 0.05; §§P < 0.01; §§§P < 0.001). 
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As expected from the results with artificial liposomes (Figure 4-5B), MM 
mimicking treated cells showed increased t-Pna τlong when compared to control ones (T 
vs. C; Figure 4-7C-D). In this case, the presence of 5 mole% of 2OHOA induced a 
slight decrease of t-Pna τlong only in MM mimicking control cells (Figure 4-7C), an 
indication that 2OHOA partitions in both ld and lo domains. In addition, higher amounts 
of 2OHOA (20 mole%) did not counteract the ordering effect of the increase in SM 
because, despite the decrease in t-Pna τlong in MM mimicking treated cells, this value 
still remained higher than in the MM mimicking control cells. In addition, the mean 
fluorescence lifetime (Equation 5) of t-Pna (τ) showed a trend that parallels the long 
lifetime component (Figure 4-7 E-F).  
Since the alterations in lipid headgroup composition explained the increased 
order of the lo domains, and neither that nor the partition of free 2OHOA explain the 
increased disorder of ld domains, this latter effect must be due to the alterations in lipid 
acyl chain composition of the ld domains. 
 
4.3 Lipid raft became more ordered and more compact 
In this chapter, we used a biophysical approach to understand the effects that 
changes in both phospholipid and fatty acid composition would have on cell membrane 
biophysical properties. 
In model membranes mimicking the lipid composition of U118 cell membranes 
before and after treatment with 2OHOA, we observed a slight increase in the fraction of 
lo domains, but a rather marked rise in the membrane hydrophobic core packing, 
probably associated with an increase in the size of these domains (Figure 4-5). 
Consequently, the global membrane order was enhanced. These biophysical effects 
were due to the substantial increase in SM content, as the amount of cholesterol was 
only modestly modified. In this context, previous studies in membrane model systems 
have shown that both an increase in SM content and an increase of the lo phase fraction 
lead to the formation of larger size domains (Figure 4-8; de Almeida et al., 2005). 
Therefore, the alterations in phospholipid composition observed in treated cells 
significantly modified the biophysical properties of the cell membrane, particularly the 
packing of SM/cholesterol-enriched lo domains, and consequently, the membrane’s 
lateral reorganization. Because SM plays a relevant role in the formation and regulation 
of lipid rafts, which in turn influence signal transduction and membrane trafficking 
(Escribá et al., 2008; Simons & Toomre, 2000), this change in the structure of 
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membrane microdomains might alter the interaction of relevant peripheral signaling 
proteins with the membrane and the subsequent propagation of messages into the cell. 
Increased compactness of the lo domains was also observed in lipid extracts from 
treated cells reconstituted into liposomes when compared to control (untreated) cells 
(Figure 4-6). However, in this case, the global order of the membranes decreased in 
lipid extracts from treated cells. These results indicated that not only the changes in the 
phospholipid headgroup but also in the fatty acid composition, such as the incorporation 
of 2OHOA, were strongly affecting membrane domains. Thus, while the increase in lo 
domains order/packing would be mainly due to the strong increase in SM content, the 
profound changes in fatty acid composition would account for the decrease in global 
order. Nevertheless, it cannot be ruled out that the presence of TAG in the artificial 
membranes could influence the decrease in the global order, although the solubility of 
TAG in cholesterol-containing liposomes is extremely low (Khandelia et al., 2010). 
 
Figure 4-8. PSM/POPC/Cho phase diagram at 23°C, showing also the boundaries and 
schematic illustrations of the size of lipid rafts.  
Rafts are present in the blue-shaded area (ld/lo, coexistence). In the darker area, lo predominates 
over ld, and the opposite situation occurs for the light-shaded area. Rafts can also exist in the green-
shaded area, where there is coexistence of three phases, but the so phase is present only in very low 
amounts. Insets: (a) region of large rafts; detected by microscopy and FRET (>75–100 nm); (b) 
region of intermediate size rafts: detected by FRET but not by microscopy (between ~20 nm and 
~75–100 nm); (c) region of small rafts: not detected by FRET nor microscopy (< 20 nm; de 
Almeida et al., 2005). 
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The lo domains in artificial membranes maintained the properties of such lipid 
structures, as t-Pna τlong was below 30 n s in artificial liposomes. However, in lipid 
extracts, where all lipid changes are represented, results pointed to the appearance of a 
different type of domain, instead of the appearance of additional very disordered 
domains. Because of the high value of the long lifetime component of t-Pna (t-Pna 
τlong>>30 ns), it cannot be ruled out that part of the lo domains become so ordered and 
rigid that they can exclude DPH. The opposite would happen to ld domains that would 
thus become even more disordered. If this composition alteration would lead to a 
coalescence of lo domains, decreasing the ordered/disordered interfacial regions, or 
would be accompanied by a small decrease of total lo domain fraction, the anisotropy of 
DPH would decrease because in fact the global order of the membrane would be 
smaller, but the mean fluorescence lifetime of t-PnA would increase, because its 
fluorescence stems primarily from the lo domains. This would explain the opposite 
behavior observed for both probes in total lipid extracts. The presence of gel-like or 
solid-ordered phase has been implicated in situations of cellular stress, apoptotic or 
pathological conditions. 
A more rigid gel-like domain formation could also be explained by the increase 
in Cer, the accumulation of Sph, or even by the accumulation of dhSM, as determined 
by MS analysis in membranes from 2OHOA-treated cells. In a ternary model system of 
palmitoyl-ceramide (PCer), PSM and POPC characterized by the same two fluorescent 
membrane probes that were used in this study; PCer recruits POPC and PSM in the 
fluid phase to form extremely ordered and compact gel domains. Gel domain formation 
by low PCer mole fraction (up to 12 mole%) is enhanced by physiological PSM levels 
(20–30 mole% total lipid). For higher PSM content, it was shown that a three phase 
situation, consisting of fluid (POPC-rich)/gel (PSM-rich)/gel (PCer-rich) coexistence is 
possible (Castro et al., 2007). Sphingosine, at 5–15 mole% total lipids, was shown to 
rigidify gel domains in liposomal and erythrocyte ghost membranes, raising their 
melting temperatures and increasing the transition cooperativity. Structural defects 
originating during the lateral phase separation of the “more rigid” and “less rigid” 
domains caused the leakage of aqueous solutes to the extravesicular medium (Contreras 
et al., 2006). DhSM rigidifies lo domains in giant unilamellar vesicles of 
PC:PE:dhSM:Cholesterol (1:1:1:1 mole ratio), inducing the formation of so phases 
interspersed in the lo domains. In cells, increasing amounts of dhSM, induced by cell 
treatment with two desaturase inhibitors or by knockdown of desaturase expression, 
correlated with lower cell susceptibility to HIV-1 infection (Vieira et al., 2010). 
In addition, the results obtained from the present study indicated that partition of 
free 2OHOA does not counteract the effects of the changes in lipid composition (Figure 
4-7). In general it was observed that at a high concentration of 2OHOA (20 mole%, far 
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above the ones used to treat the cells) slightly reduced the global order of the membrane 
as well as the order of the lo domains. At low concentrations (5 mole%, similar to those 
used to treat the cells), 2OHOA did not have any effect or this was rather small when 
compared to the effect of the changes in lipid composition. Therefore, a plausible 
explanation for the strong decrease in the global order may be the incorporation of 
2OHOA in the glycerophospholipids PC and PE. Although the effect of such 
hydroxylated glycerophospholipids in the biophysical properties of fluid domains is yet 
to be studied, it was found that the presence of 2-hydroxylation in the fatty acyl chain of 
sphingolipids in S. cervisiae cells significantly reduces acyl chain packing of their 
sphingolipid-enriched domains (Aresta-Branco et al., 2011). In this way, both effects 
would be explained: reduced global order caused by the incorporation of 2OHOA into 
the phospholipids (and possibly increased PUFA content) and increased compactness of 
the ordered domains due to accumulation of SM. Finally, the fact that the variation in t-
PnA average lifetime parallels that of its long component indicates that there are no 
significant alterations in the fraction of lo and ld domains. 
It is worth to point out that the changes in the biophysical properties observed in 
this study were due to changes in total cell lipid composition. Therefore, a more 
accurate study focused on the plasma membrane would be necessary. In fact, this aspect 
was addressed without successful results. On the one hand, the induction and isolation 
of plasma membrane blebs was tested, but the protocol provoked cellular stress, 
affecting the lipid composition of the plasma membrane and consequently, biasing the 
biophysical properties of membranes (data not shown). On the other hand, we tried to 
obtain plasma membrane after cell fractionation, but the purity of the fractions was not 
as expected in order to carry out this type of study.  
In summary, 2OHOA affected the properties of both lo and ld domains and 
induced the formation of membrane microdomains with biophysical properties different 
from the existing ones. Because many proliferative signals start at the plasma 
membrane, the changes found here could influence signaling in cancer cells. Thus, 
2OHOA induced complex changes in the glioma cell membranes lipid composition that 
would lead to significant changes on the biophysical properties of cell membranes, and 
thus to a m embrane lateral reorganization, which may in part explain 2OHOA 
biological action. 
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5 Effect of 2OHOA on the lipid composition of tissues 
In order to study whether 2OHOA affects the lipid composition of tissues, we 
determined the individual glycerophospholipid classes, cholesterol levels and 
phospholipids fatty acid composition of the liver, heart, and brain of untreated and 
2OHOA-treated CD-1 mice (600 mg kg-1 day-1, 10 days).  
The effect of 2OHOA on mice tissues glycerophospholipid composition is 
shown in Figure 5-2 (A-C). Thus, tissue glycerophospholipid composition was not 
significantly altered by 2OHOA neither had changed cholesterol content in treated mice 
(Figure 5-1). Likewise, fatty acid composition, analyzed by gas chromatography in 
basic conditions, was not affected in treated mice compared to control (Table 5-1). Only 
18:1n-9 decreased 23% in liver PE. 
Hence, 2OHOA did not significantly affect either glycerophospholipid or fatty 
acid composition of brain, liver and heart of healthy mice. Nevertheless, it remains to be 
determined whether 2OHOA is incorporated in tissue lipids. 
 
Figure 5-1. Effect of 2OHOA treatment on brain, heart and liver total cholesterol content. 
Total cholesterol mass from brain, heart, and liver of mice treated with 2OHOA (600 mg kg-1 day-1, 10 days). 
After treatment, lipids were extracted and the total cholesterol mass was determined by an iron binding assay 
according to the Experimental procedures section. Values represent mean ± SD, n = 4-5. 
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Figure 5-2. Effect of 2OHOA treatment on brain, heart and liver phospholipid composition. 
(A) Brain, (B) Heart, and (C) Liver glycerophospholipid composition of mice treated with 2OHOA (600 mg 
kg-1 day-1, 10 days). After treatment, lipids were extracted and analyzed by TLC. The glycerophospholipids 
mass was determined by assaying for the lipid phosphorus content of individual lipid classes separated by 
TLC, according to the Experimental procedures section. Values are expressed as mole% and represent mean ± 
SD, n = 4-5. (D) Representative TLC plate stained with iodide. 
Thus, the lack of changes in tissues lipid composition might be related to the low 
toxicity shown in other studies and complements the previous findings of this work, 
where it was shown that non-tumor MRC-5 cells were not significantly affected by 
2OHOA. The low toxicity of the compound is an important feature of the lipid therapy 
with 2OHOA (Martínez et al., 2005b). In this study, the authors were unable to 
determine the maximally tolerated dose of this drug because after treatments up to 3 g 
kg-1 per day for 2 weeks, the animals were still alive. Histological analyses of several rat 
organs showed that high doses of 2OHOA (1.2 g kg-1 day-1 p.o.) did not induce 
observable toxicity. In this context, the tissues analyzed here (brain, liver and heart) 
might have regulatory controls of lipid metabolism capable of maintaining a relatively 
normal lipid pattern facing 2OHOA treatment (Thompson, 1992). 
 
  
Table 5-1. Effect of 2OHOA on PE fatty acid composition from brain, heart and liver. 
 
 
Brain Heart Liver 
   Control 2OHOA Control 2OHOA Control 2OHOA 
FAME   Mean ± SD  Mean ± SD  Mean ± SD  Mean ± SD  Mean ± SD  Mean ± SD 
16:0    7.3 ± 0.4   7.5 ± 0.2  8.3 ± 0.5    7.9 ± 0.6  23.2 ± 1.5  22.9 ± 2.5 
18:0  25.0 ± 0.6  25.1 ± 0.6  26.2 ± 1.5  27.7 ± 1.7  16.6 ± 1.7  19.2 ± 2.3 
18:1n-9   11.9 ± 0.7  11.7 ± 0.7  7.4 ± 1.3    6.4 ± 1.1    7.8 ± 1.2  6.0  ± 0.6* 
18:1n-7     3.2 ± 0.3   3.2 ± 0.2  3.7 ± 0.4    3.9 ± 0.3    3.1 ± 1.0    3.2 ± 0.6 
22:0    0.9 ± 0.1   1.1 ± 0.8  0.9 ± 0.2    1.2 ± 0.2    1.1 ± 0.2    0.9 ± 0.1 
20:4n-6   15.2 ± 0.4  15.5 ± 0.6  9.4 ± 1.4    9.5 ± 1.0  19.4 ± 1.2  18.9 ± 2,0 
24:0    5.7 ± 0.2   6.0 ± 0.5  1.2 ± 0.4    1.3 ± 0.2    0.7 ± 0.1    0.1 ± 0.3 
22:6n-3   26.5 ± 0.2  25.6 ± 1.0  33.6 ± 1.7  33.4 ± 1.4  17.4 ± 0.8   21.0  ±1.5** 
 
Mice were treated with 2OHOA (600 mg kg-1 day-1) for 10 days. After each treatment, lipids were extracted and analyzed by TLC. Then PE acyl chains were converted to FAME 
in basic conditions and analyzed by gas chromatography. Values are expressed as mole% and represent mean ± SD, n = 4-5. The asterisk (*) indicates a significant effect of the 
2OHOA treatment as compared with the control (*P < 0.05). 
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6 DISCUSSION 
Lipid alterations are often associated with the etiology of important human 
diseases, such as atherosclerosis, infectious diseases, Alzheimer’s disease and cancer. In 
cancer, although it has not been described a common feature among the different types 
of tumors, a number of lipid changes have been described. Among all of them, two were 
of special interest for this study. Thus, altered phospholipid levels were described in 
different human tumor tissues compared to their normal non-tumors counterparts 
(Reviewed by Hendrich & Michalak, 2003). Moreover, increased oleic acid content and 
reduced stearic acid content have been usually found in tumors, in comparison to the 
non-tumor tissues (Meng et al., 2004c; Mikirova et al., 2004). Therefore, it is clear that 
a molecular understanding of the lipid contribution to the disease process would allow 
the development of novel approaches to prevention, diagnosis and cure of cancer and 
other diseases (van Meer et al., 2008). 
The participation of membrane lipids in cellular activities indicates that they 
might constitute targets for drugs whose pharmacological effects would be associated 
with the modulation of the physicochemical properties of membranes (Escribá, 2006). 
These are the foundations of the novel pharmacological approach called Membrane 
Lipid Therapy, which consists in the modulation of the structural and functional 
properties of cell membranes, by external means (Martínez et al., 2005b). Thus, 2-
hydroxyoleic acid (2OHOA) was designed based on this principle. From the molecular 
point of view, 2OHOA is a first-in-class anticancer drug because its mechanism of 
action is not shared by other drugs used for the treatment of cancer. In addition, within 
the heterogeneous family of the drugs used in the treatment of human glioma, 2OHOA 
is a best-in-class molecule, because it has greater efficacy and lesser toxicity than 
temozolomide and other drugs used to treat this condition (Terés et al., 2011). 
Although some of the mechanisms of action induced by 2OHOA have been 
elucidated, the way this molecule exerts its anticancer action without killing normal 
cells is not fully understood. Neither the regulatory effects of 2OHOA on membrane 
lipids were known. To address this point we analyzed whether 2OHOA modified the 
lipid composition of tissues and cells. This study describes for the first time not only the 
effects of 2OHOA on the lipid composition of membranes but also elucidates part of its 
metabolism, i.e., its entrance into the cells, its accumulation and incorporation into 
different lipid classes. The results of this study indicate that the lipid composition of 
human cancer cells was greatly altered. According to our analyses a large number of 
changes occurred, affecting the levels of glycerolipids, glycerophospholipids, and 
sphingolipids as well as the fatty acyl composition. Among these changes, the present 
study focused mainly on two. First, the net increase in SM mass via direct and specific 
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activation of SMS; and second, the decrease in oleic acid, via SCD1 inhibition and its 
substitution by 2OHOA. Consequently, these changes had an impact on the structure of 
membrane microdomains.  
The rapid SMS activation by 2OHOA indicated that this could be one of the first 
critical events in its effect against tumors. The striking increase in plasma membrane 
SM, an important component of ‘lipid rafts’, led to modifications of the lipid bilayer 
properties (Futerman & Hannun, 2004). Hence, if lipid rafts containing a given set of 
proteins can change their size and composition in response to intra- or extracellular 
stimuli; this will modulate specific protein–protein interactions, resulting in the 
activation or inhibition of signaling cascades (Simons & Toomre, 2000). These effects 
could include FasR capping or Ras translocation from the membrane to the cytosol, 
which have been associated with the induction of apoptosis and autophagy, respectively 
(Lladó et al., 2010; Terés et al., 2011). It is worth mentioning that the markedly lower 
levels of SM in cancer cells suggested that the malignant transformation of glioma and 
other cancer cells not only requires the activation of certain oncoproteins (e.g., Ras) but 
also, the modification of the membrane structure to permit their membrane docking and 
proliferative signal propagation. Therefore, the alterations found in the lipid 
composition of cancer cell membranes appeared to be crucial in the activation of 
tumorigenesis. Figure 6-1 and Figure 6-2 depict the model where the results presented 
in this study are related with the antitumor effect of 2OHOA. 
Two different molecular mechanisms are known to be activated by 2OHOA in 
cancer cells. In leukemia cells, 2OHOA induces FasR capping and activates extrinsic 
apoptosis pathway (Lladó et al., 2010) while in human glioma and lung cancer cells, 
2OHOA induces translocation of Ras from the membrane to the cytosol and cell cycle 
arrest, which is followed by cell differentiation and autophagy (Lladó et al., 2010; Terés 
et al., 2011). Both these mechanisms may be triggered by the significant alterations that 
2OHOA induced, increases in membrane SM and changes in the fatty acid profiles, on 
the properties of both ld and lo domains. Indeed, Ras has a bulky isoprenyl lipid anchor 
and requires ld microdomains with loose surface packing (e.g., PE-rich domains) to 
permit its insertion into the membrane, which is necessary for subsequent interactions of 
Ras with upstream (e.g., EGFR) and downstream (e.g., Raf) proteins in the MAPK 
pathway (Figure 6-2). The alteration of both ld and lo domains could also result in the 
inactivation of the MAPK pathway. Through cross-talk, this inhibition can impair the 
PI3K/Akt pathway and the cell cycle machinery (cyclin/cdk complexes). Additionally, 
SCD1 inhibition by 2OHOA could contribute to the inactivation of the Akt pathway 
since knockdown of SCD1 reduces Akt phosphorylation and activity in cancer cells 
(Fritz et al., 2010; Scaglia & Igal, 2008). In turn, as a feedback mechanism, Akt and 
MAPK pathways regulate the process of lipogenesis in mammalian cells (Plas & 
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Thompson, 2005; Porstmann et al., 2005). The sustained activation of SMS increases 
1,2-DAG synthesis, which together with the presence of 2OHOA in membranes, would 
be involved in the relatively sustained and mild activation of PKC (ca. 3-fold; Cerbon & 
del Carmen Lopez-Sanchez, 2003; Martínez et al., 2005b). This activation could lead to 
the overexpression of the CDK inhibitors, p21Cip1 and p27Kip1, which are associated with 
the hypophosphorylation of the pRb, and the ensuing inhibition of E2F-1 and β-catenin 
(Martínez et al., 2005a; Martínez et al., 2005b; Terés et al., 2011). The cellular outcome 
of these molecular processes is the inhibition of cell growth, and the induction of cell 
differentiation and autophagy (Gwak et al., 2006; Gwak et al., 2009; Jiang et al., 2010; 
Lladó et al., 2009; Terés et al., 2011). In addition, the accumulation of sphingolipids in 
lysosomes could also contribute to the induction of autophagy. 
On the other hand, the FasR oligomerizes in the presence of the Fas ligand, 
which initiates the formation of the death-inducing signaling complex (DISC) that 
activates the “extrinsic” caspase-8-mediated apoptosis pathway. In this context, 
2OHOA provokes the clustering (capping) of FasR to defined cell membrane areas, 
favoring spontaneous interactions of FasR subunits and ligand-free induction of 
apoptosis in human leukemia cells (Lladó et al., 2010). Previous studies have shown 
that alteration of lipid rafts by lipid-interacting molecules (including anticancer drugs) 
induces apoptosis in a ligand-free manner (Beneteau et al., 2008; Gajate & Mollinedo, 
2007). Moreover, FasR capping has been linked to SM synthesis (Miyaji et al., 2005), 
such that the changes in the composition and structure of membranes induced by 
2OHOA also explain the induction of apoptosis observed in Jurkat cells (Lladó et al., 
2010). Thus, a co mmon molecular mechanism that activates SMS and increases the 
amount of SM in the membrane can induce either autophagy (glioma) or apoptosis 
(leukemia) in different cancer cells. Interestingly, a similar mechanism is described for 
edelfosine, a synthetic ether lipid with a high apoptotic activity which also induces 
reorganization of membrane rafts, FasR capping and cell apoptosis (Busto et al., 2007; 
Conesa-Zamora et al., 2005; Escribá, 2006; Gajate & Mollinedo, 2007; Jendrossek & 
Handrick, 2003). Thus, SM levels not only appear to be relevant in tumorigenesis but 
also in the molecular mechanism of action of 2OHOA against cancer. 
Because 2OHOA is a potent and specific drug to combat tumors, with no side 
effects at therapeutic doses, the data presented in this study not only introduce the first 
known activator of SMS but also, define a novel molecular target for the design of new 
drugs against cancer. Considering the scarce information available on SMS proteins, we 
consider that this study may be helpful to future studies focused on understanding the 
regulation and role of these enzymes in the cell biology. 
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Figure 6-1. Role of the lipid changes induced by 2OHOA in its antitumor mechanism. 
The model depicts our current view of the lipid changes in the effects of 2OHOA against tumors. The model 
includes new and reported data from our group, as well as data from the literature (see text). The activated 
lipid pathways are indicated by blue arrows. The sustained SMS activation by 2OHOA (1 and 2) increases the 
SM content at the plasma membrane leading to the deregulation of the sphingolipid metabolism evidenced by 
the activation of both the de novo synthesis (4) and the salvage pathway (5-6). In addition, 2OHOA provokes 
a profound remodeling of the cell fatty acid composition mainly caused by the incorporation of 2OHOA into 
the glycerolipids and glycerophospholipids (A and C) fractions and the inhibition of SCD1 (B). All together, 
these lipid changes affect the lipid raft properties as well as raft dependent signaling pathways, such as the 
Fas- and Ras-regulated (see Figure 6-2) pathways (Lladó et al., 2010; Miyaji et al., 2005; Terés et al., 2011). 
In addition, an increase in nuclear SM (3) may compromise DNA duplication (Albi & Magni, 1999; Albi et 
al., 2003), an effect that is reflected by the decrease in DHFR and E2F1, and that leads to cell cycle arrest, 
apoptosis or differentiation, all effects that can be observed after treatment with 2OHOA (Lladó et al., 2009; 
Martínez et al., 2005a).  
 
Figure 6-2. 2OHOA mechanism of action in glioma. 
Scheme of 2OHOA molecular mechanism of action in human glioma cells. Signals that induce cell 
proliferation, loss of differentiation and survival, are often propagated through Receptor Tyrosine Kinases 
(RTK, e.g., EGFR) that activate Ras, which in turn activates Raf. Then, Raf activates MEK (MAPKK), which 
finally phosphorylates and activates ERK (MAPK). The Ras/MAPK signaling cassette regulates positively the 
PI3K/Akt and Cyclin/CDK pathways. The alterations of both lo and ld domains induced by 2OHOA, caused 
Ras translocation to the cytosol, preventing RTK-Ras and Ras-Raf interactions (which only occur at the 
plasma membrane) and impairing the signaling and cross-talk events mentioned above. MLT, membrane lipid 
therapy.  
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7 CONCLUDING REMARKS 
Collectively, these results indicated that, 
1. 2OHOA induced a profound effect on cell membrane lipid composition: 
a. 2OHOA induced an increase of SM mass and a decrease in PC and PE 
mass in several human cancer cells but not in the non-tumor cells MRC-5; 
b. These changes were time- and concentration- dependent and specifically 
related to the synthetic structure of the fatty acids used to treat cells; 
c. The increase in SM was due to a rapid and specific activation of SMS, 
which could be the first event triggered in the 2OHOA antitumor 
mechanism;  
d. The sustained activation of SMS and the ensuing SM accumulation 
provoked the deregulation of the sphingolipid metabolism, activating both 
the de novo synthesis and the salvage pathway;  
e. 2OHOA dramatically affected fatty acid composition of lipids; mainly 
replacing oleic acid in phospholipids by 2OHOA and inhibiting SCD1. 
2. The changes induced by 2OHOA on glioma cell lipid composition altered the 
biophysical properties of the membranes by inducing a c omplex 
reorganization of membrane lipid domains:  
a. The ld domains became more disordered, probably because of the changes 
in fatty acid composition; 
b. The lo domains became more rigid and compact, due to the robust SM 
enrichment; 
3. Altogether these results support the idea that 2OHOA effects on membrane 
structure and composition would lead to its antitumor action. Specifically, the 
present results showing that cancer cells had lower SM content than non-
tumor cells, indicate that SM levels in membranes are 
a. Relevant in the induction of tumorigenesis and 
b. Critical in the pharmacological mechanism of action of 
2OHOA against glioma and possibly other types of cancer. 
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4. Mice tissue glycerophospholipid composition, glycerophospholipids fatty 
acids and cholesterol content were not significantly altered by 2OHOA, 
constituting a new evidence on the lack of toxicity of the drug. 
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8 Experimental procedures 
 
8.1 Lipids 
2OHOA was kindly provided by Lipopharma Therapeutics (Palma de Mallorca, 
Spain) and analyzed for its purity as it was described previously (Lladó et al., 2009). 2-
hydroxystearic acid (2OH-18:0) and 2-methyloleic acid (2Me-18:1n-9) were kindly 
provided by Dr. Oliver Vögler (Dpt. of Biology, University of the Balearic Islands, 
Palma). The rest of 2-hydroxy fatty acids were synthesized by Medalchemy, SL 
(Alicante, Spain). NBD-C6-PE, NBD-C6-PC, 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC), N-palmitoyl-sphingomyelin (PSM), and 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphoethanolamine (POPE) were also purchased from Avanti Polar 
lipids (Alabaster, AL). Oleic acid and cholesterol were purchased from Sigma 
Chemicals Co (Madrid, Spain). NBD-C6-Cer, NBD-C6-SM and the probes trans-
parinaric acid (t-PnA) and 1,6-diphenyl-1,3,5-hexatriene (DPH) were purchased from 
Invitrogen, Molecular Probes (Barcelona, Spain). NBD-C6-GlcCer was purchased from 
Larodan (Sweden). LUDOX (diluted 50 wt% colloidal silica in water) and cholesterol 
were from Sigma-Aldrich (Steinheim, Germany). [H3]-palmitic acid was purchased 
from Amersham biosciences (Now GE Healthcare, England). Organic solvents for lipid 
and probe solutions were spectroscopic grade from Merck (Darmstadt, Germany). 
 
8.2 Animals 
The protocols used in this study were revised and approved by the Ethics 
Committee of the University of the Balearic Islands. CD-1 male mice (International 
Genetic Standard) were treated with 600 mg kg-1day-1 of 2OHOA during 10 days. After 
treatment they were killed by decapitation, and brains, hearts, and livers were snap 
frozen in liquid nitrogen and stored at -80ºC till processing.  
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8.3 Cell culture 
The cell lines used in this work, human glioma (U118 and 1321N1), human non-
small lung adenocarcinoma (A549), Jurkat-T lymphoblastic human leukemia cells, and 
non-tumor human fibroblast MRC-5 cells were obtained from the European Collection 
of Cell Cultures (ECCAC) through Sigma Aldrich Co (St Lous, MO). The human 
glioma SF767 cell line was obtained from the Brain Tumor Research Center Tissue 
Bank (San Francisco, CA). Cells were maintained at 37°C in a fully humidified 
atmosphere of 5% CO2 in air. U118, A549, SF767, 13221N1 monolayer cultures and 
Jurkat suspension cultures were maintained in exponential growth using 2 mM 
glutamine-supplemented RPMI 1640 medium, containing 10% fetal bovine serum, 100 
units/ml penicillin, 100 µg/ml streptomycin, and 0.25 µg/ml amphotericin B. In 
addition, the complete RPMI medium used for MRC-5 monolayers contained 1% non-
essential aminoacids. Tissue culture medium and supplements were all purchased from 
Sigma (Madrid, Spain). 
Monitoring and observation of morphological changes induced by 2OHOA were 
performed using an optical inverted microscope Leica DMIL (100 × or 400 ×, Leica 
Microsystems, Wetzlar, Germany). Pictures of control and treated cells were taken at 
different times of treatment, using a digital camera Coolpix 4500 (Nikon Corp., Tokyo, 
Japan) coupled to the inverted microscope. 
 
8.4 Lipid extraction 
Frozen tissues were homogenized with a t issue blender (Ultra-Turrax, Janke & 
Kunkel). Lipids were extracted using n-hexane/2-propanol (3:2 vol/vol, 1.8 ml/100 mg 
tissue). Tissue extracts were centrifuged at 1,000 g to pellet debris. The lipid-containing 
the organic phase was decanted and stored under nitrogen at −80°C until analysis. 
Cellular lipids were extracted directly from the frozen monolayer of cells using a 
modified n-hexane/2-propanol (3:2, by volume) extraction method (Hara & Radin, 
1978). After washing cells with phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 
mM KCl, 12 mM Na2HPO4, 1.38 mM KH2PO4, pH 7.4), lipids were extracted by 
addition of 2.2 ml of 2-propanol and the frozen cells were removed from the plate by 
scraping with a Teflon cell scraper. The 2-propanol was added to 6 ml of hexane and the 
cell dish was rinsed with 2.2 ml of 2-propanol, which was then combined with the 
hexane containing the first wash (Murphy et al., 1997; Murphy et al., 2000). Cell 
extracts were centrifuged at 1,000 g for 5 min at room temperature, to pellet the 
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denatured protein and other cellular debris. The lipid-containing organic phase was 
decanted and stored under a N2 (g) atmosphere at -80ºC until analysis. The residual 
protein pellet was dried under a N2 (g) atmosphere, and stored at -20ºC for protein 
analysis. 
Alternatively, lipids were extracted by the method of Bligh and Dyer (Bligh & 
Dyer, 1959). Briefly, for each 1 ml of sample, 3.75 ml of 1:2 (v/v) CHCl3:MeOH was 
added and vortexed thoroughly for 1 min. Then 1.25 ml of CHCl3 was added and also 
vortexed thoroughly for 1 min. Finally 1.25 ml of 1 M  NaCl was added and again 
vortexed thoroughly for 30 sec. Samples were centrifuge at 1,000 g for 5 min at room 
temperature to give a two-phase system (aqueous top, organic bottom) and the bottom 
phase was recovered and stored under a N2 atmosphere at -80ºC until analysis. In order 
to measure the protein a 10 µl aliquot was taken from the sample before the extraction 
procedure and stored at -20ºC for protein analysis. 
 
8.5 Protein analysis 
Protein concentration in the pellet was measured using the bicinchoninic acid 
assay, according to manufacturer’s instructions (Pierce Biotechnologies, Thermo Fisher 
Scientific, Rockford, USA). Briefly, this assay is based on the reduction of Cu+2 to Cu+1 
by proteins in an alkaline medium, followed by colorimetric detection of the cuprous 
cation using bicinchoninic acid. Absorbance was then measured at 560 nm (Smith et al., 
1985). 
Alternatively, the RC DC protein assay was used (Bio-Rad, Barcelona, Spain). It 
is a co lorimetric assay for determining protein concentration in the presence of both 
reducing agents and detergents. This assay is based on a m odification of the Lowry 
protocol, which involves the reduction of the Folin phenol reagent, and the absorbance 
is measured at 750 nm (Lowry et al., 1951). 
In both cases, the protein concentration was calculated interpolating absorbance 
values into a standard curve with known amount of bovine serum albumin (BSA; 
Pierce, part of Thermo Fisher Scientific, Rockford, USA). 
 
8.6 Thin Layer Chromatography 
Individual phospholipids classes and neutral lipids were separated by thin layer 
chromatography (TLC) or HPTLC. Advancement in TLC is termed high-performance 
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TLC (HPTLC; Sherma, 2000). HPTLC utilizes gel grades that are finer, allowing plates 
to be thinner and smaller. This allows for faster separation times and better separation 
efficiency. HPTLC has improved resolution and lowered detection limits (Peterson & 
Cummings, 2006). Whatman silica gel-60 plates (20 × 20 cm, 250 μm, GE Healthcare, 
England) or (10 × 10 cm, Merck, Darmstadt, Germany) were heat-activated at 110°C 
for 1 h, and samples were streaked onto the plates. On the 10 × 10 Silica gel 60 HPTLC 
plates, lipids were spotted using a Camag Linomat III auto-TLC spotter (Camag 
Scientific Inc., Wilmington, NC, USA). Phospholipids were separated using 
chloroform/methanol/acetic acid/water (55:37.5:3:2 by vol; Jolly et al., 1997), which 
separates all major glycerophospholipids. Neutral lipids were separated in petroleum 
ether/diethyl ether/acetic acid (75:25:1.3 by vol; Marcheselli V. L., 1988). Lipids were 
identified using commercially available standards (Larodan, Sweden). In some cases, 
plates were air-dried after development, sprayed with 8% (w/v) H3PO4 containing 10% 
(w/v) CuSO4, and charred at 180°C for 10 min (Gellermann et al., 2005). Then, lipids 
were quantified by photodensitometry. 
 
8.7 Phosphorus and cholesterol assay  
The phospholipids mass was determined by quantitation of the lipid phosphorus 
content of individual lipid classes separated by TLC (Rouser et al., 1966). Briefly, 0.5 
ml of water was added to the scrapped TLC bands containing the phospholipids, then 
0.65 ml of perchloric acid (70%) was added and the tubes were heated at 185ºC for 1 h. 
Following digestion, the tubes were cooled to room temperature and 0.5 ml of ascorbic 
acid (10% w/v), 0.5 ml of ammonium molybdate (2.5% w/v) and 3.3 ml of water were 
added and mixed by vortexing. Color was developed by boiling the mixture for 6 min 
and, after cooling, the absorbance was measured at 797 nm. The phospholipid mass was 
calculated interpolating absorbance values into a standard curve with known amounts of 
K2HPO4. 
Cholesterol mass of the neutral lipid fraction was determined by an iron binding 
assay after separation by TLC (Bowman & Wolf, 1962). Briefly, the lipids were 
dissolved in 3 ml of ethanol. Then 3 ml of a 0.2% solution of ferric chloride 
hexahydrate (FeCl3-6H2O) in phosphoric acid (85%) and concentrated sulfuric acid 
(H2SO4) were added. Color was developed by mixing and the absorbance was measured 
at 550 nm. The cholesterol mass was calculated interpolating absorbance values into a 
standard curve with known amounts of cholesterol. 
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8.8 Fatty acid transesterification and gas liquid 
chromatography 
The PC and PE fractions were subjected to base-catalyzed transesterification, 
converting the glycerophospholipids acyl chains to fatty acid methyl esters (FAME). To 
each fraction, 2 m l of 0.5 M KOH dissolved in anhydrous methanol was added 
(Brockerhoff, 1975). They were incubated at 37°C for 30 min and the reaction was 
stopped by adding 200 µl of methylformate. Heptadecanoic acid (17:0) was used as the 
internal standard. 
For 2OHOA identification, total lipid extract was subjected to acid-catalyzed 
transesterification. To each fraction, 1.5 ml of 5% HCl was added and the reaction 
occurred at 80ºC for 2 h. Water was added to stop the reaction. 
In both cases, FAMEs were extracted using 3 ml of n-hexane. The lower phase 
was reextracted two more times with 3 ml of n-hexane, and these washes were 
combined with the original aliquot. Individual FAMEs were separated by gas liquid 
chromatography using a SP-2330 column (0.32 mm ID, 30 m length, Supelco, 
Bellefonte, PA, USA) and a gas chromatograph (GC5890 Agilent, USA) equipped with 
dual autosamplers and dual flame ionization detectors.  
 
8.9 Cell viability assay 
Viability was evaluated by measuring the mitochondrial dehydrogenase activity 
of living cells with the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) method according to the manufacturer’s instructions. Briefly, cells were 
seeded in flat-bottom 96-well plates (2 ·  104 cells per ml, 200 μl per well) for the times 
indicated in the corresponding figure, at 37ºC. MTT (0.2 mg/ml in PBS; Sigma-Aldrich) 
was added during the last hour. The mitochondrial dehydrogenases of viable cells 
reduce the tetrazolium salt yielding water insoluble colored formazan crystals. Then, 
these formazan crystals were solubilized by adding 100 μl of DMSO. The absorbance of 
the resulting purple solution was measured spectrophotometrically at 590 nm. The 
absorbance was also measured at 650 nm as a background measurement and substracted 
from the 590 nm value. 
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8.10 Electrophoresis (SDS/PAGE), Immunoblotting, and Protein 
Quantification  
Cells were incubated in the presence or absence of 2OHOA, in 6-well culture 
plates under the experimental conditions indicated above. The cells were then washed 
twice with PBS and harvested by using a Teflon cell scraper in 100 μl 10 mM Tris-HCl 
buffer, pH 7.4, containing 50 mM NaCl, 1 mM MgCl2, 2 mM EDTA, 1% SDS, 5 mM 
iodoacetamide, 1 mM phenylmethylsulfonylfluoride, 1 μM sodium orthovanadate, and 
1 μM cantharidin. Then the cells were homogenized by ultrasounds (3 cycles of 10 s at 
50 W) in a Braun Labsonic U sonicator (10% cycle), and 10-μl aliquots were removed 
for total protein quantification by the Bradford method (Bio-Rad). Then, 10 µl of 10× 
electrophoresis loading buffer (120 mM Tris-HCl, pH 6.8, 4% SDS, 50% glycerol, 
0.1% bromphenol blue, and 10% mM β-mercaptoethanol) was added to the remaining 
suspension, which was then boiled for 3 min. For immunoblotting, 25 μg total protein 
were resolved on the same SDS-polyacrylamide gel (9% polyacrylamide) and 
transferred to nitrocellulose membranes (Whatman, Schleicher, and Schuell). After 
protein transference, membranes were incubated with blocking solution (PBS 
containing 5% nonfat dry milk and 0.1% Tween) for 1 h at room temperature. Then, 
membranes were incubated overnight at 4°C in fresh blocking solution containing the 
specific primary antibodies: rabbit anti-SMS1 (diluted 1:1,000, Santa Cruz); mouse 
anti-SMS2 (diluted 1:1,000, Abcam); mouse anti-DHFR (diluted 1:250, Abcam); 
chicken anti-ADRP (1:1,000, Sigma Aldrich); mouse anti-α-tubulin (1:10,000, Sigma). 
After removing the primary antibody, membranes were washed three times for 10 min 
with PBS containing Tween 0.1%, and all membranes (except for ADRP) were 
incubated with fluorescent-labeled secondary antibody at 1:5,000 dilution with 3% BSA 
in PBS for 60 min at room temperature protected from light and after washing with PBS 
containing 0.1 % Tween, the proteins were visualized and quantified by near infrared 
fluorescence spectroscopy (Odyssey Infrared Imaging System, LI-COR, Inc., Lincoln, 
NE, USA). In the case of ADRP, the membrane was incubated with the horseradish 
peroxidase-linked goat anti-chicken secondary antibody (1:5,000, Sigma Aldrich) for 1 
h at room temperature in blocking solution and immunoreactivity was detected with the 
enhanced chemiluminescence Western blot detection system (Amersham Biosciences 
UK, Ltd.) followed by exposure to ECL hyperfilm (Amersham Biosciences UK, Ltd). 
Films were scanned with a resolution of 63.5 µm (400 dpi). The protein content 
measured for a given protein was normalized by the α-tubulin content.  
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8.11 Quantitative Reverse Transcription-Polymerase 
Chain Reaction (qRT-PCR) 
Cells were incubated in the presence or absence of 2OHOA for 24 h and then, 
total RNA was extracted from U118 cells using the RNeasy Mini kit in combination 
with the RNase-free DNase kit (Qiagen) according to the manufacturer’s instructions. 
Total amount and purity of RNA was determined using a Nanodrop 1000 
spectrophotometer (Thermofisher Scientific, Waltham, MA), by optical density at 260 
and 280 nm. Product quality was assessed by electrophoresis on 1% agarose gel and 
ethidium bromide staining. Reverse transcription of RNA was carried out in a thermal 
cycler Eppendorf Master Cycler Gradient using the Transcriptor First Strand cDNA 
Synthesis Kit (Roche Diagnostics) according to the manufacturer’s instructions. Briefly, 
1 µg of RNA was mixed with oligonucleotides (random hexamers and Poly-A hexamer, 
1 µl from stock 500 µg/ml) and incubated at 65°C for 10 min, and then immediately 
transferred to ice. Then, a reaction mix was added containing, first-strand buffer (4 µl 
from 5× stock), dNTP mix (2.5 µl, 10 nM), protector RNase inhibitor (0.5 µl, 40 
units/µl) and the transcriptor reverse transcriptase (0.5 µl, 20 units/µl). The reaction 
tubes were then incubated at 25°C for 10 min, followed by 55°C for 30 min and finally 
85°C for 5 min. The cDNA samples obtained were stored at -20°C before use. For PCR 
amplification, the primers were designed with a SDSC Biology Workbench Program 
(http://workbench.sdsc.edu) based on the gene sequences in the GenBank. To 
differentiate between cDNA and genomic DNA, primers were designed at distinct sites 
of the exon-exon boundaries (Table 8-1). 
Real-time PCR amplifications were carried out in 96-well plates in a StepOne 
Plus thermal cycler (Applied Biosystems) using the SYBR Premix Ex Taq 2× (Perfect 
Real Time, Takara). The reaction also contained an internal probe ROX 1 and 0.1 µM 
of each primer. An initial denaturation step at 95°C for 30 s preceded thermal cycling. 
DNA amplification and fluorescence quantification was determined over 35 cycles with 
a denaturation step at 95°C for 5 s, followed by an annealing/extension step at 60°C for 
34 s. Fluorescence detection and quantification was carried out after each DNA 
extension step, and the data were analyzed using the StepOne software (v2.0). As 
endogenous control, the expression of β-actin was determined, as it is not modulated by 
2OHOA. 
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Table 8-1. Primers used in this study. 
 
Gene Orientation Sequence (5’-3’) 
SMS1 Forward GAG CCT CTG GAG CAT TTC AC 
Reverse TGC TCC ATT TTC AGG GTT TC 
SMS2 Forward CAA CAC TGT TTT GGT GG 
Reverse GGA GAA GCA GCA AGG AAT TG 
CerS1 Forward GGC CAC TCC ATC TAC GCT AC 
Reverse ACT CAA GCT GCA CGT CAC TG 
CerS2 Forward TCT CTA TAT CAC GCT GCC CC 
Reverse GCT TGC CAC TGG TCA GGT AG 
CerS3 Forward ATC AAG AGA GGC CTT CCA GG 
Reverse ATA GCC ATT CCA AAC CTC CC 
CerS4 Forward ATC AGA CCA GGA GGC AAG TG 
Reverse GAA CTT CTT GGT CAG CTG GG 
CerS5 Forward CCA ATG CCA TCC TTG AAA AG 
Reverse AAC CAG CAT TGG ATT TTT CG 
CerS6 Forward TTC GAC AAA GAC GCA ATC AG 
Reverse AGC AAT GCC TCG TAT TCC AC 
β-actin Forward GCG GGA AATCGT GCG TGA CAT 
Reverse CTA CCT CAACTT CCA TCA AAG CAC 
 
The ratio between the expression of the genes of interest and β-actin was 
determined by means of the equation described by Pfaffl et al. (Pfaffl, 2001): 
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Where Ex is the efficiency of the gene of interest and Eend is the efficiency of the 
endogenous. This value was used to calculate the relative expression in 2OHOA-treated 
cells with respect to untreated cells (control = 1). The efficiency of the reaction was 
estimated via increase in absolute fluorescence according to Pfaffl, 2002 (unpublished, 
from http://www.gene-quantification.de/efficiency01.html#e-fluoro-2): 
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Where Rn is the fluorescence measured at two treasholds and CP is the cycle at 
that threshold. Melting curve analysis and agarose gel electrophoresis were used to 
further characterize the PCR products. 
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8.12 SMS activity assay in cell culture 
SMS activity assay in cell culture was carried out similarly as described 
elsewhere (Tafesse et al., 2007). Briefly, control and treated U118 cells were incubated 
with 3 μM NDB-C6-Cer for 4 h prior to lipid extraction with hexane:2-propanol (3:2 
vol/vol). Lipids were separated by HPTLC as described above and the NBD-lipids were 
visualized on a Bio-Rad Molecular Imager FX and quantified using Quantity One 
software (Bio-Rad, Barcelona, Spain). The SMS activity was associated with the newly 
synthesized NBD-C6-SM. 
 
8.13 In vitro SMS activity assay 
The in vitro SMS synthase activity protocol was adapted from Ding et al. and 
Villani et al. (Ding et al., 2008; Villani et al., 2008). Thus, U118 cells were collected 
and homogenized in ice-cold lysis buffer (50 mM Tris/HCl, 1 mM EDTA, 1 mM 
PMSF, 8% (w/v) CHAPS, pH 7.4) by passing 20 times through a 28.5 gauge needle. 
The cell lysate was centrifuged at 500 g for 5 min at 4ºC, and the enzymatic activity was 
measured in the post-nuclear supernatant. Protein concentrations were determined using 
the Bio-Rad assay and the SMS assay was performed using 100 μg of protein. The 
substrate was prepared as a mixture of 0.1 μg/μl of NBD-C6-Cer, 0.01 μg/μl of 
synthetic PC and PE resuspended by sonication and vortexing until clear in 50 m M 
Tris/HCl, 25 mM KCl, 1 mM EDTA, pH 7.4. The substrate was diluted 1:1 with the 
proteins resuspended in reaction buffer (final incubation volume of 200 μl) and the 
incubation was carried out for 2 h at 37ºC in the dark. The reaction was stopped on ice 
by adding 2 vol. of chloroform/methanol (1:2, v/v). Lipids were extracted using the 
Bligh and Dyer method and analyzed as described above. 
 
8.14 Cell surface SMS activity assay 
Cell surface SMS activity assay was adapted from Tafesse et al. (Tafesse et al., 
2007). Briefly, subconfluent U118 cells pretreated with 2OHOA (200 μM) for 6 h were 
washed with ice-cold Hanks’ Balanced Salt Solution (HBSS, Gibco, Invitrogen, 
Barcelona, Spain) and incubated for 3 h at 0°C in HBSS containing 3 μM NBD-C6-Cer 
and 1% (w/v) fatty acid-free BSA followed by a 30-min incubation in HBSS containing 
only 1% (w/v) fatty acid free BSA. Under these conditions, any vesicular transport from 
the Golgi apparatus to the plasma membrane is impaired. All HBSS media were 
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collected and lipids from medium and from cells were extracted by the Bligh and Dyer 
method (Bligh & Dyer, 1959) and analyzed as described above. 
 
8.15 Nuclei lipid composition analysis 
Nuclei of control and treated cells were isolated using the Nuclear Extract Kit 
(Active Motive, Belgium) following the manufacturer’s instructions. Then, lipids were 
extracted with hexane:2-propanol (3:2 vol/vol) and analyzed as described above.  
 
8.16 RNA interference assay 
RNA interference assay was performed on A549 and U118 cells transfected with 
small interfering RNA duplexes (siRNAs; Qiagen, Germantown, MD) using HiPerfect 
Transfection Reagent (Qiagen), according to the manufacturer’s instructions. A number 
of different SMS1- and SMS2-directed siRNAs were initially tested on U118 and A549 
cells. Because results showed that the silencing worked better on A549 cells, this cell 
line was selected to continue with these experiments. The tests yielded one custom 
made SMS1 siRNA (target sequence, 5’-AACTACACTCCCAGTACCTGG-3’) that 
reduced the expression of the SMS1 60-80% (50 nM, 48 h) and two different 
commercially available SMS2 siRNA (Hs_MGC26963_1 target sequence, 5’-
AACGCTGTAACCAAAGGTATA-3’ and Hs_MGC26963_8, target sequence, 5’-
AACGATTAGAAAGATGAACAA-3’) that strongly reduced the expression of SMS2 
80-90% (25 nM, 24 h or 48 h) (Figure A 2). As the Hs_MGC26963_8 siRNA had been 
already validated, all the experiments were carried out with this sequence. The non-
specific All Star siRNA sequence (SCR; scrambled siRNA) was used as non-silencing 
control and All Star Hs Cell Death Control siRNA was used as a transfection positive 
control (Qiagen). Briefly, the day before transfection cells were seeded at 1.5 cells/cm2 
in 24-well plates with 0.5 ml per well of complete RPMI medium as indicated above. 
The day of transfection, the corresponding siRNA (50 nM for SMS1 and 25nM for 
SMS2, stocks at 20 µM) were mixed with the transfection reagent (7 µl for SMS1 and 5 
µl for SMS2) in 100 µl of serum- and antibiotic-deprived RPMI medium. These 
mixtures were incubated 10 min at room temperature to allow the formation of the 
transfection complexes and then dropped-wise onto the cells. After 24 h, the medium 
was changed with fresh medium and cells were incubated for 24 h more. For cell 
treatments 2OHOA (200 µM, 24 h ) was added with the fresh medium (after 24 h of 
silencing, i.e.; 48 h of silencing and 24 h of 2OHOA treatment). When double silencing 
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was done, the total concentration of silencing siRNA was 75 nM and 12 µl of 
transfection reagent were added. Thus, scramble and mock controls were done with the 
same amounts. As a validation method for the silencing, a qRT-PCR was performed as 
indicated above. After the 48 h, cells were subjected to either lipid extraction as detailed 
above or to DNA content analysis by flow cytometry as explained below. 
 
8.17 D609 Inhibition experiments 
A549 cells were incubated with D609 (potassium tricyclodecan-9-yl xanthate, 
Figure 8-1) for 16 h (350 µM, a gift from Dr Amadeu Llebaria, Dept. of Biomedicinal 
Chemistry IQAC-CSIC, Barcelona) and 2OHOA (200 µM) was added 1 h after the 
addition of D609. Among different biological effects, D609 is a potent inhibitor of PC-
PLC (Muller-Decker, 1989). In addition, a few reports show that D609 can also inhibit 
the enzymes of the sphingomyelin cycle, namely sphingomyelin synthase (Luberto & 
Hannun, 1998; Luberto et al., 2000; Meng et al., 2004a). SM levels were established as 
described above while the effect of SMS inhibition on the cell cycle was evaluated by 
flow cytometry. Thus, after treatment, A549 cells were washed with PBS and harvested 
using trypsin. Cells were then fixed with ice-cold 70% ethanol for 1 h a t 4°C, 
centrifuged for 5 min at 1,260 g, and then resuspended in sodium citrate (38 mM, pH 
7.4). Finally, cells were incubated for 20 min at 37°C with buffer A (sodium citrate (38 
mM, pH 7.4), 50 µg/ml propidium iodide and 5 µg/ml RNase A; Sigma-Aldrich) and 
analyzed on a Beckman Coulter Epics XL flow cytometer. Cell populations in the 
different phases of cell cycle (subG1, G0 /G1, S, and G2/M) were determined on the basis 
of their DNA content. 
 
Figure 8-1. Chemical structure of D609. 
From Enzo Life Sciences data sheet (catalog number ST-330). 
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8.18 Measurement of S1P and sphingosine 
S1P was extracted by a modified two-step lipid extraction previously described 
(Ruwisch et al., 2001; Yatomi et al., 1995). Briefly, the cell monolayers were washed 
with PBS and then removed from the 6 cm petri dishes in 1 ml of methanol containing 
0.25% hydrochloric acid by scraping with a Teflon cell scraper into a siliconized glass 
tube. An aliquot of 100 µl of the sample was transferred into another siliconized glass 
tube and 200 pmol dihydro-S1P as internal standard was added. After alkalization with 
100 µl of a 3N NaOH solution, lipids were extracted by addition of 1 ml of chloroform 
and 1 m l of 1N NaCl. The mixture was centrifuged (300 g, 5 min) for an effective 
separation of the alkaline aqueous phase containing S1P. The organic phase was 
reextracted with 0.5 ml of methanol, 0.5 ml of 1N NaCl and 50 µl of 3N NaOH. The 
collected aqueous phases were acidified with 100 µl of concentrated HCl and extracted 
twice with 1.5 ml of chloroform each. The combined organic phases were evaporated 
using a Centrivac vacuum system and the dried lipids were resolved in 325 µ l 
methanol/0.07 M K2HPO4 (8:2) by thorough vortexing and sonication on ice for 5 min. 
A derivatization mixture of 7 mg of o-phthaldialdehyde, 7 µ l of 
mercaptoethanol, 100 µl of ethanol and 4.9 ml of boric acid solution adjusted to pH 10.5 
with potassium hydroxide was prepared and 25 µl of this mixture was added to the 
resolved lipid fraction. After 15 min at room temperature the derivatives were analyzed 
on a Merck Hitachi LaChrom HPLC system (Merck Hitachi, Darmstadt, Germany). 
Fluorescence was measured at an emission wavelength of 455 nm after separation on a 
RP 18 Kromasil column (Chromatographie Service, Langerwehe, Germany) kept at 
35°C. The flow rate was adjusted to 1.3 ml/min and a gradient program with methanol 
and 0.07 M K2HPO4 solution as solvents was used (Table 8-2). Resulting profiles were 
evaluated using the Merck system manager software. 
Table 8-2. Gradient program for S1P and dihydro-S1P separation utilized for the HPLC analysis of 
S1P.  
Time (min) 0.07 M K2PO4 (%) Methanol (%) 
0 24 76 
10 24 76 
30 16 84 
40 8 92 
46 0 100 
56 0 100 
58 24 76 
(Prakash et al., 2010). 
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8.19 Mass Spectometry 
Lipid extraction and mass spectrometry based targeted lipid analysis in the 
presence of isotopic labeled or not naturally occurring lipid species as internal standards 
was performed essentially as described previously (Liebisch et al., 1999; Liebisch et al., 
2004; Scherer et al., 2010a; Scherer et al., 2009; Scherer et al., 2010b). In brief, cells 
were washed with PBS and lysed in 0.1% sodium dodecyl sulfate SDS by scrapping, 
sonicated and aliquots corresponding to 100 µg total protein were used for lipid 
extraction and analysis. Direct flow injection utilized a 1200 series binary pump 
(Agilent, Waldbronn, Germany) coupled via electrospray ionization (ESI) to a Quattro 
Ultima tandem mass spectrometer (Micromass, Manchester, UK). Reversed phase and 
hydrophilic interaction chromatography ESI tandem mass spectrometry (HILIC LC-
ESI-MS/MS) was conducted using a 1 ,200 series binary pump and a hybrid triple 
quadrupole linear ion trap mass spectrometer API 4,000 Q-Trap equipped with a Turbo 
V source ion spray operating in positive ESI mode was used for detection (Applied 
Biosystems, Dasrmstadt, Germany). Analysis of fatty acid species was performed after 
FAME derivatisation using a Shimadzu 2,010 GC-MS. Quantification was performed 
by standard addition calibration to cell homogenates using a number of naturally 
occurring lipid species for each lipid class. 
 
8.20 Metabolic labeling of cells to measure de novo [H3]-Cer 
synthesis 
Control and treated (200 µM, 6 and 24 h) U118 cells were pulse labeled with 
0.30 µCi/ml of [H3]-palmitic acid (stock at 1 mCi) for 5 min. After incubation, total cell 
lipids were extracted and separated by TLC. After running two-thirds of the separation 
distance in chloroform/ethanol/water/triethylamine (35:40:9:35, by vol.), the plates were 
dried at room temperature and subsequently separated in isohexane/ethylacetate (5:1, by 
vol) for the full distance (Kuerschner et al., 2005). The plates were dried at room 
temperature and the side with the standards was sprayed with 8% (w/v) H3PO4 
containing 10% (w/v) CuSO4, air-dried and charred at 180°C for 10 min to develop the 
non-radioactive standard bands. The area corresponding to each lipid was scraped off, 
and the radioactivity was measured by liquid scintillation counting. The level of [H3]-
Cer produced was normalized to cellular protein content. 
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8.21 Electron microscopy 
Cells were seeded at 1.1 ·  104 cell/cm2 in 4-well Lab-Tek chamber slides (Nalge 
Nunc International, Naperville, IL) as indicated above in the presence or absence of 
2OHOA (200 µM, 48 h or 72 h). After washing twice with 0.1 M phosphate buffer (PB; 
NaH2PO4 20 mM, Na2HPO4 80 mM, pH 7.4) for 5 min, cells were fixed in 3.5% 
glutaraldehyde for 1 h at 37°C. After washing four times with 0.1 M PB for 10 min, 
cells were postfixed in 2% OsO4 for 1 h at room temperature protected from light. Then, 
cells were washed with distilled H2O three times for 5 min and were sequentially 
washed with ethanol 30°, then ethanol 50° and ethanol 70°, each for 5 min. Afterwards, 
cells were stained in 2% uranyl acetate (in ethanol 70°) in the dark for 2 h at 4°C and 
again sequentially dehydrated in ethanol 70° (2 × 5 m in), ethanol 96° (2 × 5 min), 
ethanol 100° (2 × 7 min and 1 × 10 min). Finally, cells were infiltrated overnight in 
Araldite (in ethanol 100°; Durcupan, Fluka, Buchs SG, Switzerland). Following 
polymerization at 70°C during 3 days, embedded cultures were detached from the 
chamber slide and glued to Araldite blocks. Serial semi-thin (1.5 µm) sections were cut 
with an Ultracut UC-6 (Leica, Heidelberg, Germany) and mounted onto slides and 
stained with 1% toluidine blue. Selected semi-thin sections were glued (Super Glue, 
Loctite) to araldite blocks and detached from the glass slide by repeated freezing (in 
liquid nitrogen) and thawing. Ultrathin (0.06 – 0.09 µm) sections were prepared with 
the Ultracut and stained with lead citrate. Finally, photomicrographs were obtained 
under a transmission electron microscope (FEI Tecnai G2 Spirit Biotwin) using a digital 
camera (Morada, Soft Imaging System, Olympus). 
 
8.22 Immunofluorescence labeling of SM by lysenin 
Cells were plated at a density of 1.1 ·  104 cell/cm2 on Chambered Coverglass 
(Lab-TekTM II, Thermo Fisher Scientific Inc.) as indicated above in the presence or 
absence of 2OHOA (200 µM, 72 h ). SM was labeled with lysenin as previously 
described by Yamaji et al with minor modifications (Yamaji et al., 1998). Lysenin is a 
natural sphingomyelin-specific binding protein without any cross reactions with other 
sphingolipids that was isolated from the coelomic fluid of earthworm (Sekizawa et al., 
1997). All steps were carried out at room temperature. After washing twice with 
phosphate buffer 0.1 M PB for 5 min, cells were fixed with 4% paraformaldehyde in PB 
for 20 min and washed again with PB. To quench any excess of reactive groups of 
paraformaldehyde, cells were incubated with 0.1 M N H4Cl in PB for 15 min and 
washed again twice with PB. After blocking with 2% BSA in PB for 30 min, cells were 
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incubated with lysenin (1 µg/ml in blocking solution; PeptaNova GmbH, Sandhausen, 
Germany) for 2 h and washed twice with PB for 5 min. Next, cells were incubated with 
rabbit anti-lysenin antiserum (1:500 in blocking solution; PeptaNova GmbH, 
Sandhausen, Germany) for 1 h, followed by incubation with a fluorescent secondary 
antibody (conjugated to Alexa Fluor 488-labelled goat anti-rabbit at 1:200 dilution, 
Molecular Probes; excitation at 488 nm and detection at 510–550 nm) for 1 h. After 
washing cells twice with PB for 5 min images were acquired using a Leica TCS SP2 
spectral confocal microscope with 630 × optical magnification and 3 × digital 
magnification (approximately 1,800 × total magnification), and analyzed with the 
software provided by the manufacturer. 
 
8.23 Metabolic labeling of cells with NBD-lipids 
Similar to the SMS activity assay, U118 cells were incubated with 3 μM NDB-
C6-SM, NBD-C6-GlcCer, NBD-C6-PC or NBD-C6-PE for 4 h prior to lipid extraction. 
Lipids were separated by HPTLC as described above and fluorescent lipids were 
visualized on a Bio-Rad Molecular Imager FX and quantified using Quantity One 
software (Bio-Rad, Barcelona, Spain). 
 
8.24 Determination of SCD activity 
Control and treated (200 µM, 48 h) U118 cells were steady-state labeled with 
trace amounts of [H3]-palmitic acid (0.25 µCi/ 60 mm petri dish, stock at 1 mCi) for 6 h. 
At the end of the incubation, total cell lipids were extracted and transesterified as 
indicated above. The derivatives methyl esters were separated by argentation TLC 
following the procedure of Wilson and Sargent (Wilson & Sargent, 2001). Briefly, silica 
gel 60 HPTLC (10 × 10 cm) plates were sprayed uniformly with 20 ml of acetonitrile 
containing 2 g of silver nitrate until the plates were saturated. The plates were air-dried 
in subdued light, heated at 110°C for 30 min to achieve activation and used within 1 h. 
FAME mixtures were applied to the silver nitrate impregnated plates and were 
separated in hexane: ethyl ether (90:10, by vol), which allows to separate SFA from 
MUFA. Lipid fractions were identified using pure methyl stearic acid and methyl oleic 
acid as standards (Larodan, Sweden) The plates were air-dried and the side with the 
standards was sprayed with 8% (w/v) H3PO4 containing 10% (w/v) CuSO4, air-dried 
and charred at 180°C for 10 min to develop the non-radioactive standard bands. SFA 
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and MUFA spots were scraped from the TLC plate and quantified by liquid scintillation 
counting. The level of [H3]-MUFA produced was normalized to cellular protein content. 
 
8.25 Nile red staining of lipid droplets for fluorescence 
microscopy 
U118 cells were plated at a density of 1.5 ·  104 cells/ml on Chambered 
Coverglass (Lab-TekTM II, Thermo Fisher Scientific Inc.) as indicated above in the 
presence or absence of 2OHOA (200 µM, 24 h). After treatment, cells were washed 
with 0.1 M PB, fixed with 4% paraformaldehyde for 10 min, and washed twice with 
PB. Cells were overlaid with 0.5 ml PB, to which 2.5 µl of a stock solution of Nile red 
(Sigma Aldrich) in acetone (0.2 mg/ml) were added, so that the final concentrations of 
Nile red and acetone were 1 µg/ml and 0.5%, respectively. Samples were kept in the 
dark until photographed on a Nikon Eclipse TE2000-S Fluorescence microscope at 40 × 
magnification. Analysis of the vesicles in photomicrographs was performed with Image 
J 1.38× public software (Wayne Rasband, National Institutes of Health; 
rsb.info.nih.gov). Briefly, the image was split into the blue, green and red channels. To 
maximize the signal to noise ratio, analysis was carried out with the blue component, as 
Nile red emission shifts to shorter wavelengths when incorporated into LDs. After 
thresholding the blue component at a value of 40, particles were counted, recording total 
amount, total area, and average size. 
 
8.26 Immunofluorescence labeling of lysosomes with 
Lysonsensor 
U118 cells were plated at a d ensity of 1.1 ·  104 cell/cm2 on Chambered 
Coverglass (Lab-TekTM II, Thermo Fisher Scientific Inc.) as indicated above in the 
presence or absence of 2OHOA (200 µM, 48 h). After treatment, cells were incubated 1 
h with 1 µM LysoSensor Green DND-189 probe pH Indicator (pH 4.5 - 6) 
(InvitrogenTM) and in the last 5 min with Hoechst stain (trihydrochloride trihidrate, 40 
µg/ml, Invitrogen molecular probesTM). Samples were observed on a N ikon Eclipse 
TE2000-S Fluorescence microscope at 40 × magnification. The LysoSensor™ dyes are 
acidotropic probes that appear to accumulate in acidic organelles, such as lysosomes, as 
the result of protonation. 
 
8 Experimental procedures 
135 
8.27 Liposome preparation 
The glycerophospholipids used to prepare multilamellar vesicles (MLV) and 
large unilamellar vesicles (LUV) were POPC, POPE and PSM as this combination of 
acyl chains is one of the most common in the plasma membrane of mammalian cells 
(Marsh, 1990). Likewise, PSM was used as it is a v ery common acyl chain in 
sphingolipids (Estep et al., 1979) and it reflects the properties of natural SM (Barenholz 
et al., 1976). POPC has a main transition temperature (Tm) of -3ºC (Koynova & Caffrey, 
1998) well below the temperature of this study (24ºC), whereas PSM has a Tm of 41ºC 
(Marsh, 1990). Therefore, the mixtures used in this study met the criteria for formation 
of raft-like domains, i.e., lo domains in coexistence with a ld phase (Marsh, 1990). In 
general, ld domains are enriched in low Tm lipids, particularly POPC, whereas lo 
domains are high Tm lipid- (in this case PSM) and cholesterol-enriched. POPE has a Tm 
that is approximately the average between the Tm of POPC and PSM, i.e., 24.5ºC 
(Polozov & Gawrisch, 2004). In addition, in the range of concentrations used POPE is 
able to mix with both POPC (Epand & Bottega, 1988) or SM/cholesterol (Shaikh et al., 
2002). Thus, POPE is expected to have a fairly homogeneous distribution between 
ordered and disordered domains in the mixtures used.  
MLV of quaternary mixtures of POPC, POPE, PSM and cholesterol were 
prepared with either t-PnA, or DPH, or no probe (blank; de Almeida et al., 2007; de 
Almeida et al., 2005). Briefly, lipid stock solutions were made in chloroform except for 
POPE which was dissolved in chloroform:methanol (2:1, v/v). Appropriate volumes of 
lipids and probe stock solutions were added to a tube to have the desired lipid mole 
fractions and lipid/probe ratio. Then, the solvent was dried under a N2 stream, and the 
residue was dried for at least 3 h under vacuum. The molar proportions of each lipid are 
given in Table 4-1. Total lipid concentration in MLV suspensions was always 0.2 mM. 
The suspension medium used was sodium phosphate 10 mM, NaCl 150 mM, EDTA 0.1 
mM buffer (pH 7.4). The samples were then progressively vortexed and submitted to 10 
freeze/thaw cycles (liquid nitrogen/water bath at 60°C). Afterwards, they were slowly 
cooled and kept in the dark at 4°C. Before measurements, they were slowly brought to 
room temperature. 
To analyze the effect of the partition of free 2OHOA into membranes, 
measurements were carried out in LUV suspension for effective 2OHOA incorporation, 
mimicking the 24 h composition of control and treated U118 cells. First, MLVs were 
prepared as described above, without probe, and with final lipid concentration of 0.5 
mM to ensure that an efficient incorporation of 2OHOA in the lipid bilayer is achieved. 
To obtain LUVs, the MLV suspensions were extruded (21 times) using an Avanti Mini-
Extruder and polycarbonate filters with a pore diameter of 100 nm  (Nuclepore, 
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Whatman). The suspension was slowly brought to room temperature and allowed to 
equilibrate. 2OHOA was then added in water to the suspension to a final concentration 
of 25 µM (5 mole%) or 100 µM (20 mole%) at least 1 h before the fluorescence 
measurements. The samples were kept in the dark until the measurements. The 
2OHOA/lipid ratio in the 25 µM 2OHOA samples is similar to the estimated 
2OHOA/lipid ratio in cells treated with 200 µM of the drug. 
In order to prepare liposomes from lipid extracts, these were dissolved in 
chloroform/methanol (2:1, v/v) to obtain a concentration of 1 µmol Pi/ml. Three 
aliquots of 150 µl were taken from each sample (for DPH, t-Pna and blank), and for the 
following calculations the cholesterol/phospholipid ratios calculated from the lipid 
analysis were also taken into consideration. Here, the lipids and probe were suspended 
in a volume of previously warmed (50°C) HEPES buffer (pH 7.4) for a total final lipid 
concentration of 0.2 mM and MLV were prepared as indicated above. 
In all cases, the probe: lipid ratios used were 1:200 for DPH and 1:500 for t-PnA, 
that were added from the stock ethanol solutions followed by 1 h incubation at 50ºC. 
The volume of ethanol was below 1% ensuring no alterations of the lipid bilayers 
(Marques et al., 2011). They were allowed to equilibrate overnight protected from light. 
The concentration of lipids was determined by phosphorous content (McClare, 1971). 
Probe concentrations in stock solutions were determined by absorption 
spectrophotometry as it was previously described (de Almeida et al., 2005). Absorption 
spectrophotometry was carried out with a Jasco V-560 UV/Vis spectrophotometer. 
 
8.28  Spectrofluorescence measurements and data analysis 
Fluorescence measurements were carried out at 24ºC on a Horiba Jobin Yvon 
FL-1057 Tau 3 spectrofluorometer. 
For steady-state measurements (450 W Xe arc lamp light source), the samples 
were under constant magnetic stirring, and the excitation/emission wavelengths were 
358 nm/430 nm for DPH and 303nm/404 nm for t-PnA, respectively. The steady-state 
anisotropy (<r>) was calculated according to: 
( )
( )vhvv
vhvv
IGI
IGIr
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×−
>=<
2
,               Equation 3 
Where G is the instrumental correction factor and “V” and “H” in the subscripts 
represent the vertical and horizontal orientations of the polarizers and the order of the 
8 Experimental procedures 
137 
subscripts corresponds to excitation and emission. An adequate blank was subtracted 
from each intensity reading. 
For time-resolved measurements by the single photon counting technique, 
nanoLED N-320 (Horiba Jobin Yvon) was used for the excitation of t-PnA, and 
emission wavelength was 404 nm. Diluted LUDOX was used as the scatterer to obtain 
the instrumental response function. The program TRFA Data Processor v.1.4 (Scientific 
Software Technologies Center, Minsk, Belarus) was used for analysis of the 
experimental fluorescence decays. An adequate blank decay was acquired and 
subtracted to the respective sample.  T he decays were analyzed by fitting a s um of 
exponentials, 
itn
i
itI
τ
α
/
1
)(
−
=
∑=                  Equation 4 
Where αi and τi are the normalized amplitude and lifetime of component i, 
respectively. The mean fluorescence lifetime is obtained through: 
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ii
τα
τατ
∑
∑>=<
2
,                Equation 5 
The quality of fit was judged by non-linear least squares (NLLS) with a reduced-
χ2 value close to 1 a nd random distribution of weighted residuals and residuals 
autocorrelation. The goal of least squares is to test whether a given mathematical model 
is consistent with the data, and to determine the parameter values for that model which 
have the highest probability of being correct (Lakowicz, 2006). 
 
8.29 Statistics 
Statistical analysis was done using GraphPad Prism 4.01 (GraphPad Software 
Inc., San Diego, CA). Unless indicated, data are expressed as mean ± SEM, from at 
least three independent experiments (n). The statistical significance of the mean 
difference was determined by Student’s t test. The asterisks indicate a significant effect 
of the treatment as compared with the control: *P < 0.05; **P < 0.01; ***P < 0.001.  
 
 
 

9 Appendix 
139 
9 Appendix 
 
Figure A 1. Effect of 2OHOA on the glycerophospholipid composition of different cell lines. 
Cells were treated in the absence (Control) or presence (200 µM, 24 h) of 2OHOA. After treatment, lipids 
were extracted and analyzed by HPTLC and quantified by densitometry. Non-small cell lung cancer (A549) 
cells (A), human glioma 1321N1 cells (B), human leukemia Jurkat cells (C), non-tumor human fetal fibroblast 
MRC-5 cells (D). Human glioma SF767 cells (E) were treated for 72 h and the phospholipid mass was 
determined by assaying the lipid phosphorous content of individual lipid classes separated by TLC, according 
to the Experimental procedures section. Values represent the mean ± SEM, n = 3–5. The asterisks indicate a 
significant effect as compared with the control (*P < 0.05; **P < 0.01; ***P < 0.001). 
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Figure A 2. RNA interference experiment on A549 cells. 
A549 cells exposed to different siRNA treatments. (A) Representative pictures of the cells. Validation of the 
method by qRT-PCR for SMS1 (B) and SMS2 (C). 
  
9 Appendix 
141 
 
Figure A 3. 2OHOA increased the sphingosine mass content in U118 cells.  
U118 cells were exposed to 2OHOA (200 μM) for 24 h and 48 h, and the lipids were then extracted and 
analyzed by HPLC as described in Experimental procedures. Values represent the mean ± SEM, n = 4. The 
asterisks indicate a significant effect of 2OHOA as compared with the control (*P < 0.05;***P < 0.001). 
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Table A 1. Effect of 2OHOA on SF767 fatty acid composition of individual phospholipid. 
 
FAME 
PC PE 
Control 2OHOA Control 2OHOA 
 Mean ± SD  Mean ± SD  Mean ± SD  Mean ± SD 
16:0  27.7 ± 1.2  25.4 ± 0.7**    8.1 ± 0.6    8.9 ± 0.8 
16:1    2.0 ± 0.2    1.6 ± 0.2**    1.1 ± 0.1    0.7 ± 0.2 
18:0  11.9 ± 1.3  13.5 ± 1.9  18.7 ± 0.9  22.3 ± 0.2*** 
18:1n-9  30.5 ± 0.7  25.4 ± 0.6***  23.8 ± 3.5  14.3 ± 0.9*** 
18:1n-7    4.4 ± 0.5    4.4 ± 0.6    4.8 ± 0.7    5.4 ± 0.3 
18:2n-6  13.5 ± 1.7  14.4 ± 1.2    6.1 ± 0.4    7.6 ± 0.4*** 
20:3n-6    1.9 ± 0.1    2.1 ± 0.8    2.1 ± 0.1    2.1 ± 0.1 
20:4n-6    4.2 ± 0.4    7.1 ± 0.7***  20.0 ± 1.5  18.2 ± 0.8* 
20:3n-3    1.2 ± 0.1    2.5 ± 0.3***    4.4 ± 0.2    4.7 ± 0.1* 
22:5n-3    1.0 ± 0.2    1.3 ± 0.1    4.0 ± 0.3    6.3 ± 0.4*** 
22:6n-3    0.8 ± 0.1    1.7 ± 0.2***    4.8 ± 0.3    7.4 ± 0.7*** 
SFA  39.5 ± 0.6  38.8 ± 2.5  26.8 ± 1.3  31.2 ± 0.7*** 
MUFA  37.5 ± 0.8  31.7 ± 0.8***  30.5 ± 3.0  21.0 ± 0.9*** 
PUFA  22.9 ± 1.3  29.4 ± 1.9***  42.7 ± 2.5  47.8 ± 1.5** 
n-3    3.0 ± 0.4    5.5 ± 0.6***  13.2 ± 0.7  18.4 ± 1.1*** 
n-6  20.0 ± 1.4  24.0 ± 1.5**  29.5 ± 2.0  29.4 ± 0.5 
n-3/n-6    0.2 ± 0.0    0.2 ± 0.0***    0.5 ± 0.0    0.6 ± 0.0*** 
 
SF767 cells were treated with 2OHOA (200 µM) for 72 h. After treatment, lipids were extracted and analyzed 
by TLC. The PC and PE fractions were converted to FAME in basic conditions and analyzed by gas 
chromatography. Values are expressed as mole% and represent mean ± SD, n = 4-5. The asterisk indicate a 
significant effect of 2OHOA compared to the control (*P < 0.05; **P < 0.01; ***P < 0.001). 
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Table A 2. Effect of 2OHOA on A549 fatty acid composition of individual glycerophospholipids. 
FAME 
PC PE 
  Control 2OHOA Control 2OHOA 
 Mean ± SD  Mean ± SD  Mean ± SD  Mean ± SD 
16:0  37.3 ± 0.6  36.3 ± 1.6    8.2 ± 0.3    9.1 ± 1.3 
18:0    4.7 ± 0.5  12.7 ± 3.5***  14.7 ± 0.4  23.9 ± 0.4*** 
18:1n-9  43.6 ± 0.9  23.1 ± 1.8***  32.0 ± 5.3  13.2 ± 0.1*** 
18:1n-7    6.5 ± 0.3    9.9 ± 0.5***  10.8 ± 0.5  10.8 ± 0.8 
18:2n-6    1.8 ± 0.0    3.7 ± 1.0**    3.3 ± 0.2    3.5 ± 0.2 
20:3n-6    0.5 ± 0.0    1.3 ± 0.1***    1.6 ± 0.1    2.0 ± 0.1*** 
22:0    0.9 ± 0.1    3.0 ± 0.2***    2.6 ± 0.2    6.7 ± 0.5*** 
20:4n-6    1.0 ± 0.0    3.1 ± 0.1***  17.7 ± 0.3  18.0 ± 0.7 
20:5n-3    0.4 ± 0.0    0.4 ± 0.0    4.8 ± 0.1    1.9 ± 0.1*** 
22:5n-3    0.2 ± 0.0    1.3 ± 0.0***    0.7 ± 0.1    4.0 ± 0.2*** 
22:6n-3    0.6 ± 0.0    1.8 ± 0.1***    5.9 ± 0.4    6.9 ± 0.4** 
SFA  42.9 ± 0.7  52.0 ± 2.1***  25.4 ± 0.6  39.7 ± 0.7*** 
MUFA  52.6 ± 0.6  36.6 ± 2.6***  40.6 ± 0.6  24.0 ± 0.8*** 
PUFA    4.4 ± 0.1  11.5 ± 0.7***  34.0 ± 0.8  36.2 ± 1.2** 
n-3    1.1 ± 0.0    3.5 ± 0.3***  11.3 ± 0.6  12.7 ± 0.6** 
n-6    3.3 ± 0.0    8.0 ± 0.9***  22.7 ± 0.3  23.5 ± 0.6* 
n-3/n-6    0.3 ± 0.0    0.4 ± 0.1*    0.5 ± 0.0    0.5 ± 0.0** 
 
A549 cells were treated with 2OHOA (150 µM) for 72 h. After treatment, lipids were extracted and analyzed 
by TLC. The PC and PE fractions were converted to FAME in basic conditions and analyzed by gas 
chromatography. Values are expressed as mole% and represent mean ± SD, n = 4-5. The asterisk indicate a 
significant effect of 2OHOA compared to control (*P < 0.05; **P < 0.01; ***P < 0.001). 
9 Appendix 
 
Table A 3. Effect of 2OHOA on U118 total lipids fatty acid composition. 
 
FAME 
Control 2OHOA 
 Mean ± SD  Mean ± SD 
16:0    3.0 ± 0.2  30.4 ± 2.8*** 
18:0  16.6 ± 5.1  18.2 ± 5.0 
18:1n-9  34.7 ± 2.8  13.0 ± 5.5*** 
18:1n-7    9.7 ± 1.4    6.7 ± 1.4* 
18:2n-6    5.4 ± 1.4    4.2 ± 2.8 
20:4n-6  10.2 ± 1.2    9.0 ± 2.1 
20:5n-3    7.5 ± 2.6    8.1 ± 2.2 
22:5n-3    3.2 ± 0.5    3.3 ± 1.4 
22:6n-3    9.7 ± 4.6    7.0 ± 4.2 
MUFA  44.4 ± 3.4  19.7 ± 5.6*** 
PUFA  36.0 ± 7.4  31.6 ± 7.6 
n-3  20.4 ± 7.1  18.4 ± 6.7 
n-6  15.5 ± 2.6  13.3 ± 3.1 
n-3/n-6    1.5 ± 0.6    1.4 ± 0.6 
 
U118 cells were treated with 2OHOA (200 µM, 72 h). After treatment, lipids were extracted and an aliquot 
was converted to FAME in basic conditions and analyzed by gas chromatography. Values are expressed as 
mole% and represent mean ± SD, n = 4 -5. The asterisks indicate a significant effect of the treatment as 
compared with the control (*P < 0.05; **P < 0.001; ***P < 0.0001). 
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Figure A 4. Mass spectra from glycerolipids lipids containing oleic acid (A) and stearic acid (B). 
U118 cells were treated in the presence or absence of 2OHOA (200 µM, 24 h). After treatment lipids were 
extracted and analyzed by LC/MS. The spectra are normalized to the highest peak in both control and treated 
samples.  
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Figure A 5. 2OHOA affected neutral lipids in A549 and SF767 cells. 
Human lung adenocarcinoma (A549, A) cells and human glioma (SF767, B) were treated in the presence or 
absence of 2OHOA (200 µM, 72 h). After treatment, lipids were extracted and analyzed by TLC. FFA, free 
fatty acids; Cho, cholesterol. Values are OD/mg protein and are expressed as % of control and represent mean 
± SD, n= 4-5. The asterisks indicate a significant effect of the treatment as compared with the control (*P < 
0.05; **P < 0.01; ***P < 0.001). 
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